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The Endoplasmic Reticulum (ER), which serves as a site for protein biogenesis in budding 
yeast, contains a quality control system that ensures that only proteins that have attained a native 
conformation are deployed to other destinations in the cell. In order to gain insight into the 
mechanisms that encompass the quality control system, two studies were conducted. First, I 
tested whether the host of chaperones and secretion machinery that is induced by the Unfolded 
Protein Response during ER stress can have a positive impact on protein biogenesis. My results 
indicate that degradation of misfolded proteins, rather than refolding, seems to be one of the 
major mechanisms activated by the Unfolded Protein Response that the cell uses to reduce the 
burden on the ER. Packaging of certain proteins into ER-derived vesicles seems to increase in 
order to counter balance the load in the ER during stress. Finally, the Unfolded Protein Response 
seems to play a role in the processing of proteins after the stress is removed; however this rescue 
does not appear to be dependent on the ER membrane expansion component of the Unfolded 
Protein Response but rather in other players like chaperones, ER- associated degradation and 
forward traffic. Second, a genome-wide screen was conducted to identify novel players involved 
in ER protein retention and export. For this purpose, extracellular secretion of the ER resident 
protein, Kar2p, was monitored in strains of the yeast gene deletion collection. We identified 73 





Kar2p in some of these strains depended on an intact Unfolded Protein Response and moreover, 
deletion of some genes was synthetic lethal with deletion of HAC1, placing these genes as prime 
candidates to be involved in protein biogenesis. Further characterization of these strains revealed 
novel candidates involved in protein glycosylation, glycosylphosphatidylinositol-anchored 
protein maturation and quality control. These results represent a strong starting point to gain 
further insight in how the processes necessary for proper ER homeostasis are interrelated.
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I. CHAPTER 1: INTRODUCTION 
 
A third of the proteins synthesized in budding yeast  are delivered to the Endoplasmic 
Reticulum (ER) in transit towards their final destination in the cell (ELLGAARD and HELENIUS 
2003). Proteins manufactured by the ribosome are co-translationally inserted into the ER lumen 
as linear polypeptides where a machinery of ER resident proteins, consisting of chaperones, 
glycosylation enzymes, oxidoreductases and isomerases among others, assist in their proper 
folding and post-translational modification. Once these proteins achieve their native 
conformation, they are packaged into ER-derived COPII vesicles for delivery to the Golgi 
apparatus. The ER has a quality-control system (ERQC) that ensures that only proteins that have 
achieved their proper conformation are packaged into vesicles, excluding terminally unfolded 
proteins which are targeted for destruction by ER-associated degradation (ERAD). In the event 
that the ER folding capacity is exceeded by the accumulation of misfolded proteins due to 
environmental insults or expression of mutant proteins, a pathway called the Unfolded Protein 
Response (UPR) is activated (ANELLI and SITIA 2008). Activation of the UPR leads to up 
regulation of a variety of targets involved in protein folding, traffic and degradation as well as 
lipid biogenesis and distal secretion, believed to function in the ability to increase capacity of the 
ER (TRAVERS et al. 2000). 
 
Protein Folding in the ER 
Unlike other protein folding compartments like the cytosol, the ER provides a unique 
environment in which newly synthesized secretory proteins can sustain a set of covalent 
modifications, which include proteolytic removal of the signal sequences, disulfide bond 
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formation, N-linked glycosylation and addition of glycosylphosphatidylinositol (GPI) anchors. 
These modifications are important in the proper folding, quality control, sorting, degradation, 
and secretion of secretory proteins (ANELLI and SITIA 2008).  
General folding in the ER is mostly mediated by abundant public chaperones and folding 
sensors. A well-characterized folding pathway is based on BiP (Kar2p in budding yeast), an 
essential protein member of the HSP70 family of molecular chaperones that contains an N-
terminal ATPase domain and a C-terminal peptide binding domain (NORMINGTON et al. 1989). 
Kar2p is one of the most abundant ER resident proteins, vital for general protein folding, 
translocation of newly synthesized polypeptides through the Sec61 channel, and for the transport 
back across the membrane of aberrant polypeptides destined for degradation.  The role of Kar2p 
as a public chaperone in the ER lumen depends on its ability to bind a wide variety of emerging 
polypeptides. It tends to bind hydrophobic patches, thereby inhibiting aggregation, and 
maintaining the protein in an adequate state for folding and oligomerization (GETHING 1999). It 
is suggested that the affinity of this chaperone for nascent protein substrates is coupled to ATP 
hydrolysis. In the ATP bound state, Kar2p is in its open low affinity conformation. Upon ATP 
hydrolysis to ADP, Kar2p closes to its tighter affinity substrate binding conformation. Therefore, 
substrates can undergo cycles of Kar2p binding and release, depending on ATP hydrolysis 
(MAATTANEN et al. 2010).  The ATPase function of Kar2p is stimulated by ER resident J-domain 
containing HSP40 co-chaperones. Kar2p interacts with the J-domain of Sec63p, part of the 
translocation machinery, in the import of newly synthesized proteins where Kar2p acts as a 
molecular ratchet (Figure I.1; MATLACK et al. 1999). In its role in the reverse reaction of retro-
translocation of misfolded proteins, it has been suggested that Kar2p binding to terminally 
unfolded proteins destined for ERAD maintains them in a soluble retro-translocation competent 
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state (NISHIKAWA et al. 2001). Kar2p has also been implied to have a function in the specific 
recognition of ERAD substrates by forming a luminal complex with Yos9p and Hrd3p. This 
surveillance complex recruits unfolded glycoproteins to the core ERAD machinery and assists in 
identifying the glycosylation state of the substrate necessary to commit it for degradation (DENIC 
et al. 2006).  
Another important process necessary for proper folding of a number of proteins is the 
formation of disulfide bonds. Disulfide bond formation is crucial in the folding and quality 
control of secretory proteins since their presence increases the stability of the native 
conformations and their absence or mispairing can produce severely misfolded proteins. Protein-
disulfide isomerase (PDI), which is one of the most abundant resident proteins in the ER, 
catalyzes the formation, reduction, and isomerization of disulfide bonds. PDI contains four 
thioredoxin-like domains and an ER retention signal at its carboxyl terminus (MAATTANEN et al. 
2010).  Mammalian PDI has also shown chaperone activity and its unfolded protein binding site 
has been mapped by NMR (DENISOV et al. 2009).  In S. cerevisiae, the formation of disulfide 
bonds in the ER is driven by the thiol oxidase Ero1p and Pdi1p. FAD-bound Ero1p oxidizes 
Pdi1p, which then subsequently oxidizes folding proteins directly (TU and WEISSMAN 2004). 
Pdi1p is the principal PDI but is aided by four additional nonessential homologs, some of them 
with chaperone activity: Mpd1p, Mpd2p, Eug1p, and Eps1p (KIMURA et al. 2005).  As with BiP 
(Kar2p), PDI has also been implicated in ERAD. In agreement with this idea, certain proteins 
like cholera toxin are reduced and unfolded by PDI to prepare them for dislocation (TSAI et al. 
2001).  PDI has also been identified as an essential player in the signal peptide peptidase-
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Figure I.1 ER import, folding and quality control of a secretory protein  
1. Nascent ER lumenal proteins enter the ER via the Sec61 translocon. Glycoproteins are co-
translationally glycosylated by the oligosaccharyl transferase (OST) complex. Together with its co-
chaperone Sec63, Kar2p drives import of post-translationally imported proteins and in general promotes 
the folding of the imported proteins. Protein disulfide isomerase (Pdi1) facilitates the formation of 
intramolecular disulfide bonds. 2. Yeast Cne1, an orthologue of mammalian calnexin, may cooperate with 
Kar2p in the folding process. In mammalian cells (denoted by asterisk) calnexin and UDP-
glucose/glycoprotein glucosyltransferase (UGGT) support a folding. Glycoproteins undergo rounds of 
deglucosylation and reglucosylation until they achieve their native conformations and are release from the 
cycle. 3. Properly folded proteins exit the ER and travel to the Golgi in route to their final destination. 
4.Terminally misfolded proteins become substrates of the ERAD machinery.(STOLZ and WOLF 2009).  
 
In yeast, a great number of proteins are estimated to be glycosylated. It is thought that the 
presence of glycans increases stability, solubility, and resistance to proteases and also serves as a 
signal that the cell modifies to reflect the folding status of the protein (HELENIUS and AEBI 
2004). Oligosaccharide chains are assembled on the carrier molecule dolichol pyrophosphate in 
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the following order: 2 molecules of N-acetylglucosamine (GlcNAc), 9 molecules of mannose, 
and 3 molecules of glucose. These 14-residue oligosaccharide cores are then transferred to 
asparagine residues on the nascent peptide chain. In the mammalian system, after addition of the 
core oligosaccharide, the two outermost glucoses are removed and then, the glycoprotein 
associates with the lectins calnexin/calreticulin (Cnx) to promote oxidative folding via 
interactions with the chaperone ERp57. Subsequently, the inner glucose is removed and the 
protein is release from Cnx. If the glycoprotein achieved its native conformation, it is targeted 
for exit. If the polypeptide is still not completely folded, UDP glucose glycoprotein 
glucosyltransferase (UGGT1) re-glucosylates carbohydrates close to the unfolded regions 
promoting re-association with Cnx (ANELLI and SITIA 2008; RUDDOCK and MOLINARI 2006). 
Terminally unfolded proteins are removed from the calnexin cycle by trimming of the outer 
mannoses of the oligosaccharide branch preventing re-glucosylation (Figure I.1). Yeast also has 
a glycoprotein quality control system; nonetheless, it differs in key steps from the mammalian 
counterpart.  Budding yeast has a version of calnexin called Cne1p (PARLATI et al. 1995) but 
does not have a predicted ortholog for  the mammalian UGGT1 (Figure I.1; MOLINARI 2007) 
therefore, is unclear if yeast glycoproteins undergo cycles of de-glucosylation and re-
glucosylation. 
 
Exit of Secretory Proteins via COPII Vesicles 
Once proteins achieve their native conformation and have passed folding quality control 
checkpoints, they may be targeted for transport in ER-derived vesicles. Formation of a COPII 
vesicle is initiated through activation of the small cytosolic G protein, Sar1p, which is mediated 
by the guanine nucleotide exchange factor (GEF), Sec12p that localizes to the ER membrane. 
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GTP binding to Sar1p results in the exposure of an N-terminal amphipathic α-helix that anchors 
Sar1p to the membrane and is believed to start membrane curvature (LEE et al. 2005). At the ER, 
Sar1p-GTP sequentially recruits two cytosolic complexes, the Sec23/Sec24p heterodimer and the 
Sec13/Sec31p heterotetramer. Sec23p is the GTPase-activating protein (GAP) for Sar1p and 
Sec24p is responsible for cargo recognition. Sec13/31p forms a cage-like structure that helps in 
the formation of the nascent vesicle (Figure I.2; LEE and MILLER 2007).    
Transport of secretory proteins can happen  either non-selectively  at their prevailing ER 
concentrations in a process called bulk flow (WIELAND et al. 1987) or at concentrations 
significantly higher than that in the general ER. Evidence that supports the idea of bulk-flow was 
reported by a quantitative immunoelectron microscopy study where two abundant secretory 
proteins in exocrine pancreatic cells, amylase and chymotrypsinogen, were found to exhibit 
identical concentrations in the ER lumen and COPII-coated buds and vesicles (MARTINEZ-
MENARGUEZ et al. 1999). However there is increasing evidence that secretory proteins can be 
actively selected to be packaged into COPII vesicle at concentrations 3 to 50 fold higher than the 
bulk flow markers (SATO and NAKANO 2007). This enrichment can be achieved in a variety of 
ways. It has been documented that for certain membrane cargo proteins, selection occurs via 
interaction of sorting signals on the cytoplasmic segments of membrane cargo with components 
of the cytoplasmic coat of the vesicle (Figure I.2). COPII coat component Sec24p recognizes 
motifs on cargo clients through  its different binding sites termed A, B and C-sites: the B-site 
recognizes the di-acidic sorting signal of the Golgi protein Sys1p and the LXXLE motif of the 
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Figure I.2. Model for COPII vesicle 
formation 
Sar1p is activated to Sar1p-GTP by the 
ER-localized nucleotide exchange 
factor Sec12p. Membrane-bound 
Sar1p-GTP recruits cytosolic 
Sec23/Sec24p. The Sec24p subunit 
binds to specific sorting signals 
displayed by transmembrane cargo or 
by soluble cargo receptors. Pre-
budding cargo complexes recruit the 
outer layer Sec13-Sec31 complex, 
leading to coat polymerization and 




Soluble and GPI-anchored proteins likely do not present cytosolic sorting signals because of 
obvious topological limitations and as such, would likely require an affiliated protein bearing the 
sorting signal.  Some soluble and GPI-anchored proteins are known to be recruited to vesicles via 
recognition by transport receptors that link the cargo protein with the COPII coat (Figure I.2). In 
yeast, the membrane protein Erv29p has been identified as the cargo receptor necessary for the 
export of certain soluble cargo proteins including glycopro-α-factor, a precursor from the α-
factor mating pheromone. Specifically, glycopro-α-factor contains a hydrophobic signal within 
the pro-region that is necessary for Erv29p-mediated cargo recruitment (OTTE and BARLOWE 
2004). Erv29p has been also implicated in the transport of CPY but not of another soluble 
secreted protein, invertase (CALDWELL et al. 2001). Similar to soluble cargoes, GPI-anchored 
proteins require receptor-mediated transport because they do not project signals into the 
cytoplasm. The yeast p24 family protein, Emp24p, has been suggested to be the putative cargo 
receptor for the GPI- anchored protein Gas1p since Emp24p can be directly cross-linked to 
Gas1p in ER-derived vesicles and deletion of EMP24 and interacting p24 partners causes a delay 
in Gas1p processing (MUNIZ et al. 2000). It has been recently reported that after full assembly of 
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the COPII coat, different classes of ER-derived vesicles are generated, defined by the type of 
cargo they carry. A population of vesicles concentrates GPI-anchored proteins like Cwp2, 
dependent on the presence of Emp24p and components of the machinery responsible for 
remodeling of the GPI anchor, Bst1p and Per1p. Another population of vesicles excludes GPI-
anchored proteins and is enriched in membrane proteins like the hexose transporter Hxt1p 
(CASTILLON et al. 2009).  
Other cargo proteins require accessory proteins in order to be targeted for exit, however, 
these accessory proteins are excluded from the ER-derived vesicles. For example, a yeast ER-
localized trans-membrane chaperone, Shr3p, was identified to interact with the COPII coat to 
assist in  the packaging of  amino acid permeases without being recruited into a vesicle itself 
(GILSTRING et al. 1999). Shr3p facilitates the functional assembly of the trans-membrane 
domains (TMDS) of Gap1p, perhaps by shielding charged amino acid residues thereby 
preventing incompletely folded amino acid permeases from being targeted for degradation. In the 
absence of Shr3p, Gap1p forms aggregates that are targeted for ERAD even though its 12 
membrane-spanning segments are correctly inserted in the ER membrane. However, when 
degradation is blocked, cells exhibit restored amino acid uptake capacities (KOTA et al. 2007).  
Other proteins that are thought to act in a similar manner to Shr3p are Chs7p and Pho86p. Chs7p 
and Pho86p facilitate the functional expression of the catalytic subunit of chitin synthase III 
Chs3p with 6 TMDS and the phosphate transporter Pho84p with 12 TMDS respectively (KOTA 
and LJUNGDAHL 2005).  
Instead of using accessory proteins, there are cargo proteins that need to be assembled into 
specific oligomeric conformations in order to be packaged into ER vesicles. Perhaps these cargo 
proteins alone do not contain the necessary exit signals and need an interacting partner that does.  
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It is also possible that the oligomeric state enhances the presentation or the affinity of an exit 
sorting signal or, on the contrary, masks a retention signal. For example, inhibiting dimerization 
of the mammalian β2-Adrenergic receptor by disruption of the putative dimerization motif leads 
to ER retention (SALAHPOUR et al. 2004). Similarly, one of the members of the Kir3 subfamily of 
mammalian inwardly rectifying potassium channels, Kir3.1, lacks ER export signals and 
therefore, depends on the sorting motif found on its partners for efficient transport from the ER 
(LEE et al. 2004).   
The need for specific cytosolic exit signals, cargo receptors, accessory proteins or oligomeric 
states for proper packaging of proteins in ER-derived vesicles provides another more specific 
layer to the quality control system. This ER quality control helps to ensure that only competent 
cargo substrates are delivered to the appropriate compartment. The full extent of the specific 
components and conditions necessary for the exit of cargo proteins is still far from being 
completely known and understood.  
 
ER Retention and Retrieval Mechanisms 
Maintenance of the proper pools of ER resident proteins is crucial for the quality control of 
newly sensitized proteins that enter the secretory pathway. The cell has developed several 
mechanisms in order to ensure that proper amounts of these proteins are present in the ER. As 
mentioned before, active inclusion of cargo proteins into ER-derived vesicle requires specific 
signals that are recognized by cargo receptors and by the COPII coat components. ER resident 
proteins lack such signals preventing their active recruitment into nascent buds. However, some 
resident proteins do escape the ER by random sampling of the ER content during vesicle 
formation (WIELAND et al. 1987).  
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In order to avoid depletion, these escaped resident proteins are retrieved back to the ER by 
retrograde transport via receptor recognition of the HDEL (KDEL in mammalian system) 
retrieval motif (DEAN and PELHAM 1990). This retrieval system is saturable: over-expression of 
HDEL-tagged prepro-α-factor results in the secretion of the HDEL-containing protein Kar2p 
(DEAN and PELHAM 1990). A classic genetic screen for strains that failed to retain an invertase 
fusion protein bearing the HDEL signal resulted in the identification of ERD1 and ERD2 as the 
genes responsible for retention of HDEL-containing proteins but only the ERD2 gene was 
essential for viability (HARDWICK et al. 1990; SEMENZA et al. 1990). Erd2p was demonstrated to 
be the HDEL receptor in yeast by protein expression, and in vitro binding studies (LEWIS et al. 
1990; SEMENZA et al. 1990; SEMENZA and PELHAM 1992; WILSON et al. 1993). Erd2p binds the 
HDEL motif in vitro in a pH dependent manner, suggesting that the sorting of lumenal ER 
proteins is facilitated by the pH differences between the Golgi and the ER (WILSON et al. 1993).   
In addition to ER resident proteins, other machinery including cargo receptors are recycled 
by retrieval back to the ER in COPI vesicles. Membrane proteins en route from the Golgi to the 
ER contain a canonical KKXX motif at their C-terminus that is recognized directly by 
components of the COPI coat (COSSON and LETOURNEUR 1994; LETOURNEUR et al. 1994). 
Another type of retrieval signal is presented by members of the p24 membrane protein family of 
cargo receptors. The short cytoplasmic tails of these proteins have a consensus 
FFXX(KR)(KR)Xn (where n >2) site that is recognized by COPI, however binding relies more 
on the diphenylalanine aromatic motif than on the two basic residues (FIEDLER et al. 1996). 
Some proteins utilize retention signals to avoid premature deployment from the ER. Arginine 
(Arg)-based motifs represent a class of these ER retention signals. These signals are often found 
on subunits of oligomeric complexes like cell-surface receptors, ion channels and MHC 
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molecules. It is suggested that these signals mediate retention of unassembled subunits in the ER. 
Upon correct assembly of the oligomers, the signal is inactivated allowing forward transport. 
Several mechanisms for signal inactivation have been suggested: masking of the signal by 
interactions of the subunits after assembly, binding of PDZ-domain proteins, and protein 
phosphorylation among others. On the other hand, Arg-based signals have been identified to 
interact with COPI components suggesting that ER localization can be due to COPI-mediated 
retrieval (BECK et al. 2009; MICHELSEN et al. 2005). 
In addition to Arg-based motifs, the ER has other retention signals, including exposed 
cysteine residues. The thiol-dependent retention mechanism was originally described for the 
biosynthesis of IgM in the mammalian system.   The secretory tailpiece of μ heavy chains of IgM 
contains a cysteine residue, Cys575, which is used for polymerization of μL and μ2L2 complexes 
into pentamers and hexamers. Mutation or oxidation by treatment with 2-mercaptoethanol leads 
to the secretion of IgM assembly intermediates that are normally retained in the ER (REDDY and 
CORLEY 1998). The effect of 2-mercaptoethanol is likely to be specific since it did not affect the 
secretion of proteins that are retained by other mechanisms (REDDY and CORLEY 1998).   
Another example of a cysteine-mediated ER retention signal comes from studies done on 
Adiponectin (AN), an adipokine that has insulin-sensitizing, anti-inflammatory, anti-atherogenic 
and cardioprotective properties. AN is synthesized as a single subunit that undergoes 
oligomerization prior to secretion from adipocytes. Crosslinking experiments suggest that the 
AN subunits form disulfide bonds with the ER protein ERp44 specifically through residue Cys39 
leading to ER retention. This residue is crucial for the stable production of AN oligomers. AN is 
released from ERp44 by the action of Ero1-Lα, which exchanges the disulfide bond between 
ERp44 and AN for a new disulfide bond between itself (Ero1-lα) and ERp44 (SIMPSON and 
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WHITEHEAD 2010; WOLF 2008). A common feature of cysteine residues that are monitored by 
the thiol-retention system in the ER is that these residues are involved in intermolecular disulfide 
bonds instead of intramolecular bonds, and therefore, are likely to be exposed rather than buried 
in the protein. 
 
ER Associated Degradation 
Proteins that fail to fold properly or assemble correctly do not proceed in the secretory 
pathway; rather they are retained in the ER and translocated to the cytosol for degradation by the 
ubiquitin/proteasome pathway in a process called ER-associated degradation or ERAD. In order 
for this to occur, it is crucial for the ER quality control system to correctly differentiate between 
folded, actively folding, and terminally unfolded proteins. Misfolding lesions can occur in 
cytosolic, luminal, and membrane domains, therefore specialized quality control components are 
required for their initial recognition, although some mechanisms are shared to carry out later 
steps of the degradation (CARVALHO et al. 2006). Thus, ERAD is composed of multiple 
pathways depending on the localization of the misfolded domain: ERAD-L for ER lumenal, 
ERAD-M for transmembrane and ERAD-C for misfolded cytosolic domains.  
ERAD substrates are ubiquitinated by two distinct E2–E3 complexes associated with the ER 
membrane: the Doa10 and the Hrd1/Hrd3 complex (Figure I.3).  ERAD-C uses the Doa10 
complex. This complex consists of the E3 ubiquitin ligase Doa10p and the E2 ubiquitin 
conjugating enzyme Ubc7p. Ubc7 is attached to this complex through Cue1p. On the cytosolic 
side of the ER, the Cdc48 subcomplex (Cdc48p/Ufd1p/Npl4p) is linked to the Doa10 complex 
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Figure I.3. The Hrd1/Hrd3 and Doa10 
E3 complexes 
A. Schematic representation of the 
Hrd1/Hrd3 complex which is utilized by 
ERAD-L/M.  B. Schematic 
representation of the Doa10 complex 
which is used by ERAD-C. Individual 
components are labeled and the 
organization of the components is 
arranged according to Carvalho et al 
2006 (XIE and NG 2010) .  
 
The channel for substrate extractions remains unknown and it is possible that the Cdc48 complex 
provides the extraction mechanisms directly. The Hrd1p complex is considerably larger and is 
used by both ERAD-L and ERAD-M. The E3 enzymes Hrd1p and Doa10p have very little 
similarity, however, both complexes have members in common (Figure I.3). The transmembrane 
cofactor Hrd3p recognizes ERAD substrates via its lumenal domain. Usa1p connects the putative 
channel component Der1p to the Hrd1 complex (reviewed in HOSEKI et al. 2010; XIE and NG 
2010).  
ERAD-L demands a specialized conduit to translocate substrates from the ER lumen to the 
cytosol. Currently, there are at least two candidates for the Hrd1/Hrd3 pathway: Der1p and the 
Sec61 translocon. Der1p and its mammalian homolog Derlin-1 are multi-spanning membrane 
proteins that are required for the degradation of certain ERAD substrates. Derlin-1 was identified 
to be involved in pro-α factor retro-translocation through an in vitro real-time fluorescence 
detection system (WAHLMAN et al. 2007). Genetic data combined with physical interactions 
between Sec61, components of the Hrd1/Hrd3 complex and the ERAD substrate CPY* just 
preceding degradation suggest a role for Sec61p in the retro-translocation of ERAD substrates 
(SCHAFER and WOLF 2009). Even though data supports functions of these proteins in retro-
translocation, the exact mechanism of how this occurs remains unclear.  
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ERAD substrate recognition is carried out primarily by molecular chaperones that reside 
within the ER lumen and on the cytosolic face of the ER membrane. These chaperones include 
the ER lumenal Hsp70 Kar2p and its Hsp40 co-chaperones Scj1p and Jem1p and the cytosolic 
Hsp70 Ssa1p and its co-chaperones Hlj1p and Ydj1p. Hsp70s promote protein folding by 
maintaining substrate solubility. They are helped by the Hsp40 co-chaperones which stimulate 
Hsp70's ATPase activity required for high-affinity substrate interaction (XIE and NG 2010). 
These ATP-dependent chaperones have also been intimately linked to ERAD substrate selection 
in both yeast and mammals. It is suggested that these chaperones facilitate ERAD by preventing 
aggregation of misfolded substrates in the ER lumen, thereby maintaining them in a retro-
translocation-competent state (NISHIKAWA et al. 2001). However, additional signals appear to 
play a role in substrate recognition. 
One of best understood mechanisms of ERAD substrate recognition is the glycan-dependent 
pathway of ERAD-L (Figure I.4 A). Early indications of a quality control system for 
glycoproteins in yeast came from studies on the well known ERAD substrate CPY*, where 
glycosylation is crucial for its degradation as well as for its folding; an unglycosylated version of 
CPY* is stably retained in the ER (KNOP et al. 1996). It was subsequently shown that only one 
of the carbohydrates was necessary and sufficient for proper degradation of CPY*(KOSTOVA and 
WOLF 2005).  
Similar to the mammalian system, it seems that modifications on the carbohydrate branches 
can serve as signals for degradation in yeast. After attachment to the newly synthesized 
polypeptide, glucoses on the A-branch of the core Glc3Man9GlcNAc2 glycan are trimmed 
sequentially by Gls1p (also known as Der7p or Cwh41p correspond to glucosidase I) and Gls2p 
(also known as Rot2p corresponds to glucosidase II) to yield Man9GlcNAc2. Next, ER 
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mannosidase Mns1p cleaves the α1,2-linked mannose on the B-branch to generate the 
Man8GlcNAc2 glycan, a common structure among folded proteins leaving the ER.  Finally, 
Htm1p(Mnl1p)/PDI cleaves the terminal mannose residue from the C-branch to yield the 
terminal α1,6-mannose residue that is recognized by the mannose-6-phosphate receptor 
homologue (MRH) domain on the ER lectin, Yos9p (XIE and NG 2010).  
Yos9p is known to selectively bind misfolded CPY* but not WT CPY. Interestingly, 
immunoprecipitation experiments revealed that Yos9p was also able to bind CPY* even when its 
sugar binding site was mutated or CPY* was unglycosylated, suggesting that Yos9p recognizes 
both the specific sugar chain and the polypeptide portion of misfolded proteins (BHAMIDIPATI et 
al. 2005). Yos9p in combination with Hrd3p and Kar2p targets the misfolded CPY* to the Hrd1p 
complex on the ER membrane (DENIC et al. 2006). However, it remains unclear how the 
exposure of a novel terminal α1,6-linked mannose couples with the folding state of  protein  to 
serve as a potential ERAD signal.  
Another interesting question is how Pdi1p, which interacts with Htm1p (Mnl1p), affects 
ERAD.  In the mammalian system, EDEM, the homolog of Htm1p/Mnl1p, interacts with BiP 
and the ER resident disulfide reductase ERdj5 to cleave disulfide bonds of misfolded proteins 
(USHIODA et al. 2008). Yeast Pdi1p might participate in ERAD of glycoproteins as a reductase in 
a similar manner to ERdj5 (HOSEKI et al. 2009).  
ERAD-M substrates use the Hrd1 complex for ubiquitination (Figure I.4 B). They require 
Cdc48p, Hrd1p and Der1p, but not Hrd3p. It has been demonstrated that Hrd1p recognizes 
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Figure I.4. ERAD pathways in budding yeast  
A. ERAD-L for glycoproteins. The substrate glycan determinant (depicted in red) is recognized by Yos9p 
and Hrd3p of the Hrd1 complex. The substrate is trasnslocated through a pore that is likely composed of 
Sec61 proteins. The driving force for translocation is via the Cdc48-Ufd1-Npl4 AAA-ATPase complex 
(blue membrane-associated complex) and ubiquitination is mediated by Ubc7p and Hrd1p. Substrate 
targeting to the proteasome is mediated by Rad23p and Dsk2p. B. ERAD-M. Polar/charged residues of 
substrate transmembrane segments are recognized by the polar face of the Hrd1p transmembrane domain. 
Ubiquitination and extraction as in panel A.  C. ERAD-C. Misfolded cytosolic domains of membrane 
substrates are recognized by cytosolic chaperones and the RING cytosolic domain of Doa10p. As in A 
d B, the E2 enzyme is Ubc7p and extraction is mediated by the Cdc48p complex (XIE and NG 2010).  
 
though is known that Hrd1p functions in both ERAD-L and -M,  mutational analysis of HRD1 
was able to generated alleles that were defective in degradation of ERAD-M substrates like 
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degradation of ERAD-M substrates did not prevent substrate binding but disrupted ubiquitination 
of the misfolded membrane domain. This suggests a two-step recognition mechanism whereby 
Hrd1p initially engages a substrate and then “scans” it to detect unburied polar residues to decide 
whether or not it should be ubiquitinated. In the proposed mechanism, membrane proteins 
displaying normally the buried polar/charged transmembrane residues to the lipid bilayer are 
con
-C utilizes the Cdc48 complex for substrate extraction 
(Fig
echanisms for substrate recognition remain poorly 
understood for many of the ERAD modes.   
sidered aberrant and recognized by Hrd1p (SATO et al. 2009).  
ERAD-C utilizes the Doa10 complex for substrate degradation. However, degradation of 
misfolded ER membrane proteins requires a different set of chaperones due to the exposure of 
protein domains to the cytosol. Degradation of ERAD–C substrates Ste6*, Pma1D378S as well 
as heterologously expressed human CFTR and apoB relies on the Hsp70 family member Ssa1p. 
As with ERAD-L and ERAD-M, ERAD
ure I.4 C; STOLZ and WOLF 2010).  
Recent advances in our understanding of ERAD pathways have provided the most insight to 
the poorly understood process of quality control.  However, there are many exiting unknowns 
regarding the degradation of misfolded proteins that still need to be elucidated. Among those is 
the identity of the conduit or conduits responsible for the retro-translocation of ERAD substrates 
to the cytosol. Furthermore, the molecular m
 
Unfolded Protein Response  
 The process of protein folding in the ER can fail, resulting in the production of misfolded 
proteins. To cope with this problem, the cell has developed two distinctive but inter-connected 
pathways:  ERAD, described above, and the Unfolded Protein Response (UPR). ERAD 
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eliminates misfolded proteins via the ubiquitin/proteasome pathway to clear the ER of aggregate-
prone polypeptides. This protective mechanism is supplemented by the UPR, which acts to 
modulate ER capacity when misfolded proteins accumulate due to environmental insults or 
xpression of mutant proteins.  
 
Ire1




The UPR pathway was first described in S. cerevisiae by Sambrook and co-workers. 
The lumenal Hsp70, Kar2p, was known to be upregulated when secretory proteins were 
over-expressed. A 22bp cis-acting element in the KAR2 promoter was determined to be 
responsible for this specific response and was called the unfolded protein response 
element (UPRE; MORI et al. 1992). This cis-acting element was later refined to a semi-
palindromic 7 nucleotide consensus sequence CAGNGTG (MORI et al. 1998).  
Subsequently, a genetic screen of mutants defective in UPR activation identified the IRE1 
gene, which was found to encode a sensor of misfolded proteins in the ER (COX et al. 
1993; MORI et al. 1993). Ire1p is a type-I transmembrane ER protein that consists of a N-
terminal ER luminal oligomerization domain that senses ER stress signals (CREDLE et al. 
2005), and a cytosolic C-terminal domain that contains serine/threonine kinase activity 
(COX et al. 1993; MORI et al. 1993; NIKAWA and
oribonuclease function (SIDRAUSKI and WALTER 1997).   
The molecular mechanism of UPR activation by Ire1p has been a topic of 
controversy. In the past it was proposed that Kar2p binding to the lumenal domain of 
Ire1p kept the protein in an inactive, unphosphorylated state. Upon exposure of cells to 
ER stress, Kar2p would be released from Ire1p, resulting in activation of Ire1p and signal 
 
 
  19 
transduction to the nucleus. UPR activation measurements using a β-galactosidase 
reporter assay indicated that over-expression of Kar2p attenuates UPR activation in 
Tunicamycin (TM)-treated cells compared to cells that did not over-express Kar2p prior 
to activation. Immunoprecipitation studies also indicated that Ire1p binds Kar2p in non-
stress conditions but not after TM or DTT treatment (OKAMURA et al. 2000). However, it 
was later discovered that mutations that abolished binding of Kar2p did not render Ire1p 
constitutively active, suggesting that Kar2p is not the principal determinant of Ire1p 
acti
olution, suggesting direct binding of Ire1p to unfolded proteins 
(KI
n 
of Ire1p upon ER stress. In the first step, Kar2p dissociation from Ire1p leads to cluster 
vity (KIMATA et al. 2004).  
More specific clues about Ire1p activation came from the crystal structure of the yeast 
Ire1p ER lumenal domain (CREDLE et al. 2005). The structure suggested that Ire1p senses 
misfolded proteins by direct binding of unfolded polypeptides.  Dimerization of Ire1p ER 
lumenal core domains forms a groove that resembles that of the peptide binding domains 
of major histocompatibility complexes (MHCs). In vitro protein aggregation experiments 
indicated that the presence of the Ire1p core lumenal domain prevents the aggregation of 
denatured proteins in s
MATA et al. 2007).  
Mutational analysis suggests that additional interactions between the Ire1p lumenal 
domain dimers are required to form higher-order oligomers needed for UPR activation 
(CREDLE et al. 2005). Fluorescent microscopy studies in cells bearing tagged versions of 
Ire1p showed that Ire1p forms clusters upon activation of the UPR by addition of DTT 
providing further supporting evidence of high-order oligomerization of Ire1p (ARAGON et 
al. 2009; KIMATA et al. 2007).  Later studies proposed a two step model for the activatio
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Figure I.5. Current model of 
IRE1 activation in yeast and 
mammals  
A. In non-stress conditions 
BiP(Kar2p) is bound to Ire1p. 
Upon accumulation of misfolded 
proteins, Ire1p oligomerizes and 
binds misfolded proteins for full 
activation. Ire1p clusters recruit 
untranslated HAC1u mRNA, 
whose translation is arrested by 
pairing of its 5'-UTR with the 
sequence of the intron through a 
bipartite targeting sequence (red) 
located in the 3'-UTR. Finally, this 
association of HAC1u mRNA with 
the Ire1p cluster initiates an 
unconventional splicing process 
that forms spliced HAC1s mRNA. 
B. In non-stress conditions, BiP is 
bound to IRE1. Upon 
accumulation of misfolded 
proteins, BiP unbinds IRE1, and it 
dimerizes and trans-
autophosphorylates. Unspliced 
XBP1u mRNA is constitutively 
recruited to ER membrane by 
tethering of the hydrophobic 
region (HR) of the partially 
translated XBP1u protein to the 
ER membrane, leading to 
facilitated splicing of XBP1u 
mRN  by IRE1A  (KOHNO 2010).  
 
 
formation of the Ire1p ER lumenal domains. In the second step, direct interaction of 
unfolded proteins with the core lumenal domains orients the cytosolic domains of 
clustered Ire1p molecules for full activation (Figure 1.5 A; KIMATA et al. 2007). 
As mentioned before, the C-terminal cytosolic domain of Ire1p has both kinase 
activity and endoribonuclease function. It has been proposed that upon sensing misfolded 
proteins, Ire1p trans-autophosphorylates, leading to activation of its endoribonuclease 
function. However, some studies indicate that the phosphorylation event per-se does not 
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determine the endoribonuclease function, but rather the conformational change caused by 
the occupation of the kinase active site is the major contributor to the endoribonuclease 
function (KORENNYKH et al. 2009; PAPA et al. 2003). The most recent crystal structures 
of the cytosolic domain also suggest that oligomerization of this part of the protein 
positions the kinase domain for trans-autophosphorylation, orders the RNAse domain, 
and creates an interaction surface for binding of the mRNA substrate of Ire1p 
(KORENNYKH et al. 2009). It is proposed that the trans-autophosphorylation event 
contributes to the endoribonuclease activity by stabilizing the oligomeric conformation.  
The only known substrate of the Ire1p endoribonuclease is an mRNA encoding the 
basic leucine zipper transcription factor Hac1p (COX and WALTER 1996; MORI et al. 
1996; NIKAWA et al. 1996; NIWA et al. 2005). In the absence of ER stress, ribosomes 
become stalled on unspliced HAC1 mRNA, causing very little protein to be synthesized 
(RUEGSEGGER et al. 2001). Upon accumulation of misfolded proteins, unspliced HAC1 
mRNA is targeted to Ire1p clusters by means of a conserved bipartite targeting element 
contained in the 3' untranslated region (ARAGON et al. 2009). Active Ire1p cleaves a 252-
base intron in the HAC1 mRNA responsible for the translational repression by base-
pairing with the 5’ untranslated region of the mRNA (RUEGSEGGER et al. 2001). After the 
intron is removed, the 5’ and 3’ exons are rejoined by the tRNA ligase, Rlg1p, thereby, 
removing the translational restraint on the HAC1 mRNA (SIDRAUSKI et al. 1996). After 
the HAC1mRNA is translated into a protein product, the transcription factor is 
translocated to nucleus where it binds the UPRE in the promoter region of the UPR 
inducible genes (Figure I.5 A). 
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The process of UPR deactivation is not well understood. Dephosphorylation of Ire1p 
has been proposed as a possible mechanism that might contribute to the inactivation of 
signal. Ptc2p, a type 2C serine/threonine phosphatase, and phosphoesterase Dcr2p have 
been shown to interact directly with Ire1p and to dephosphorylate Ire1p in vitro. Over-
expression of wild-type versions of both proteins but not catalytically inactive types 
reduces the levels of spliced HAC1 mRNA and attenuates UPR activation, demonstrating 
that the phosphatase activity of Ptc2p and Dcr2p are required for regulation of the UPR 
(GUO and POLYMENIS 2006; WELIHINDA et al. 1998).  Since it has been suggested that 
the trans-autophosphorylation of Ire1p is not crucial for its endoribonuclease activity per 
se but rather contributes to the stabilization of the Ire1p oligomer, it is plausible that 
dephosphorylation might help destabilize the oligomer once the episode of stress has 
ceased.  
Recently, it has been reported that Kar2p might also have a role in deactivation of the 
UPR. Microscopy-based fluorescence resonance energy transfer (FRET) assay was use to 
monitor the disassociation of oligomers formed by Ire1p or Ire1bipless (lacks a 51 amino 
acid segment that contains the Kar2p binding site) after removal of DTT. Results 
indicated that, after removal of DTT, Ire1p oligomers disassociate more rapidly than 
Ire1bipless oligomers suggesting that Kar2p binding to Ire1p contributes to the efficient de-
oligomerization of active Ire1p complexes (PINCUS et al. 2010).  
The Ire1/Hac1 UPR signaling pathway is conserved from yeast, plants, worms and 
flies to humans. However, unlike the relative simple UPR in yeast, the mammalian UPR 
has 3 transmembrane ER stress sensors:  inositol requiring enzyme 1 (IRE1), PKR-like 
ER kinase (PERK) and activating transcription factor 6 (ATF6; Figure I.6).  The IRE1  
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Figure I.6. UPR mechanism in mammals  
There are at least 3 main stress sensors at the ER membrane: IRE1α, PERK, and ATF6. Upon ER stress, 
IRE1α autophosphorylates, leading to the activation of its endoribonuclease domain. This activity 
mediates the processing of the mRNA encoding XBP1, which is a transcriptional factor that upregulates 
many essential UPR genes involved in folding and protein quality control and regulates ER/Golgi 
biogenesis. Active PERK phosphorylates and inhibits translation initiator factor eIF2α, decreasing the 
synthesis of proteins and the overload of misfolded proteins at the ER. In addition, this event leads to the 
specific translation of ATF4, a transcription factor that induces the expression of genes that function in 
amino acid metabolism, the antioxidant response, and apoptosis regulators including CHOP. The third 
UPR pathway is initiated by ATF6, a type II ER transmembrane protein encoding a bZIP transcriptional 
factor in its cytosolic domain and localized in the ER in unstressed cells. Upon ER stress induction, ATF6 
is processed, increasing the expression of some ER chaperones, and ERAD-related genes (MORI 2009) .  
 
branch is the most conserved among species. Similar to Ire1p in yeast, mammalian IRE1 
has an ER lumenal domain that senses ER stress and a cytosolic domain with kinase and 
endoribonuclease activity (KOHNO 2009). However, the mechanism of sensing misfolded 
proteins by mammalian IRE1 is suggested to be different in comparison to the yeast 
system.  The crystal structure of the lumenal domain of human IRE1α  does not support 
direct binding of misfolded proteins; the structure shows that the groove formed by the 
hIRE1α dimers is too narrow for peptide binding and is predicted to be obscured by 
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facing the ER membrane (ZHOU et al. 2006). Disassociation of BiP from hIRE1 seems to 
play a more important role in hIRE1 activation upon ER stress in the mammalian system. 
Mutations that abolish or reduce the affinity of IRE1 for BiP cause constitutive activation 
of the UPR under non-stress conditions (OIKAWA et al. 2009).  
IRE1 also performs unconventional splicing of mRNA in the cytosol to modify the 
message of the HAC1-related transcription factor XPB1 (UEMURA et al. 2009). Unlike 
unspliced HAC1 mRNA in yeast, unspliced XBP1 mRNA is translationally active and 
constitutively produced, however only the spliced version has been demonstrated to 
function as a transcription factor (YOSHIDA et al. 2001). Nascent XBP1u polypeptide 
recruits its own mRNA to the ER membrane that then gets released to the cytosol as 
spliced XBP1 mRNA during an episode of stress (YANAGITANI et al. 2009). XBP1u also 
functions as a negative feedback regulator that shut off induction of UPR target genes 
during the recovery phase following ER stress (Figure I.5 B; YOSHIDA et al. 2006).  
The second protein sensor in higher eukaryotes is PERK (Figure I.6). PERK contains 
a stress-sensing lumenal domain similar to IRE1 and a cytosolic domain with kinase 
activity that phosphorylates eukaryotic initiation factor 2  (eIF2 ). Phosphorylation of 
eIF2  results in the attenuation of general protein synthesis, thereby, reducing the load of 
protein folding in the ER (HARDING et al. 1999). The third sensor protein is the type II 
transmembrane protein ATF6 (Figure I.6). ATF6 has a cytosolic N-terminal half that 
contains a basic leucine zipper motif (HAZE et al. 1999). Upon ER stress, it is suggested 
that ATF6 is transported from the ER to the Golgi via COPII vesicles and is sequentially 
cleaved by the proteases S1P (site-1 protease) and S2P (site-2 protease) that reside in the 
Golgi (CHEN et al. 2002). The cleaved cytosolic domains are then released from the 
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membrane and are transported to the nucleus to induce ER chaperones and ERAD-related 
genes (SCHINDLER and SCHEKMAN 2009; YE et al. 2000).  
 
Genetic Targets of the UPR 
Microarray analysis of gene expression following ER stress has identified 381 UPR 
inducible-genes in budding yeast (TRAVERS et al. 2000). However, this study used 
relatively high stringency criteria to define the UPR targets: genes were induced by both 
DTT and TM treatments in an IRE1- and HAC1-dependent manner. Therefore, the 
resulting list of inducible genes is likely an underestimation of the full scope of the UPR.  
Transcriptional targets of the UPR play roles in virtually every stage of the secretory 
pathway: from translocation of newly synthesized proteins into the ER, protein folding 
and post-translational modifications and ER-to-Golgi traffic to distal secretion. Targets 
are also involved in ERAD and lipid biosynthesis (Figure I.7). This suggests that multiple 
processes are important to maintain the folding capacity of the ER during stress.  
Regulation of these components is fast but not indiscriminate. Induction of target genes is 
completed after 15 min and is maintained over the time of the DTT treatment. Specificity 
of the targets is suggested by the fact that although many components of the COPII 
vesicle machinery are targets, components of the COPI vesicles are less well represented.  
Moreover, the COPI components that are upregulated show only minor induction. This 
specificity suggests that rather than increasing the general capacity of the secretory 
pathway, the UPR results in selective induction of those activities that are essential under 
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Figure I.7. UPR genetic targets 
distributed by cellular process 
Many aspects of the secretory pathway are 
regulated by the UPR, including protein 
translocation, folding, post-translational 
modification, ER-to-Golgi traffic and 
degradation. Other processes like lipid 
metabolism and cell wall biogenesis are also 








Of the 381 HAC1- and IRE1-dependent UPR-induced genes, only 48 contain the 
canonical UPRE originally identified by Sambrook and co-workers. Computational 
analysis of the promoter regions of these genes identified two novel and biologically 
relevant UPRE’s. Furthermore, the basic leucine zipper transcription factor Gcn4p and its 
activator Gcn2p were identified to be required for induction of the majority of UPR target 
genes during ER stress. Both Hac1p and Gcn4p bind promoters on UPR target genes to 
stimulate transcriptional induction (PATIL et al. 2004). This provides evidence that the 
UPR in yeast might be more complex than previously anticipated. Other lines of evidence 
support this idea. There are about 87 ORFs that are strongly induced upon ER stress but 
their upregulation is not dependent on IRE1 or HAC1. Moreover, Leber et al 2004 
proposed that the unconventional splicing of HAC1mRNA can be seen as a simple UPR 
on/off switch; however, this switch is not the only regulatory step of the UPR. HAC1 
mRNA levels also seem to modulate the UPR signal; HAC1 mRNA production is 
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induced under conditions of severe protein misfolding in the ER. For example, HAC1 
mRNA is induced when DTT treatment is combined with inositol starvation or heat 
shock but not with DTT treatment alone. This upregulation of HAC1 mRNA is 
independent of IRE1, and the resulting increase in the Hac1p transcription factor drives a 
qualitatively different transcriptional program termed the super-UPR (LEBER et al. 2004).  
 
UPR activation is essential to cope with an increase in the ER folding load. 
Without the UPR, cells cannot adjust their levels of ER chaperones according to need 
and are unable to maintain ER homeostasis. Intact UPR is not necessary for viability in 
normal, unstressed conditions; however, in circumstances where protein folding is 
severely impaired, the UPR becomes essential for survival. Ire1Δ as well as hac1Δ strains 
show extreme growth sensitivity to reducing agents (DTT or β-ME) and the glycosylation 
inhibitor TM (COX et al. 1993; COX and WALTER 1996; MORI et al. 1996). In the same 
manner, increasing the folding load by over-expression of misfolded proteins requires the 
activation of the UPR to maintain viability. Cells lacking IRE1 ceased to grow upon over-
production of either Δpro, a mutated secretory proteinase derived from a filamentous 
fungus Rhizopus niveus, or the misfolded vacuolar hydrolase CPY*(SPEAR and NG 2003; 
UMEBAYASHI et al. 1999).  These data underscore the importance of the UPR as a 
homeostatic mechanism that is crucial for tolerance of stress by the cell.  
In addition to its role in handling ER stress, the UPR seems to play a growing role in 
a number of cellular functions that increase the protein folding load in the ER such as 
growth and differentiation. For example, it has been reported that the UPR is involved in 
cytokinesis; UPR-deficient ire1Δ or hac1Δ cells are defective in cytokinesis even in the 
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absence of external ER stress. Conversely, cytokinesis mutants, hof1Δ, cyk3Δ, and bni1Δ, 
show a constitutively active UPR. The UPR likely functions during cytokinesis by 
sensing small changes in ER load and making complimentary changes in ER capacity 
(BICKNELL et al. 2007).  
A role for the UPR in haploid tolerance has also been described. Hac1p is required for 
the maintenance of ploidy after sporulation: hac1Δ spores start out haploid but give rise 
to diploid progeny during subsequent mitotic divisions. Inhibition of the UPR pathway 
results in autodiploidization, and over-expression of Kar2p suppresses this phenotype, 
suggesting that a functional UPR is required for ploidy maintenance. However, it is 
important to mention that the ploidy increase associated with hac1Δ was dependent on 
the genetic background (LEE et al. 2003).  
Specialized secretory cells of the mammalian systems, like B cells, also utilized the 
UPR to maintain proper function. Terminal differentiation of B lymphocytes into 
antibody-secreting plasma cells is characterized by a sharp rise in immunoglobulin 
biosynthesis that increases the protein folding load of the ER. It has been documented 
that the UPR transcriptional activator XBP1 is required for plasma cell differentiation; 
XBP1-deficient B lymphoid cells express immunoglobulin (Ig) genes and undergo 
isotype switching, but are defective in plasma cell differentiation and do not secrete high 
levels of Igs (REIMOLD et al. 2001). Expression of the spliced form of XBP1 efficiently 
restores production of secreted Igs in XBP-1-/- mouse B cells (IWAKOSHI et al. 2003). In 
addition, the UPR transducer ATF6 may be involved in the process of terminal 
differentiation of B cells by regulating secretion of Igs. Expression of a dominant-
negative ATF6α mutant in differentiating B cells reduced the secretion of properly 
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assembled IgM and increased improper release of IgM assembly intermediates (GUNN et 
al. 2004)  
 
The UPR regulates multiple aspects of the secretory pathway and quality control. 
One interesting question that arises is how the components upregulated by the UPR 
act in concert to alleviate stress or help the cell adapt to the stress. An attractive 
hypothesis is that the UPR can help the cell by reducing the amount of misfolded proteins 
in the ER. This can be achieved in a variety of ways: promoting folding of misfolded 
proteins, increasing retro-translocation of misfolded proteins to be targeted for ERAD 
and/or, increasing the capacity of specific COPII components to enable efficient 
packaging of cargo proteins (possibly including unfolded proteins) into anterograde 
vesicles or otherwise simply increase the overall capacity of anterograde transport.  
A major genetic target of the UPR is a host of chaperones and folding factors. 
Chaperones are known to play roles in distinct steps of protein biogenesis from 
translocation, folding, to degradation of terminally misfolded polypeptides.  It is also 
known that some of these chaperones aid in refolding of proteins that had become 
partially unfolded by stresses like heat shock. For example, Hsp70 homologue Lhs1p, 
which is induced by activation of the UPR (TRAVERS et al. 2000) has been reported to 
have a role in refolding heat-denatured proteins. Cells lacking LHS1 failed to solubilize 
and reactivate Hsp150Δ–β-lactamase that became heat-denatured when returned to 
physiological temperature (SARIS et al. 1997). Therefore, a plausible mechanism to 
reduce the amount of unfolded proteins in the ER is to refold them. 
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Increasing the rate of ERAD upon induction of the UPR is clearly one of the 
mechanisms that can help the cell diminish the amount of misfolded proteins in the ER. 
Several lines of evidence reveal a tightly coordinated relationship between the UPR and 
ERAD. Besides being targets upregulated by the UPR, deletion of ERAD components 
causes constitutive activation of the UPR and also present extensive negative genetic 
interactions with ire1 and hac1 null alleles, indicating that the UPR compensates for the 
loss of ERAD (FRIEDLANDER et al. 2000; SCHULDINER et al. 2005; TRAVERS et al. 2000). 
Moreover, it has been suggested that the UPR more directly controls the rate of ERAD. 
In unstressed ire1Δ cells, misfolded CPY* is degraded at a slightly slower rate than in 
WT  cells, conversely, in cells expressing a constitutive spliced version of HAC1, CPY* 
is degraded faster than in a WT control (TRAVERS et al. 2000). In conditions of ER stress 
induce by treatment with DTT or TM and to a lesser extent by over-expression of a 
misfolded protein, degradation of CPY* is greatly reduced in WT cells and even more so 
in ire1Δ cells, indicating that the ERAD machinery has been saturated by the 
overwhelming amount of misfolded proteins (FRIEDLANDER et al. 2000; TRAVERS et al. 
2000). In addition, sustained stress becomes lethal in strains lacking the UPR. However, 
stressed cells with defective ERAD are still viable and degrade CPY* at the same rate as 
WT cells under the same stress conditions(SPEAR and NG 2003). Taken together, these 
observations indicate that in the absence of a functional UPR, the ERAD capacity is 
sufficient to dispose of misfolded proteins provided the cell does not suffer an episode of 
stress. Conversely, when the UPR is available in a cell where ERAD capacity is deficient 
or saturated, misfolded proteins can still be cleared by other mechanisms. In fact it has 
been reported that in conditions of over-expression of misfolded CPY*, its degradation 
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becomes dependent on Pep4p suggesting that the ER-to-vacuole pathway functions to 
degrade excess CPY*(SPEAR and NG 2003).  
An alternative pathway that targets proteins for degradation is autophagy. Autophagy 
describes a process in which sections of the cytoplasm, including its organelles, can 
become sequestered into membrane-bounded compartments that then fuse with the 
vacuole (or lysosomes). Contents are then degraded by acid hydrolases. In this way, 
whole organelles can be degraded, regardless of their size or the folding state of their 
constituent proteins (YORIMITSU and KLIONSKY 2005). Many of the components that 
mediate autophagy have recently been identified as UPR target genes and are important 
for cells to survive severe ER stress; therefore, as the cell produces more ER to handle an 
increased protein-folding load, it concurrently prepares to degrade the organelle and the 
damaged proteins within it. During UPR-induced autophagy, ER membranes are 
selectively sequestered into autophagosomes. This novel, organelle-selective branch of 
autophagy has been named ER-phagy ('ER eating'). In contrast to other types of 
autophagy, such as starvation-induced autophagy, the autophagosomes that accumulate in 
UPR-induced yeast cells do not fuse with the vacuole until the stress has finished, 
suggesting that the sequestration of damaged ER is more important than its eventual 
degradation. ER-phagy seems to occur at later stages of ER stress and requires stress 
conditions since activation of the UPR through the use of an inducible spliced version of 
Hac1p, therefore in the absence of misfolded protein, do not cause the formation of the 
autophagosomes (BERNALES et al. 2006). 
Increasing the rate of ER-to-Golgi traffic can be another way to reduce the amount of 
proteins accumulated in the ER.  Links have also been established between the UPR and 
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vesicle formation and transport.  Over-expression of IRE1 or HAC1s, which induces UPR 
activation, suppress the growth defects presented in strains bearing temperature sensitive 
(TS) alleles of COPII components (sec12-4, sec13-1, sec23-1, sec24-20, and sec31-1, 
sar1 (E112K), sec16-2, and sec23-2) but did not affect TS alleles of the COPI or fusion 
machinery. Interestingly, the vesicular transport components that are upregulated during 
ER stress correlate with the TS alleles that are suppressed by IRE1 or HAC1 over-
expression (HIGASHIO and KOHNO 2002; SATO et al. 2002; TRAVERS et al. 2000). 
Furthermore, deletion of cargo receptors like ERV29 renders cells more sensitive to stress 
caused by over-expression of a misfolded protein (SPEAR and NG 2003). Over-expression 
of a misfolded protein already increments the folding load of the ER, but deletion of a 
cargo receptor causes properly folded proteins to fail to be package into vesicles, thereby 
crowding the ER even more. This highlights the importance of a properly functioning 
vesicular pathway during an event of stress.  
Clues as to how the UPR and upregulation of the vesicle transport components might 
help the cell cope with stress come from studies that assess adaptation of ER exit sites 
(ERES) to variations in cargo load in mammalian cells. Over-expression of secretory 
cargo GABA transporter 1 (GAT1) for 24 hr, whose ER export is dependent on a 
cytosolic motif that is recognized by the COPII subunit Sec24D, causes a chronic 
response in which the UPR is induced, COPII components are upregulated, and the 
number and intensity of ERES, as determined by fluorescent SEC31, are increased 
compared to a WT cell.  Moreover, this increase in number and size of ERES upon GAT1 
over-expression is dependent on the presence of IRE1 since in IRE1−/− mouse 
embryonic fibroblasts the number of ERES remained unchanged (FARHAN et al. 2008).   
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It would be interesting to see if this increase in the amount of vesicles formed upon 
increase of ER folding load translates into more proteins being packaged into ER-derive 
vesicles in order to decrease the crowding in the ER.  
ER size and shape can change dramatically to adjust to the protein production 
demands of the cell. Perhaps the most impressive example of ER proliferation occurs 
during the differentiation of B lymphocytes into plasma cells.  These cells expand the ER  
3 to 4 times its original size (WIEST et al. 1990) and dramatically increase the levels of 
ER chaperones in order to accommodate the high burden of antibody production (VAN 
ANKEN et al. 2003). Over-expression of ER transmembrane proteins also produces 
ordered arrays of expanded ER in yeast (WRIGHT et al. 1988). The same phenomenon of 
ER expansion is seen in yeast cells upon treatment with DTT, which induces 
accumulation of misfolded proteins and subsequent activation of the UPR (BERNALES et 
al. 2006).  
Since genes involved in lipid biosynthesis correspond to targets upregulated during 
the UPR induction, it is reasonable to think that UPR mediates ER expansion. Several 
lines of evidence support this model. In yeast, activation of the UPR using a spliced 
version of HAC1 under the control of a glucocorticoid response element was sufficient to 
cause expansion of the cortical ER even in the absence of ER stress (BERNALES et al. 
2006).  Ire1Δ and hac1Δ cells cannot generate morphologically normal expanded ER 
upon addition of DTT or TM as in WT cells (SCHUCK et al. 2009).  
Similarly, in mammals, expression of active XBP1 stimulates lipid biosynthesis and 
ER enlargement in fibroblasts and B lymphocytes (SRIBURI et al. 2004; ZHANG and 
KAUFMAN 2006), whereas, XBP1 deficiency impairs ER membrane proliferation during 
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the development of specialized secretory cells (REIMOLD et al. 2001). However, it 
remains unknown whether the absence of XBP1 directly abolishes the ability of these 
cells to expand their ER or prevents them from reaching a developmental stage in which 
ER expansion would normally occur.  
ER enlargement mediated by the UPR can help alleviate stress by simply decreasing 
the concentration of misfolded proteins and by accommodating the newly produced ER 
folding machinery. Investigation of the role of the UPR in ER expansion revealed that 
experimentally induced ER membrane expansion can be uncoupled from chaperone 
induction and that ER proliferation by itself is able to relieve ER stress. Membrane 
proliferation upon ER stress is mediated by the UPR through the Ino2/4p complex, a 
heterodimer that acts as a transcription factor for enzymes involved in phospholipid 
biosynthesis. Under conditions where lipid amounts are sufficient, the Ino2/4p complex is 
inhibited by Opi1p, which binds to Ino2p.  However, as more lipids are needed, Opi1p 
dissociates from Ino2p, allowing Ino2/4p to activate its target genes. Strains where the 
UPR is defective are able to expand their ER if the lipid biosynthesis negative regulator 
OPI1 is deleted; this leaves chaperone levels unaffected. Conversely, UPR-competent 
cells are unable to expand their ER in ino2Δ and ino4Δ strains if grown in media lacking 
lipids. Moreover, deletion of OPI1, which results in ER expansion, rescues growth of an 
ire1Δ strain exposed to TM. Deletion of INO2 also causes the same growth sensitivity to 
TM as deletion of IRE1, despite the normal induction of chaperone to levels as expected 
for a UPR-activated cell. Taken together, these observations indicate that ER expansion 
by itself is capable of alleviating stress in the absence of upregulated chaperones. This 
key study suggested that the UPR maintains ER homeostasis by two intimately connected 
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but distinct mechanisms: by providing new ER-folding machinery and by providing more 
ER surface area and lumenal space  (SCHUCK et al. 2009).  
The UPR represents just one aspect of the ER quality control system that helps the 
cell regain ER homeostasis upon alteration of its protein folding load. Evidence suggests 
that the UPR utilizes many interconnected mechanisms to remodel the secretory pathway 
according to the demands imposed in the cell. However, how the diverse sets of genes 
upregulated by the UPR contribute to this process still requires further study. 
 
Quality Control and Disease 
Disturbances in the protein quality control mechanisms within the secretory pathway are the 
cause of many diseases. Diseases can arise because of mutations in cargo proteins that impair 
folding, transport or signaling mechanisms (ANELLI and SITIA 2008). A classical example of how 
the quality control system is involved in disease comes from studies on Cystic Fibrosis (CF). 
Cystic Fibrosis is caused by mutations in the CF transmembrane conductance regulator (CFTR) 
gene, which encodes a cAMP-activated anion channel expressed in epithelial cells. The most 
common mutation, a deletion of F508, leads to an unstable protein conformation that, although 
still partially functional, is retained in the ER, and targeted for degradation. This demonstrates 
how a strict protein quality control system can, in some cases, have detrimental consequences. 
Therapeutic approaches for this kind of disease have aimed to find ways to bypass the quality 
control system and restore ER folding and traffic by using chemical and pharmacological 
chaperones.  
Other diseases arise from mutant secretory proteins that are prone to form aggregates that can 
become toxic to the cell. These aggregates can form intracellular deposits (ER storage diseases) 
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or extracellular deposits (systemic amyloidoses)(OTSU and SITIA 2007).  One example of an ER 
storage disease is the liver disease caused by α1-antitrypsin deficiency. A point mutation (Z 
variant) in the gene encoding α1-antitrypsin causes a conformational change in the protein that 
leads to its polymerization and retention in the ER of hepatocytes. The very presence of the Z 
variant aggregates rather than plasma deficiency of the α1-antitrypsin causes liver damage 
(KELLY et al. 2010). Systemic amyloidoses is the collective name given to diseases that are 
caused by abnormal proteins that aggregate extracellularly forming insoluble fibrillar deposits in 
various tissues and organs. Organ dysfunction results from disruption of tissue architecture by 
the amyloid deposits. Light-chain (AL) amyloidosis is the most common type of systemic 
amyloidosis (SANCHORAWALA 2006). In this case, a ”weak” quality control system, instead of 
retaining and degrading  these mutant proteins,  lets them escape the ER to be released in the 
extracellular space where they can cause severe damage (OTSU and SITIA 2007). 
Disease can also develop through defective quality control machinery, including defective 
UPR signaling.  Wolcott-Rallison syndrome (WRS) is a rare autosomal recessive disorder caused 
by mutations in PERK and characterized by diabetes mellitus, multiple epiphyseal dysplasia, 
osteoporosis and growth retardation (DELEPINE et al. 2000).  The UPR may also play an 
important role in the regulation of cellular responses to insulin:  ER stress is a central feature of 
peripheral insulin resistance and type 2 diabetes, and the IRE1 /XBP1 UPR pathway is critical 
for this process. Mice deficient in XBP1 develop insulin resistance and ER stress in obese mice 
directly causes suppression of insulin receptor signaling through hyperactivation of c-Jun N-
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 These are just a few examples of the many diseases that occur from alterations in the quality 
control system. Pathogenesis of disease arises not only from how ER quality control machinery 
handles individual mutant secretory cargo but also from specific defects in its components.  This 
underlies the importance of furthering our understanding of how the mechanisms that encompass 
the ER quality control are interconnected and the precise function of all the members that 
participate in these processes.  
 
Research Interests 
The main goal of my research is to gain further insight into the molecular mechanisms that 
cells employ to ensure correct protein biogenesis and intracellular transport. Specifically, I want 
to study different aspects of the ER quality control system and how they are interconnected in 
order to maintain proper ER homeostasis. In this dissertation, I will present results for two 
distinct but interrelated projects. The first one is titled Role of the Unfolded Protein Response in 
Folding and Transport of Misfolded Proteins. As mentioned above, accumulation of misfolded 
proteins in the ER activates a  the UPR signaling network, which  results in the transcriptional 
activation of many genes that encode components that affect protein folding, trafficking, and 
degradation. It is believed that upregulation of these UPR targets assists the cell in coping with 
ER stress. However, the molecular mechanisms by which the UPR may contribute to improved 
protein folding and trafficking remain unclear. I am interested in testing whether the host of 
chaperones and secretion machinery that is induced during UPR can have a positive impact on 
protein biogenesis. The specific aims for this project are: (1) to determine if upregulation of 
chaperones during UPR activation help rescue unfolded proteins, (2) to determine if packaging 
of proteins into ER-derived vesicles is increased during UPR in order to clear misfolded proteins 
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from the ER and (3) to determine if activation of the UPR is important in the recovery of the cell 
after removal of the stress. According to our results, upregulation of chaperones upon UPR 
activation did not help refold 2 model misfolded proteins Yor1ΔF-HA and Gas1*-HA which are 
instead targeted for more rapid degradation. In the same manner, we have concluded that 
packaging of proteins into ER-derived vesicles is increased upon treatment with stressor DTT. 
Finally, I propose that increased expression of the protein folding, traffic and degradation 
machinery upon UPR but not ER expansion induction is essential for the cell to rapidly recover 
following removal of the stress condition. 
The second project is titled Identification of Novel Genes Involved in Protein Modification 
and Endoplasmic Reticulum Quality Control. The ER quality control system encompasses many 
processes, including protein folding, ERAD, ER exit and retrieval.  However the extent of the 
inter-connection between these processes as well as the full array of components involved in the 
different pathways are not entirely known. For this reason we conducted a genome-wide study to 
identify novel genes involved in the quality control system by screening the yeast deletion 
collection (YDC) for mutant strains that secrete the ER resident protein Kar2p to the 
extracellular environment.   Our screen yielded 73 non-essential genes which deletion causes ER 
retention defects. These genes are involved in a variety of processes: protein trafficking and 
folding, glycoprotein biosynthesis and lipid/GPI synthesis among others.  This research 
concentrates on understanding how deletion of individual genes leads to the Kar2p secretion 
phenotype.  In order to do this, the relationship between the Kar2p retention defect and the 
activation of the UPR was examined. Our candidate mutant strains were also tested for defects in 
post translational modification and breakdown of quality control system resulting in the 
identification of novel genes involved in processing of Gas1p, glycosylation of CPY and quality 
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control of misfolded protein CPY*.  These studies provide a good starting point from we expect 
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II. CHAPTER 2: ROLE OF THE UPR PROTEIN RESPONSE IN FOLDING AND 
TRANSPORT OF MISFOLDED PROTEINS 
 
Research Basis 
The ER maintains a quality control system to ensure that only correctly folded proteins exit 
the ER and that misfolded proteins are retained and eventually degraded. Environmental insults 
as well as the presence of mutant proteins can impose stress on the ER, altering its homeostasis 
and leading to the accumulation of aberrant proteins in the ER lumen. Abnormal folding, 
processing and trafficking of secretory proteins causes human diseases collectively known as 
conformational diseases of the secretory pathway, including metabolic as well as developmental 
and neurological diseases such as insulin resistant diabetes and Alzheimer’s disease (OTSU and 
SITIA 2007).  
The presence of misfolded proteins in the ER activates a signaling network called the 
Unfolded Protein Response (UPR). The UPR has evolved as an integrated signaling network in 
higher eukaryotes, however, in yeast, it remains as a simpler pathway mediated by Ire1p/Hac1p. 
Ire1p is a type-I transmembrane ER protein that consists of an amino-terminal ER lumenal 
oligomerization domain that senses ER stress signals (CREDLE et al. 2005), and a carboxyl-
terminal cytosolic domain that contains serine/threonine kinase activity (COX et al. 1993; MORI 
et al. 1993; NIKAWA and YAMASHITA 1992) and endoribonuclease function (SIDRAUSKI and 
WALTER 1997).  The only known substrate of the Ire1p endoribonuclease is an mRNA encoding 
Hac1p, a basic leucine zipper transcription factor (COX and WALTER 1996; MORI et al. 1996; 
NIKAWA et al. 1996; NIWA et al. 2005). Activated Ire1p cleaves a 252-base intron from the 
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HAC1 mRNA that enhances translation and creates a new carboxyl-terminus that binds the 
promoters of many UPR target genes.   
Induction of the UPR results in the transcriptional activation of many genes that encode 
components that affect protein translation, ER translocation, protein folding, trafficking, and 
degradation (TRAVERS et al. 2000).  A question that arises is how the upregulation of these 
components works in concert to remodel the secretory pathway in order to cope with the 
increased folding load imposed by different stressors. One attractive hypothesis is that 
upregulation of these genes can help cells cope with stress by decreasing the concentration of 
misfolded proteins in the ER. This can happen in a variety of ways. The protein degradation 
capacity can be increased to destroy the surplus of misfolded protein created by the stress. As 
described previously, an intimate link between ERAD and the UPR has been established. In the 
absence of a functional UPR, the ERAD capacity is sufficient to dispose of misfolded proteins 
provided that the cell does not suffer an episode of stress. Conversely, when ERAD capacity is 
deficient or saturated by the overwhelming presence of misfolded proteins, the UPR helps cells 
to cope with the stress by other mechanisms (SCHUCK et al. 2009; TRAVERS et al. 2000). Other 
pathways have also been suggested to contribute to degradation of misfolded proteins upon ER 
stress including autophagy (BERNALES et al. 2006) and vacuolar degradation (SPEAR and NG 
2003) 
Other UPR transcriptional targets include a group of chaperones encompassing members of 
the Hsp70 and Hsp40 families as well folding factors like the peptidyl-prolyl cis-trans 
isomerases and genes involved in disulfide bond formation. It has been documented that over-
expression of different folding factors can increase tolerance to different kinds of stresses. For 
example, over-expression of cytosolic peptidyl-prolyl cis-trans isomerase (cyclophilin) Cpr1p 
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increases cell tolerance to heavy metals believed to induce oxidative stress by the production of 
reactive oxygen species (ROS; KIM et al. 2010) Also, there is evidence of the refolding power of 
some of these Hsp70 chaperones. For example Ssa1/2p, a cytosolic Hsp70, is necessary for 
renaturation of firefly luciferase upon addition of guanidine hydrochloride  (BUSH and MEYER 
1996).   More importantly, it has been reported that Lhs1p, a UPR inducible target, has a role in 
refolding of proteins denatured by thermal insult in living cells (SARIS et al. 1997). Therefore, it 
is plausible that one mechanism that the cell could use to alleviate ER stress and reduce the 
amount of aberrant proteins is to improve or promote refolding of misfolded proteins.   
Finally, activation of the UPR upregulates components of the ER-to-Golgi traffic machinery.  
Besides the genetic link between forward transport and the UPR (HIGASHIO and KOHNO 2002; 
SATO et al. 2002), it has also been reported that  the UPR is imperative to maintain to ER-to-
Golgi transport in cells challenged by over-expression of CPY*(SPEAR and NG 2003).  Perhaps 
upregulation of these traffic components also leads to increased packaging of proteins into ER 
derived vesicles in order to decrease the amount of proteins in the ER. 
In order to gain further insight in how the different components upregulated by the UPR can 
help the cell cope with ER stress, I studied the effect of UPR in protein folding and trafficking 
using the budding yeast, Saccharomyces cerevisiae, as a model system. I tested whether the host 
of chaperones and secretion machinery that is induced during UPR can have a positive impact on 
protein biogenesis.  I specifically wanted to study if upregulation of chaperones during UPR 
activation can help refold unfolded proteins or if they are just eliminated by ERAD. Also, I am 
interested to determine if packaging of proteins into ER-derived vesicles is increased during UPR 
in order to clear misfolded proteins from the ER. Finally, I examined the impact of UPR 
activation on protein processing after ER stress has been removed. My findings suggest that 
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packaging of proteins into ER-derived vesicles seems to increase upon addition of an ER 
stressor. However despite dramatic accumulation of ER chaperones, misfolded proteins do not 
gain folding competence. Lastly, my data suggest that the UPR also functions to allow cells to 
rapidly recover from ER stress, once the environmental insult has finished.  
 
Materials and Methods 
 
Yeast strains and growth conditions 
Yeast strains were grown in standard rich media YPD (2% w/v glucose, 1% w/v yeast 
extract and 2% w/v peptone), or synthetic complete media SC (0.67% w/v yeast nitrogen 
base, 2% w/v glucose and amino acids appropriate for auxotrophic growth) at 30oC. Cell 
transformations were done using standard lithium acetate protocols. Knock-out mutant 
strains were obtained from the MATα haploid yeast deletion collection (Open 
Biosystems, Part of Thermo Fisher Scientific, Huntsville, AL). Opi1ΔhacΔ double 
mutant was constructed by PCR-mediated gene disruption where the HAC1 locus of a 
 opi1Δ MATα strain from the yeast deletion collection was replaced with a His3MX 
cassette (LONGTINE et al. 1998)  
 
Plasmids 
The UPRE-LacZ reporter plasmid was constructed from pMZ11 by EcoRI/Xho1 
digest and subsequent subcloning into pRS423 to create pLM38. pEAE83 containing 
HA-tagged YOR1 in pRS316 was a gift from Scott Moye-Rowley (University of Iowa). 
YOR1ΔF670-HA in pRS316 was created by site-directed mutagenesis by using 
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QuikChange mutagenesis (Stratagene, La Jolla, CA) of pEAE83 to generate pLM309. 
Plasmid pMF616 containing GAS1G291R-HA (Gas1*-HA) in pRS306 was kindly 
provided by Morihisa Fujita (FUJITA et al. 2006b).  pMS261 (pcIRE1) which contains a 
version of  Ire1p with 9 missense mutations in the ER lumenal domain  (R2G, I21V, 
E69V, S103P, E167D, Q272R, F377S, L466S, K510R) that renders it constitutively 
active (PAPA et al. 2003) ,  pT2.GN795 which contains the glucocorticoid receptor under 
control of a GPD promoter and pCP274 that has a spliced form of the HAC1 gene under 
the control of a glucocorticoid response element were provided by Peter Walter 
(TRAVERS et al. 2000).  
 
Induction of the UPR 
UPR was induced by treatment with two chemical agents that disrupt protein folding 
in the ER: Dithiothreitol (DTT, Sigma-Aldrich) and Tunicamicyn (TM, Sigma-Aldrich). 
Cells bearing the UPRE-LacZ reporter were grown to mid-log phase in selective media. 
Cultures were treated with increasing concentrations of DTT (0, 1, 2, 3, 4, and 5mM) or 
TM (0, 0.5, 1.0, 1.5, and 2.0 μg/mL) for 1h. UPR activation was also measure after 
incubation with increasing concentrations of H2O2, 1M Sorbitol or heat shock from 30oC 
to 37oC for increasing amount of times.  
 
Detection of the UPR   
Cells bearing the UPRE-LacZ reporter plasmid were grown in selective media to mid-
log phase. 5ml of liquid culture were harvested and washed in Z buffer (60mM Na2HPO4, 
40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 50mM β-mercaptoethanol, pH 7.0). Cell 
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pellet was resuspended in 5ml of Z buffer and OD600 was taken. 100μL of resuspended 
cells were combined with 800mL of Z buffer in a 1.5mL tube. Using a Pasteur pipette, 1 
drop of 0.1% w/v SDS and 2 drops of chloroform were added to the tubes followed by 
vortexing for 15 sec. Tubes were equilibrated at 30oC for 15 min.  160µl of  4mg/ml  2-
Nitrophenyl β-D-galactopyranoside (ONPG, Sigma-Aldrich, St. Louis, MO)  were added 
to each tube followed by vortexing for 10 sec. Tubes were incubated at 30oC for ~15-20 
min. Time of incubation was recorded. Reactions were quenched by addition of 400µl of 
1M Na2CO3 and cell debris was spun down. OD at 420nm and 550nm were taken for 
each sample and activity units were calculated using the following formula:          











where V is volume of cell culture added to reaction in mL, and T is time in  min. 
 
Limited proteolysis of Yor1-HA 
Cells bearing a plasmid borne copy of Yor1-HA or Yor1ΔF670-HA were grown to 
mid-log phase in selective media. 10.0 OD600 of cells were harvested and lysed by 
vortexing with glass beads in B88 buffer (20 mM HEPES, pH 6.8, 250mM Sorbitol, 
150mM KCH3CO2, and 5mM Mg(CH3CO2)2) at 4oC for 5 min.  Membranes were 
collected by centrifugation and resuspended in 200μL of B88 buffer. 25μl of resuspended 
membranes (2.5OD600/reaction) were treated with increasing concentrations of trypsin (0, 
25, 50, or 100 ng/µl final concentration; Sigma-Aldrich, St. Louis, MO) for 10 min on 
ice. Reaction was inhibited by addition of 0.2 μg/mL soybean trypsin inhibitor (SBTI; 
Sigma-Aldrich St. Louis, MO) for 15 min on ice. Proteins were solubilized from treated 
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membranes and separated by SDS-PAGE. Proteins were then transferred to PDVF 
membranes and immunoblotted with α-HA antibodies (Covance, Princeton, NJ) to detect 




Cells were grown to mid-log phase in YPD or selective media. 10 OD600 were 
harvested and resuspended in synthetic medium lacking methionine and cysteine, and 
incubated for 15 min at 30°C with gentle agitation. Cells were metabolically labeled with 
30 µCi of Express protein labeling mix (MP Biomedicals, Irvine, CA) per OD600 unit of 
cells for 5 min. 250μL of  10x chase solution (10mM L-cysteine, 50mM L-methionine, 4% 
w/v yeast extract, and 2% w/v glucose) was added and cells were harvested at different 
times. At each time point, 2.5 OD600 aliquots of cells were transferred to tubes containing 
NaN3 to a final concentration of 20mM and kept on ice. Cells were washed once with 
cold 20mM NaN3 and resuspended in 100 µl of 1% w/v SDS. Cells were lysed by 
vortexing with glass beads for 15 min at 4°C. Cell lysates were heated at 55°C for 5 min, 
diluted with 500μL of IP buffer (50 mM TrisBase, pH 7.5, 160mM NaCl, 1% v/v Triton 
X-100, and 2mM NaN3), and centrifuged to discard cell debris. Proteins were 
immunoprecipitated using monoclonal α-HA antibodies (Covance, Princeton, NJ)  pre-
coupled to protein G-Sepharose beads (GE Healthcare, Little Chalfont, Buckinghamshire, 
United Kingdom), or polyclonal antibodies against Gas1p,  or CPY, (gifts from R. 
Schekman) coupled to protein A-Sepharose beads (GE Healthcare, Little Chalfont, 
Buckinghamshire, United Kingdom). Immune complexes were separated by SDS-PAGE 
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and analyzed by phosphorimaging using a Storm PhosphorImager (GE Healthcare). 
Proteins were quantified using ImageQuant software (GE Healthcare).  
a) DTT washout before labeling: Cells at mid-log phase were treated with 
2.5mM DTT for 1h. 10 OD600 were harvested and resuspended in synthetic 
media lacking methionine/cysteine and containing 2.5mM DTT, and 
incubated for 15 min at 30°C with gentle agitation. Cells were resuspended in 
fresh synthetic media without DTT and metabolically labeled with 30 µCi of 
Express protein labeling mix (MP Biomedicals, Irvine, CA) per OD600 unit of 
cells for 5 min. Protocol was fallowed as described above. 
b) DTT washout after labeling: Cells at mid-log phase were treated with 2.5mM 
DTT for 1h. 10 OD600 were harvested and resuspended in synthetic media 
lacking methionine/cysteine and containing 2.5mM DTT, and incubated for 
15 min at 30°C with gentle agitation. Cells were metabolically labeled with 30 
µCi of Express protein labeling mix (MP Biomedicals, Irvine, CA) per OD600 
unit of cells for 5 min in presence of DTT. 250μL of 10x chase solution were 
added to cells and a sample was taken (0 min). Cells were resuspended in 
fresh synthetic media without DTT and samples were taken after 5, 15 and 30 
min. 
c) Pulse-chase in media without lipids: Cells were grown to mid-log phase in 
YPD. Cells were resuspended in synthetic media lacking methionine/cysteine 
15 min prior to incubation with 2.5mM DTT for 1 hr at 30°C with gentle 
agitation. Cells were metabolically labeled with 30 µCi of Express protein 
labeling mix (MP Biomedicals, Irvine, CA) per OD600 unit of cells for 5 min. 
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250μL of  10x chase solution (10 mM L-cysteine, 50 mM L-methionine, 0.67% 
w/v yeast nitrogen base, and 2% w/v glucose) were added and samples were 
taken at different times. 
 
Cytosol preparation 
2L of RSY620 cells (pep4Δ::TRP1; ade2-1; his3-11,-15; leu2-3,-112; ura3-1)  
bearing the pIRE1 plasmid or treated with 2.5mM DTT for 1hr were grown to mid-log 
phase and harvested. Cell pellets were washed once with cold dH2O and then with B88 
buffer containing protease inhibitors. Pellets were stored at -20Co and then thawed in ice. 
Cells were snap frozen with liquid N2 and crushed to a powder using a mortar and pestle. 
Lysed cell powder was thawed on ice. Membranes were removed from cytosol by 
centrifugation:  13,000 rpm for 15 min to remove heavier debris and then 30,000 rpm for 
1.5 hrs. The protein concentration of the cytosol was measured using a Bradford assay 
(Bio-Rad, Hercules, CA) 
 
In vitro vesicle budding 
Cells were grown to mid-log phase in YPD or selective media. 5 OD600 were 
harvested and resuspended in synthetic media lacking methionine/cysteine, and incubated 
for 15 min at 30°C with gentle agitation. Cells were metabolically labeled with 70 µCi of 
Express protein labeling mix (MP Biomedicals, Irvine, CA) per OD600 unit of cells for 5 
min. Cells were treated with NaN3 and KF (final concentration of 20mM each), 
resuspended in 900μL of TrisBase/DTT/NaN3 buffer (100mM TrisBase pH 9.4, 10mM 
DTT and 100mM NaN3) and incubated at room temperature for 10 min. Cells were then 
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resuspended in 900μL of spheroplasting buffer (10mM TrisBase pH 7.4, 0.7M Sorbitol, 
20mM NaN3, 1mM DTT and lyticase 30 units/OD600 of cells) and incubated for 25min at 
30oC.  The resulting spheroplasts were washed once in 900μL of lysis buffer (20mM 
HEPES pH 6.8, 0.4M Sorbitol, 150mM KCH3CO2, 2mM Mg(CH3CO2)2 and 0.5mM 
EGTA), resuspended in 95μL of lysis buffer and stored at -80oC.  Thawed spheroplasts 
were washed once with 1mL of low acetate B88 (20 mM HEPES, pH 6.8, 250mM 
Sorbitol, 50mM KCH3CO2, and 5mM Mg(CH3CO2)2) and twice with 1mL of B88 before 
being resuspended in 100μL of B88.  Vesicle budding reactions were set up by 
combining 50μL of resuspended membranes (2.5 OD600), with previously purified COPII 
proteins (10 µg/ml Sar1p, 10 µg/ml Sec23/24p, and 20 µg/ml Sec13/31p)  or contained in 
isolated cytosol (10mg/mL of protein) and 0.1 mM GTP with a 10x ATP regeneration 
system. Negative control reactions were set up by combining 50μL of resuspended 
membranes (2.5 OD600), with previously purified COPII proteins (10 µg/ml Sar1p, 10 
µg/ml Sec23/24p, and 20 µg/ml Sec13/31p)  or contained in isolated cytosol (10mg/mL 
of protein)  and 0.1 mM GDP. 5μL of membranes were reserved for total protein fraction.  
Reactions were let go to completion at room temperature for 25 min. Vesicles were 
separated from donor membranes by centrifugation at 16,000 rpm for 5 min. Proteins 
were solubilized from vesicles and total membrane donor fraction with 1% w/v SDS 
(final concentration) and heating at 55oC for 5min. Samples were diluted with 900μL of 
IP buffer. Proteins were immunoprecipitated with antibody-conjugated beads, 
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Results  
 
The UPR is activated by environmental stressors. 
ER homeostasis is constantly monitored and maintained in the face of stresses including 
nutrient deprivation, altered redox balance, impaired glycosylation, or simply increased 
secretory protein synthesis. These demands on or insults to the system can activate a 
coordinated program of ER-associated signaling events collectively called the unfolded 
protein response (UPR). I initially tested several stresses to verify activation of the UPR 
using a reporter system in which the canonical UPR element (UPRE) is upstream of the LacZ 
gene. Briefly, cells bearing the UPRE-LacZ reporter plasmid were grown to mid-log phase 
and treated with different stressors. Cell lysate was incubated with ONPG, a β-galactosidase 
substrate. β-galactosidase hydrolyzes the ONPG molecule into galactose and ortho-
nitrophenol, which has a yellow color that is used to check for enzyme activity by means of a 
colorimetric assay.  
First, I tested two classical UPR activators: Dithiothreitol (DTT) and Tunicamycin (TM; 
MORI et al. 1998). DTT reduces intramolecular and intermolecular disulfide bonds that form 
between cysteine residues, thereby interrupting oxidative folding; however, it cannot reduce 
buried, solvent-inaccessible sulfur bridges. TM belongs to a class of nucleoside antibiotics 
that acts as a tight binding competitive inhibitor of the enzyme GlcNAc phosphotransferase 
(Alg7p in budding yeast). Alg7 catalyzes the transfer of N-actelyglucosamine-1-phosphate 
from UDP-N-acetylglucosamine to dolichol phosphate in the first step of glycan synthesis 
(VARKI 1999)  blocking the synthesis of all N-linked glycoproteins, and leading to 
accumulation of misfolded proteins.  Cells bearing the UPRE-LacZ construct were treated 
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with increasing concentrations of DTT or TM for 1hr and β-galactosidase activity was 
measured.  Dose-response curves (Figure II.1A and II.1B) show basal levels of β-
galactosidase activity, which is consistent with the observation that UPR activity is detected 
to a small degree in unstressed cells. This basal UPR activity has been implicated in control 
of cellular responses to fluctuations in nutrient levels (KUHN et al. 2001; SCHEUNER et al. 
2001). DTT dose-response experiments indicate that the maximum UPR activation is reached 
with DTT 2.5M for 1hr; higher concentrations of DTT did not significantly increase β-
galactosidase activity. For TM, maximum β-galactosidase activity was reached with a 
concentration of 2μg/mL. Figure II.1C shows the increase of UPR activation over WT cells 
upon insult with different stresses. As depicted in Figure II.1C, DTT and TM cause a 
statistically significant increase over the untreated cell control.  Similar concentrations of 
DTT and TM for 1 hr have been previously used for UPR activation in yeast (TRAVERS et al. 
2000).   
It is well known that reactive oxygen species (ROS) can lead to modification of proteins. 
ROS lead to the formation of primary or secondary protein carbonyl on the side chains of 
certain amino acids, and oxidation of methionine to methionine sulphoxide (HERRERO et al. 
2008). Therefore, it is plausible that addition of a strong oxidant like H2O2 can lead to 
aberrant protein accumulation in the ER and subsequently to UPR activation. In order to 
determine whether oxidative stress caused by addition of hydrogen peroxide can cause UPR 
activation, I treated cells bearing the UPRE-LacZ reporter with various concentrations of 
H2O2. Figure II.1C indicates that treatment with 0.6mM H202 for 1hr yielded an increase in 
β-galactosidase activity over WT control of 1.4, which was not significantly different from 
untreated cells (p-value=0.15, n=4). 
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Figure II.1. Activation of the 
Unfolded Protein Response 
upon treatment with 
different environmental 
insults  
Cells containing the UPRE-
LacZ plasmid were grown to 
mid log-phase at 30oC. Cells 
were lysed and subjected to β-
galactosidase activity assay. 
A. Cells were treated with 
increasing concentrations of 
DTT for 1 hr. B. Cells were 
treated with increasing 
concentrations of TM for 1 
hour. C. For DTT, 
Tunicamycin and H2O2 
treatments, cells were 
incubated for different times 
and concentrations as 
indicated. For heat shock, cells 
were grown in YPD at 25oC 
and the shifted to 37oC for 
different amounts time. For 
hyperosmotic shock, cells 
were grown in YPD at 25oC 
and combined with one 
volume of YPD containing 
2M Sorbitol for increasing 
lengths of time. The results 
presented correspond to the 
treatment conditions where the 
maximum β-galactosidase 
activity over the WT control 
was obtained. D. Cells bearing 
the pcIRE1 were harvested at mid-log phase and β-galactosidase activity was measured. Activity was 
normalized to WT control. Normalized β-galactosidase activity for DTT treated cells was also plotted for 
comparison purposes. E. Cells bearing the GRE-Hac1s and the glucocorticoid receptor were treated with 
different concentrations DOCA for 90 min and β-galactosidase activity was measured. Asterisk denotes 
that the fold of increase in β-galactosidase activity was statistically different from WT as determined by a 
student t-test: DTT 5 mM, 1hr has p-value=0.0002 with n=4; TM 2μg/mL has p-value=0.0008 with  n=3; 
pcIRE1 has p-value= 0.0181 with n=4.                                                                                                                   
 
I also tested UPR induction upon heat shock by temperature shift from 25oC to 37oC.  
High temperatures can lead to denaturation of proteins and it is plausible that this might 
lead to accumulation of misfolded proteins and, in turn, UPR activation. Figure II.1C 
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indicates β-galactosidase activity in cells shifted from 25oC to 37oC for 90 min, only 
increased 1.3 fold over the control, which is not significant according to Student’s t-test 
(p-value=0.42, n=3). These results suggest that thermal stress is not sufficient for 
activation of the UPR, however, this particular increase in temperature may not be high 
enough to create a misfolded protein concentration that is able to trigger Ire1p activation.  
The last stress tested for UPR activation was hyperosmotic shock. Increase in 
extracellular osmolarity leads to water loss and cell shrinking. The cell needs to 
counteract those effects in order to maintain shape and turgor and to ensure appropriate 
water and ion concentration in the cytosol and its organelles for optimal functioning 
(O'ROURKE et al. 2002). I tested whether or not hyperosmotic shock is able to trigger 
UPR as part of its adaptive response. For this, 1 volume of mid-log phase WT cells 
bearing the UPRE-LacZ plasmid grown in YPD were combined with 1 volume of YPD 
containing 2M Sorbitol. Cells were grown in 1M Sorbitol for 1hr, harvested, lysed and 
subjected to the β-galactosidase assay. Figure II.1C shows that the β-galactosidase 
activity of the cells submitted to hyperosmotic shock normalized to the untreated control 
is close to 1 indicating that there is no UPR activation.   
In order to assess the role of the UPR in different aspects of protein folding, traffic 
and degradation, I treated cells with 2.5 DTT or 2ug/ml TM for 1 hr, conditions proven to 
activate the UPR (Figure II.1A and II.1B; TRAVERS et al. 2000). However, treatment with 
DTT or TM causes an overwhelming amount of misfolded proteins that can occlude the 
effect of the UPR on a particular protein. In order to overcome this problem, we acquired 
several systems to activate the UPR in the absence of misfolded proteins (non-stress 
conditions). First, we obtained from Peter Walter a version of Ire1p that is constitutively 
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active (pcIRE1). Figure II.1D shows β-galactosidase activity of cells bearing the pcIRE1 
normalized to a WT control (5.2 fold of increase). UPR activation in these cells is 
comparable to activation induced by 2.5mM DTT for 1 hr. Second, we obtained a system 
in which a spliced version of the UPR transcription factor HAC1 (HAC1s) is under the 
control of an inducible promoter that allows its expression in the absence of misfolded 
proteins. The promoter is a Glucocorticoid Response Element (GRE), which is bound by 
the Glucocorticoid Receptor upon induction with deoxycorticosterone acetate (DOCA). 
This plasmid, along with the plasmid that encodes for the Glucocorticoid Receptor, was 
introduced into yeast strains containing the UPRE-LacZ reporter. UPR activity was 
measured after induction with different concentrations and treatment times of DOCA to 
determine the optimal conditions for UPR induction. Figure II.1E shows that UPR 
activation achieves a maximum after 6 hrs of treatment with 50μM DOCA. 
 
UPR activation does not correct the folding of mutant misfolded proteins. 
It has been proposed that the UPR can help the cell reduce the concentration of 
misfolded proteins in the ER in a variety of ways (TRAVERS et al. 2000) (SCHUCK et al. 
2009). One attractive possibility is that activation of the UPR promotes the refolding of 
misfolded proteins through upregulation of chaperones and folding factors in order to 
decrease the abundance of aberrant proteins in the ER. To test this hypothesis, I assessed 
the folding state of the model misfolded protein, Yor1ΔF670 (Yor1ΔF-HA), upon UPR 
activation. WT Yor1-HA, is an ABC transporter localized at the plasma membrane that 
acts as a drug pump to clear toxic substances from yeast cytoplasm (KATZMANN et al. 
1995). Yor1ΔF-HA is a homolog of human CFTRΔF; it presents a similar membrane 
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topology and an equivalent phenylalanine residue deletion causes Yor1ΔF-HA to be 
retained in the ER and eventually degraded by ERAD (KATZMANN et al. 1999).  Our lab 
has developed this drug transporter as a model to study protein folding and export from 
the ER. Yor1ΔF-HA presents the following advantages: an extra copy of Yor1ΔF-HA 
introduced on a plasmid does not interfere with endogenous Yor1p since the misfolded 
version is not dominant negative and the WT version exists mostly as a monomer; low-
level expression of misfolded Yor1ΔF-HA does not activate the UPR; Yor1ΔF-HA does 
not contain any known disulfide bonds and is not glycosylated, therefore it can not be 
directly perturbed by DTT or TM treatment.     
The folding state of Yor1ΔF-HA was monitored by limited proteolysis, an assay that 
has been extensively used to probe conformational features of proteins (FONTANA et al. 
2004). Cells bearing copies of either Yor1-HA or Yor1ΔF-HA were grown to mid-log 
phase, harvested and lysed. Isolated membranes containing the protein were treated with 
increasing concentrations of trypsin on ice and reactions were stopped by addition of 
SBTI. Proteins were solubilized and separated by SDS-PAGE. Protein fragments were 
detected using a α-HA antibody and a secondary HRP antibody.  
As shown in Figure II.2A, Yor1-HA and Yor1ΔF-HA show different digestion 
patterns after treatment with increasing concentrations of trypsin. Yor1ΔF-HA is 
significantly more susceptible to proteolytic cleavage as evidenced by the loss of the 
higher molecular weight bands including the full length Yor1ΔF-HA as well as further 
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Figure II.2. Folding state of Yor1-HA and 
Yor1ΔF-HA upon activation of the UPR 
Cells bearing Yor1-HA or Yor1ΔF-HA were 
grown to mid-log phase, harvested and 
lysed. Membranes were isolated and treated 
with increasing concentrations of trypsin for 
10 min on ice. Reactions were stopped by 
addition of SBTI on ice.  Proteins were 
solubilized from membranes and separated 
by SDS-PAGE. Protein digestion pattern 
was visualized by immunoblotting with a α-
HA antibodies and a secondary HRP 
conjugated antibody. A. Cells were treated 
with 2.5mM DTT for 1 hr prior to 
harvesting B. Cells were pre-treated with 
2μg/ml TM for 1 hr and then harvested. C. 
Cells bearing the pcIRE1 construct were 
grown to mid log phase, harvested and then 








In the event that a given treatment is able to help in the correct folding of Yor1ΔF-
HA, its digestion pattern might more closely resemble that of Yor1-HA. Figures II.2A 
and II.2B show the trypsin digestion patterns for Yor1-HA and Yor1ΔF-HA upon UPR 
activation by DTT and TM.  The digestion patterns for Yor1-HA in the presence of DTT 
or TM seem very similar to the pattern yielded from untreated cells suggesting that this 
treatment does not directly affect the folding of WT protein. In the case of Yor1ΔF-HA 
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under DTT and TM treatment, the 60kD band is further degraded as in untreated cells 
suggesting that Yor1ΔF-HA remains unfolded, at least as indicated by this assay.   
Activation of the UPR by DTT or TM causes massive accumulation of misfolded 
proteins, most likely exceeding the folding capacity of the ER and potentially preventing 
us from detecting any improvement in the folding of Yor1ΔF-HA. Therefore, the folding 
state of Yor1-HA and Yor1ΔF-HA was tested upon activation of the UPR in the absence 
of misfolded proteins using the constitutive active version of Ire1p or the inducible GRE-
HAC1S. Figure II.2C presents the digestion pattern of Yor1ΔF-HA in cells expressing the 
pcIRE1. Yor1ΔF-HA still presented more of the lower molecular weight bands in 
comparison with Yor1-HA indicative of more susceptibility to trypsin and therefore of a 
more unstable protein. I repeated this experiment using the inducible HAC1s system 
however the results were inconclusive for Yor1ΔF-HA because the protein was massively 
degraded even in un-induced cells, probably due to different growth conditions (data not 
shown).  
These results indicate that activation of the UPR by ER stress or by pcIRE1 did not 
help correct the folding of Yor1ΔF-HA. However these results cannot conclusively rule 
out refolding of misfolded proteins as a mechanism to reduce the amount of misfolded 
proteins upon ER stress. First, the misfolding lesion in Yor1ΔF-HA is located in NBD1, 
which faces the cytosolic side of the ER membrane; therefore upregulated ER chaperones 
might not have access to it. Yor1p is not an essential protein and it maybe that the folding 
machinery is dedicated to help in the folding of proteins that are necessary for survival 
under stress conditions. Also, it is plausible that, due to experimental conditions, any 
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interaction that might help Yor1ΔF-HA folding is lost and therefore is not reflected in the 
digestion pattern.  
Another misfolded protein model that I studied was Gas1G291R-HA (Gas1*-HA). 
Gas1p is a β-1,3-glucanosyltransferase required for cell wall assembly that localizes to 
the cell surface via its glycosylphosphatidylinositol (GPI) anchor. Gas1p is synthesized 
and translocated to the ER where it receives its GPI anchor and is core-glycosylated. 
Following packaging into ER derived vesicles, Gas1p is trafficked to the Golgi where it 
is further glycosylated and then transported towards its final destination at the cell wall. 
Misfolded Gas1*-HA is retained in the ER and degraded, presumably by ERAD (FUJITA 
et al. 2006b).  The distinctive glycosylation events in the ER and Golgi can be used as a 
maturation signal for Gas1p and represent an indirect way to track the folding state of 
Gas1p using pulse chase analysis. For this assay, cells are metabolically labeled with 
radioactive met/cys, which is incorporated into newly synthesized proteins. Cells are 
chased with excess of cold amino acids and harvested at different times to track the fate 
of the labeled protein. Cells are lysed and subjected to immunoprecipitation of the 
proteins of interest that are later separated by SDS-PAGE and visualized by 
phosphorimaging.  Figure II.3A presents a pulse chase of WT Gas1p for 0, 30, 60 and 90 
min. At time point 0 min the majority of Gas1-HA is in the ~105kD ER form, but by 30 
minutes only the ~125kD Golgi form can be detected.  In the case of Gas1*-HA, only the 
ER form can be detected over time, presumably because it is misfolded, retained in the 
ER, and therefore, unable to be glycosylated in the Golgi. This misfolded Gas1*-HA is 
rapidly degraded in comparison to WT Gas1-HA; by 30 min only ~20% of Gas1*-HA 
remains compared to ~73% of Gas1-HA (Figure II.3B).  
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Figure II.3. Degradation of misfolded Gas1*-HA and Yor1ΔF-HA upon UPR activation  
Cells were grown in media lacking metionine and cysteine for 15 min, metabolically labeled with 35S for 
5 min and chased with excess of cold amino acids. Samples were taken over time and cells were lysed. 
Protein of interest was immunoprecipitated using α-HA conjugated sepharose beads from clarified lysate 
and separated on SDS-PAGE. Proteins were visualized by phosphorimaging. A Cells bearing Gas1*-HA 
treated with 2.5mM DTT for 1hr or transformed with the pcIRE1 construct were pulse-chase for 0, 30, 60, 
and 90 min. B. Gas1-HA or Gas1*-HA was quantified as a percentage of the total protein remaining over 
time relative to the  0 min time point. C. Cells bearing Yor1ΔF-HA treated with 2.5mM DTT for 1hr or 
transformed with the pcIRE1 construct were pulse-chase for 0, 60, 120, and 180min. D. Yor1ΔF-HA was 
quantified as a percentage of the total protein remaining over time relative to 0min time point.  
 
In order to assess the impact of UPR activation on Gas1*-HA, cells were either 
treated with DTT for 1 hr or alternatively exposed to the pcIRE1 system and submitted to 
pulse chase analysis (Figure II.3A and II.3B). Pulse chase analysis of Gas1*-HA in DTT-
treated cells showed that over time only the ER form is present indicating that Gas1*-HA 
likely remains misfolded and unable to be trafficked to the Golgi. However degradation 
of Gas1*-HA under this condition is delayed in comparison to untreated cells: by 30 min, 
42% of Gas1*-HA remained in DTT-treated cells compared to 16% of Gas1*-HA in 
 
 
  60 
untreated cells.  Similar results were also obtained for the cells bearing the constitutive 
active form of Ire1p: only the lower molecular weight ER form is present over time, 
however it is more rapidly degraded in comparison with Gas1*-HA in DTT-treated cells 
(24% of Gas1*-HA remained in pcIRE1 cells versus 42% in DTT-treated cells at 30 
min). These results suggest that UPR activation does not help refold misfolded Gas1*-
HA, however, it does have an effect on the degradation of misfolded proteins. It has been 
previously reported that in conditions of stress, degradation of misfolded proteins seems 
to be delayed due to saturation of the ERAD machinery (TRAVERS et al. 2000). 
Degradation of misfolded Yor1ΔF-HA was also assessed by metabolic pulse chase 
upon activation of the UPR (Figures II.3C and II.3D). Degradation of Yor1ΔF-HA was 
accelerated in cells bearing the pcIRE1 construct compared to Yor1ΔF-HA in untreated 
cells: by 30 min ~29% of Yor1ΔF-HA still remains in pcIRE1cells compared to 69% of 
Yor1ΔF-HA in untreated cells. Surprisingly Yor1ΔF-HA was degraded faster in cells 
treated with DTT (by 30 min 38% of Yor1ΔF-HA remains in DTT-treated cells versus 
69% in untreated cells), which seems to contradict previous results that indicate that 
presence of overwhelming amount of misfolded proteins seems to saturate the ERAD 
machinery.  
 
ER stress increases packaging of cargo proteins into ER-derived vesicles  
Another possible way to reduce the amount of misfolded proteins accumulated in 
the ER is to increase packaging into ER-derived vesicles toward other destinations in the 
cell. Components of ER-to-Golgi traffic are upregulated upon induction of the UPR and 
present synthetic interactions with IRE1 and HAC1 (HIGASHIO and KOHNO 2002; SATO et 
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al. 2002; TRAVERS et al. 2000). Vesicle formation starts with recruitment of the small 
GTPase Sar1p to the ER membrane, which subsequently recruits the Sec23p/Sec24p 
dimer and the Sec13p/Sec31p heterotetramer, which forms the outer layer of the COPII 
coat (LEE et al. 2004). This budding event can be recapitulated in vitro to assess direct 
packaging of proteins into COPII vesicles.  For this assay, membranes derived from 
metabolically labeled cells are combined with the COPII proteins Sar1p, Sec23/24p and 
Sec13/31p (purified proteins or contained in cytosol), GTP and an ATP regeneration 
system. Newly formed ER derived vesicles are isolated from donor membranes by 
differential centrifugation. Proteins are then solubilized and detected by 
immunoprecipitation, SDS-PAGE and phosphorimaging. Budding efficiency is 
calculated as the percentage of protein present in the GTP or GDP-containing reactions 
relative to the total protein present in the membrane fraction. Packaging into ER derived 
vesicles of the cargo proteins Yor1-HA and Sec22p was monitored upon activation of the 
UPR under stress and non-stress conditions (Figures II.4 A-C).  In order to determine the 
effect of the UPR on both the cytosolic and membrane components of vesicle budding, 
membranes derived from cells containing Yor1-HA treated with 2.5mM DTT for 1 hr or 
bearing the pcIRE1 plasmid were combined with cytosol also derived from DTT-treated 
cells or pcIRE1 cells. 
The budding efficiency of Yor1-HA in untreated cells was 5.9%, in DTT-treated cells 
was 16.4% and in cells bearing pcIRE1 construct was 8%. Statistical testing (student t-
test) indicates that the increase in budding efficiency of Yor1-HA in DTT-treated cells 
and in pcIRE1 cells is significant compared to the untreated cells (p-values DTT= 0.007, 
n=5; pcIRE1= 0.018 n=5). 
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Figure II.4. Packaging of Yor-HAp, YorΔF-HAp and Sec22p into ER derived vesicles upon UPR 
activation 
A. Membranes derived from metabolically labeled cells treated with 2.5mM DTT or transformed with 
pcIRE1 were incubated with cytosol obtained from DTT treated cells or pcIRE1 cells, GTP or GDP and 
an ATP regeneration system for 25 min at RT. Newly formed vesicles were isolated for donor membranes 
by centrifugation. Proteins were solubilized from vesicles, isolated by immunoprecipitation and 
visualized by phosphorimaging. T lane corresponds to the total protein in the reaction, GTP lane is the 
vesicle fraction and GDP lane is the budding negative control.  A. Budding reactions for Yor1-HA and 
Yor1ΔF using membranes and cytosol from WT cells, cells treated with 2.5mM for 1 hr and cells bearing 
pcIRE1 construct. Sec22p was used as budding reaction control. B. Budding efficiency of Yor1-HA and 
Yor1ΔF-HA was quantified as the percentage of protein present in the vesicle fraction (GTP or GDP 
lanes) from the total protein in the membrane fraction (T lane). C. Budding efficiency of Sec22p control 
was quantified as describe before. Asterisk denotes that budding efficiency was statistically different from 
budding efficiency in untreated (WT) cells according to student t-test.  
 
A similar experiment was done to look at the effect of UPR activation on the 
budding of misfolded Yor1ΔF-HA, which is usually excluded from COPII vesicles. The 
average budding efficiency of Yor1ΔF-HA in untreated cells was less than 1%, as 
expected. In the case of DTT-treated cells, the budding efficiency of Yor1ΔF-HA was 
4.1%, which is a significant increase in budding compared to untreated cells (p-
value=0.014, n=5), however, it is not as high as the budding efficiency of Yor1-HA.  
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Budding efficiency of Yor1ΔF-HA in cells bearing pcIRE1 was 2.4%, which was not 
statistically different from the budding in untreated cells (p-value=0.08, n=5; Figures 
II.4A and II.4B).  
The Sec22p budding control indicated that budding reactions proceeded normally 
in all conditions, therefore the lack of budding of Yor1ΔF-HA was not due to an overall 
inefficient budding reaction. Sec22p budding efficiency was also significantly increased 
in DTT treated cells with an efficiency of 19% versus 11% in untreated cells (p-value 
=0.043 n=10) but not in pcIRE1 bearing cells, which had a budding efficiency of 14.8% 
(p-value = 0.25 n=10) (Figures II.4A and II.4C). These results indicate that there is an 
overall significant increase in budding efficiency in DTT-treated cells even of misfolded 
proteins, but the slight increase in pcIRE1 bearing cells is not significant in all cases. 
 In the negative control budding reaction, in which GDP is used instead of GTP and 
little or no budding should occur, the budding efficiency was high for both the DTT and 
pcIRE1 reactions. Budding reactions using cytosol instead of purified COPII proteins are 
notorious for yielding higher budding efficiency in the GDP negative control, possibly 
because of residual GTP contained in the isolated cytosol. Also, because of the various 
treatments, is possible these membranes are more prone to non-specific fragmentation.  
Similar budding reactions using purified COPII proteins instead of cytosol were 
performed in order to reduce the background budding due to the use of cytosol. Therefore 
any difference in budding efficiency should come from the effect of the different 
treatments on the membranes alone.  For these experiments I evaluated the budding 
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Figure II.5. Packaging of COPII machinery Sec22p and cargo client Vph1 and Yor1-HA into ER 
derived vesicles upon UPR activation using purified cytosolic COPII components  
Membranes derived from metabolically labeled cells treated with 2.5mM DTT or transformed with 
pcIRE1 were incubated with purified COPII proteins (Sar1p, Sec23/24, and Sec13/31), GTP or GDP and 
an ATP regeneration system for 25 min at RT. Proteins of interest were detected as described before. A. 
Budding reactions for V-SNARE Sec22p. B. Budding efficiency of Sec22p control was quantified as 
described before. C. Budding reactions for cargo client Vph1p. D. Budding efficiency of Vph1p was 
quantified as described before. E. Budding of Yor1-HA and Yor1ΔF-HA  using membranes derived from 
cells treated with DOCA to induce expression of the spliced version of Hac1p (pGRE-HAC1s) and COPII 
purified proteins. Asterisk denotes that budding efficiency was statistically different from budding 
efficiency in untreated (WT) cells according to student t-test.  
 
and II.5B) and of cargo client Vph1p, a subunit of the vacuolar-ATPase V0 domain 
(Figures II.5C and II.5D).  For Sec22p, the average budding efficiency in untreated cells 
was 29%, in DTT-treated cells 40%, and in pcIRE1 bearing cells 28%. The increase in 
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budding in DTT treated cells was significant in comparison to the untreated cells (p-value 
= 0.050 n=6). The overall budding efficiency of Sec22p is higher with the use of purified 
COPII proteins in comparison to the use of cytosol because the purified proteins are 
added in excess. For Vph1, the budding efficiency was 7.5% in untreated cells, 11.7% 
DTT treated cells and 8.4% in pcIRE1 bearing cells, however only the increased in 
budding in DTT cells was significant (p-value = 0.015 n=3).  
Budding efficiency of Yor1-HA and Yor1ΔF-HA using membranes derived from 
cells bearing the inducible spliced version of the UPR transcription factor Hac1p (GRE-
HAC1s) and purified COPII showed that Yor1ΔF-HA packaging into ER derived vesicles 
was not improved (Figure II.5E). The GDP controls for these experiments were 
substantially lower than in the reactions where cytosol was used as a source of COPII 
proteins indicating that the cytosol was contributing to the signal in the GDP control. 
These results indicate that there is an increase in the packaging of proteins, including 
misfolded protein, into vesicles in ER stressed cells (DTT-treated cells) but not upon 
induction of the UPR in non-stress conditions (cells bearing pcIRE1 or GRE-HAC1s). 
 
UPR activation is necessary to regain protein traffic upon removal of stress. 
Our data suggest that budding of misfolded proteins is increased upon UPR, however 
this is not due to refolding of aberrant proteins. We wanted to further examine the role of 
the upregulated chaperone machinery upon UPR activation after removal of the stress. 
For this, I monitored the processing of endogenous Gas1p and CPY after removal of ER 
stress using pulse chase analysis (Figure II.6A). In untreated cells, Gas1p completely 
matures after 10 min in contrast to DTT-treated cells where only the 105kD ER form is 
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present over time. Gas1p has 7 disulfide bonds that might be affected by DTT, likely 
causing misfolding of the protein and subsequent degradation.  In fact, it has been shown 
that mutations of Cys348 and Cys74 results in a 105kDa ER form that is unable to reach the 
Golgi and progressively degraded (CAROTTI et al. 2004; POPOLO et al. 2008). However, 
in cells where the DTT has been removed prior to labeling, Gas1p matures in a similar 
manner as in untreated cells, albeit with a slight delay.  
A similar washout experiment was done using 2μg/ml TM (Figure II.6A). Pulse chase 
analysis of Gas1p under TM treatment shows that only the ER form is present over time. 
Even in the washout experiment, only the unmodified version of Gas1p is present. As 
mentioned above, TM is a competitive inhibitor of Alg7p, which binds very tightly to this 
glycosylation enzyme, therefore just removing the media containing TM might not be 
enough to reverse it effects. In contrast, the effects of DTT are known to be reversible 
once the drug is removed (JAMSA et al. 1994). Due to the quick recovery of Gas1p 
transport after DTT removal, it was used to assess the importance of UPR activation in 
the recovery process of the cell after the stress is eradicated.  
In order to determine the importance of UPR in the recovery of the cell after removal 
of DTT, I tracked the processing of Gas1p in a hac1Δ strain (Figure II.6B). In untreated 
hac1Δ cells, Gas1p matures at a similar rate as in WT cells, whereas in DTT-treated 
hac1Δ  cells Gas1p is only present as the ER form. There is a slight increase in the 
molecular weight of the ER band over time probably due to extensive O-mannosylation 
in the ER (HIRAYAMA et al. 2008).  Nonetheless, the degradation of Gas1p that has 
become misfolded during DTT treatment in the hac1Δ strain is not as fast as in the WT 
counterpart.  Pulse chase of washed-out hac1Δ cells, shows persistence of the ER form of  
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Figure II.6.  Gas1p processing during and after ER stress in cells lacking UPR  
WT or hac1Δ cells were starved from Met and Cys for 15 min, metabolically labeled with 35S for 5min, 
chased with cold amino acids and time points were taken as indicated. Cells were lysed and Gas1p was 
isolated from lysate by immunoprecipitation.  Proteins were solubilized from beads, separated by SDS-
PAGE and visualized by phosphorimaging. A. WT cells were treated with 2.5mM DTT or 2μg/mLTM for 
1 hr prior to pulse chase analysis. First 4 lanes correspond to untreated cells. For DTT and TM lanes, 
drugs were maintained during in all parts of experiment. For DTT; WO 5 min or TM; WO 5 min lanes, 
cells were resuspended in fresh media without drugs just prior to radioactive labeling. B. WT or hac1Δ 
cells were treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. C. WT or hac1Δ cells were 
treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. For DTT; WO 30 min lanes, cells were 
resuspended in fresh media without DTT and incubated for 15 min before starvation. D. WT or hac1Δ 
cells were treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. For the last 4 lanes, cells were 
labeled in presence of DTT, cold amino acids were added, a sample was taken was taken (0 min) and cells 
were resuspended in fresh media without DTT. E. Degradation of Gas1p was quantified for untreated WT 
cells and DTT pre-treated cells in which DTT was removed after labeling. Gas1p remaining was 




  68 
Gas1p after 60 min. At the 60 min time point it seems that a higher molecular weight 
band starts to appear however the resolution of the band is not good enough to determine 
if the band corresponds to the Golgi form or to an O-mannosylated ER form.   
In order to see if processing of Gas1 is eventually rescued in hac1Δ cells after 
removal of DTT, a similar experiment was performed extending the recovery time to 30 
min (Figure II.6C).  DTT wash-out experiment in hac1Δ cells showed that after 10 min a 
higher molecular band starts to appear indicative of traffic to the Golgi. From these 
experiments we can conclude that: (1) in the presence of DTT, Gas1p probably becomes 
misfolded and degraded in a UPR-dependent manner; (2) quick processing of newly 
synthesized Gas1p after removal of DTT depends on an intact UPR but given enough 
time, Gas1p traffic is re-established. 
Another aspect that I tested is the fate of proteins synthesized in the presence of DTT 
after the stress is removed. For these experiments cells were treated with DTT for 1hr and 
labeled for 5 min with 35S Met/Cys in the presence of DTT. After labeling, cold amino 
acids were added, a time point was taken (0min) and DTT was removed from media. 
Pulse chase analysis in WT cells washed after labeling showed that Gas1p is trafficked to 
the Golgi after removal of DTT indicated by the appearance of the 125kD band. However 
the degradation of Gas1p under these conditions appears to be faster than in untreated 
cells (Figure II.6E); by 30 min only %14 of Gas1p remains in washed-out cells compared 
to 52% of Gas1p that remains in untreated cells.  Perhaps after removal of the stress, part 
of the pool of Gas1p synthesized in presence of DTT is refolded whereas another pool is 
degraded. A similar washout experiment after labeling was repeated on hac1Δ cells.  As 
indicated on Figure II.6D, after 5 min of recovery in media without DTT, previously 
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labeled Gas1p does not mature or degrade in hac1Δ cells. These results indicate that 
activation of the UPR is important for the refolding and/or degradation of Gas1p after the 
ER stressed has been removed.     
Another model protein tested was CPY. CPY has three forms: a p1 ER form, a p2 
Golgi form and a vacuolar m form that can be easily tracked over time by pulse chase 
analysis.  An analysis of CPY in untreated cells shows that by 15 min all the CPY has 
matured to its vacuolar form as evidenced by the sole presence the lower molecular 
weight band (Figure II.7A). However, in the presence of DTT, traffic of CPY seems to be 
delayed; by 60 min the p1 and p2 bands are still present. Poor resolution of the protein 
gels and the small difference between the molecular weights of the p1 and p2 forms 
prevents the distinction of whether the delay occurs at the ER or the Golgi.  
After removal of DTT, traffic of CPY remained delayed, however when the washout 
time was extended from 5 to 30 min (Figure II.7B), traffic of the newly synthesized CPY 
was eventually restored. These same experiments were repeated in hac1Δ cells (Figure 
II.7A). As with Gas1p, CPY is normally trafficked in hac1Δ untreated cells. However, in 
DTT treated cells, traffic of CPY seemed to be completely blocked as no vacuolar band 
appears over time. Therefore, the presence of an intact UPR does contribute to the fate of 
CPY during conditions of stress (DTT treatment). In hac1Δ cells, where DTT was 
removed just prior to labeling, CPY matures in a similar way to WT cells (Figure II.7B.) 
When CPY is labeled in the presence of DTT and then subjected to washout in hac1Δ 
cells (Figure II.7C), only the higher molecular weight band is visible indicating that the 
reversible effect of DTT also depends on the UPR. These results indicate that the UPR 
has a role in maintaining traffic of CPY during stress and after the stress is removed. 
 
 



























Figure II.7.  CPY processing during and after ER stress in cells lacking UPR  
WT or hac1Δ cells were starved from Met and Cys for 15 min, metabolically labeled with 35S for 5min, 
chased with cold amino acids and samples were taken as indicated. Cells were lysed and CPY was 
isolated from lysate by immunoprecipitation.  Proteins were solubilized from beads, separated by SDS-
PAGE and visualized by phosphorimaging. A. WT or hac1Δ cells were treated with 2.5mM DTT for 1 hr 
prior to pulse chase analysis. First 4 lanes correspond to untreated cells. For DTT lanes, drug was 
maintained during in all parts of experiment. For DTT; WO 5min lanes, cells were resuspended in fresh 
media without DTT after the starvation step, just prior to radioactive labeling. B. WT or hac1Δ cells were 
treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. For DTT; WO 30 min lanes, cells were 
resuspended in fresh media without DTT and incubated for 15 min before starvation. D. WT or hac1Δ 
cells were treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. For the last 4 lanes, cells were 
labeled in presence of DTT, cold amino acids were added, a sample was taken (0min) and cells were 
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Membrane expansion is not necessary for restoration of protein processing upon 
removal of ER stress.  
  Another group of genes that are upregulated upon UPR activation are those involved 
in lipid biosynthesis (TRAVERS et al. 2000). It has recently been reported that ER stress 
caused by addition of DTT or TM leads to ER expansion dependent on UPR activation. 
In fact, it seems that ER expansion by itself is able to confer resistance to DTT even 
when the rest of the UPR targets are not upregulated. Therefore, ER expansion seems to 
be one of the mechanisms induced by the UPR that the cell uses to cope with 
accumulation of misfolded proteins.  
ER expansion is driven by the Ino2/4 complex (SCHUCK et al. 2009). Ino2p and Ino4p 
form a heterodimer that positively regulates phospholipid synthesis enzymes at the 
transcriptional level by driving expression of genes containing UASINO cis-acting 
elements. This complex is negatively regulated by Opi1p: Opi1p inhibits the Ino2/4p 
complex by binding Ino2p when lipid pools are abundant. When more lipids are needed, 
Opi1p dissociates from Ino2p, allowing Ino2/4p to activate its target genes (CARMAN and 
HENRY 2007). 
Our results indicate that UPR activation seems to be necessary for the rapid 
restoration of Gas1p traffic to the Golgi after the stress has ended and also for the 
degradation of Gas1p and processing of CPY during the stress event.  Since ER 
expansion alone has been shown to be sufficient to confer tolerance to stress (SCHUCK et 
al. 2009), I wanted to test if this event is responsible for restoring Gas1p processing upon 









Figure II.8. Gas1p and CPY processing during and after ER stress in cells with a constitutive 
expanded ER but unable to activate the UPR 
Opi1Δhac1Δ cells were subjected to pulse chase analysis as described before. After immunoprecipitation 
with α-Gas1p, lysate was submitted to a second round of immunoprecipitation using an α-CPY antibody. 
Proteins were solubilized, separated by SDS-PAGE and visualized by phosphorimaging. A and C. 
Opi1Δhac1Δ cells were treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. First 4 lanes 
correspond to untreated cells. For DTT lanes, drug was maintained during in all parts of experiment. For 
DTT; WO 5min lanes, cells resuspended in fresh media without DTT after the starvation step. B and D. 
Opi1Δhac1Δ cells were treated with 2.5mM DTT for 1 hr prior to pulse chase analysis. For DTT, cells 
were labeled in presence of DTT, cold amino acids were added, time point 0 min was taken and cells 
were resuspended in fresh media without DTT. 
 
 
In order to test this, Gas1p maturation was tracked after DTT removal in 
hac1Δopi1Δ cells.  Deletion of the OPI1 gene causes constitutive ER expansion since 
these cells are not able to negatively regulate the Ino2/4p complex (SCHUCK et al. 2009).  
The hac1Δopi1Δ  strain should have ER expansion and no UPR activation; however ER 
expansion was not demonstrated in my hands. The processing of Gas1p and CPY in 
hac1Δopi1Δ  untreated cells, DTT-treated cells and cells where the DTT was washed out 
before and after the labeling is similar to that in hac1Δ cells (Figure II.8). These results 
indicate that membrane expansion alone is not enough to aid in the quick recovery of 
Gas1p and CPY processing after stress removal and the other targets of the UPR are 
necessary for this event.  
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Since membrane expansion alone was not able to rescue Gas1p and CPY processing 
after stress removal, I asked if ER membrane expansion upon UPR activation contributes 
to cell recovery. To test this, Gas1p and CPY maturation was assessed in cells lacking 
INO2. Ino2Δ cells are capable of activating the UPR in the presence of DTT but are 
unable to expand the ER membrane in the absence of exogenous lipids, therefore cells 
were grown in media lacking lipids for this set of experiments. In contrast, WT cells can 
expand their ER in the absence of exogenous lipids because they can produce their own 
(SCHUCK et al. 2009).  
Figure II.9 shows the processing of Gas1p and CPY in WT and ino2Δ  untreated 
cells, DTT-treated cells and cells where the DTT was washed-out before and after 
labeling. Gas1p and CPY maturation profiles do not differ significantly between WT and 
ino2Δ cells under the same experimental conditions. These results indicate that the 
membrane expansion component of the UPR is not necessary for restoring trafficking of 
Gas1 and CPY after removal of the stress highlighting the importance of the other 










Figure II.9. Gas1p and CPY processing during and after ER stress in cells unable to expand its ER 
membranes  
WT or ino2Δ cells were grown to mid-log phase in YPD. Cells were switched to media without lipids 
(SC+ amino acids) 15 min prior to incubation with 2.5mM DTT for 1 hr.  Cells were metabolically 
labeled with 35S for 5min, chased with cold amino acids and samples were taken as indicated. Cells were 
lysed and Gas1p was isolated from clarified lysate by immunoprecipitation. After immunoprecipitation 
with α-Gas1, clear lysate was submitted to a second round of immunoprecipitation using a α-CPY 
antibody. Proteins were solubilized from beads, separated by SDS-PAGE and visualized by 
phosphorimaging. A and C. WT or ino2Δ cells were treated with 2.5mM DTT for 1 hr prior to pulse 
chase analysis. For DTT; WO 5min lanes, cells resuspended in fresh media without DTT after the 
starvation step, just prior to radioactive labeling. B and D. WT or ino2Δ cells were treated with 2.5mM 
DTT for 1 hr prior to pulse chase analysis.  For last 4 lanes, cells were labeled in presence of DTT, cold 
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Discussion 
 
Not all types of environmental stress activate the UPR. 
Accumulation of misfolded protein leads to activation of the Unfolded Protein 
Response. This response encompasses very distinct but interconnected processes that 
work in concert to maintain ER homeostasis upon environmental insults. Our results 
confirmed that treatment with DTT as well as with TM results in UPR activation as 
evidenced by the UPRE-LacZ reporter assays.  The ER is one of the main sites of 
oxidative folding in the cell, therefore is directly affected by DTT since this chemical 
breaks disulfide bonds important for correct protein structure. TM prevents glycosylation 
of proteins, which is important in folding as well as degradation of glycoproteins.  
However, our results suggest that not all kinds of environmental insults are able to 
trigger the UPR. Treatment with H2O2 did not activate the UPR in our experimental 
conditions. In mammalian cells, oxidative stress caused by TNFα-induced ROS 
accumulation activates the UPR whereas by H2O2 treatment does not (XUE et al. 2005). 
Also, treatment with the toxic metal Cd2+ which leads to ROS production and oxidative 
stress, activates the UPR in yeast as well as the 3 major branches of the mammalian UPR 
(GARDARIN et al. 2010) .This suggests that different oxidative stresses specify activation 
of different signaling pathways. Perhaps accumulation of ROS due to addition of H2O2 
occurs in another cellular compartment rather than the ER, therefore the folding process 
in the ER is not affected. 
Another stress tested for UPR activation by the UPRE-LacZ reporter assay was heat 
shock (25oC to 37oC). Thermal stress is known to activate a response called the Heat 
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Shock Response (HSR). In contrast to UPR, which senses ER stress, HSR is 
predominantly a response to stress conditions in the cytosol. In Saccharomyces 
cerevisiae, this response is mediated by the Hsf1p transcription factor, which binds to 
heat shock elements (HSE) in the promoters of a wide range of target genes. Similar to 
UPR, HSR causes transcriptional activation of molecular chaperones and elements of the 
ubiquitin–proteasome system among others (SHAMOVSKY and NUDLER 2008).  
Interestingly, genomic analysis has revealed that targets of Hsf1p overlap with targets 
also induced by UPR. Other links between the UPR and the HSR have also been 
established. HSR induced artificially by over-expression of HSF1 is able to relieve ER 
stress in the absence of UPR. Over-expression of HSF1 rescues the growth ire1Δ cells 
over expressing the misfolded protein, CPY*, or treated with TM and also releases the 
ER-to-Golgi traffic block of Gas1p in ire1Δ cells that over-express CPY*. Moreover, ER 
stress induced by TM treatment or CPY* over-expression is able to activate the HSR 
under conditions where the UPR is impaired; however, HSR induced by ER stress is 
significantly less compared with HSR induced by mild heat stress (LIU and CHANG 
2008).  Nonetheless, our results indicate that thermal stress was not able to activate the 
UPR, perhaps because the mild temperature shift from 25oC to 37oC was not able to 
create a substantial amount of misfolded proteins in the ER in order to activate Ire1p. 
cDNA Microarray analysis from mild heat-shocked (30oC to 43oC for 1hr) WT cells 
indicate that certain UPR genetic targets are upregulated upon this treatment, implying 
some UPR activation due to heat stress (MATSUMOTO et al. 2005). However, some of the 
genes upregulated by this treatment are known targets of both the HSR and the UPR, 
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including ERO1 and KAR2 (LIU and CHANG 2008), therefore upregulation might be due 
to Hsf1p activation instead of the UPR. 
Finally, UPR activation upon hyperosmotic shock was also tested. Most cells adapt to 
increased osmolarity by accumulating compatible solutes to balance the cellular osmotic 
pressure with the external environment. Saccharomyces cerevisiae uses glycerol as a 
compatible solute. It performs this role by partly replacing water and protecting 
biomolecules inside the cell as well as by increasing the intracellular water potential and 
thereby driving water back into the cell.  Upon hyperosmotic shock, the high osmolarity 
glycerol (HOG) pathway is activated to coordinate the adaptation of yeast cells to 
increased osmolarity of the surrounding medium (O'ROURKE et al. 2002). The HOG 
pathway consists of two discrete signaling branches composed of putative osmosensors 
coupled to a Mitogen Activated Protein Kinase (MAPK) cascade, some of which can lead 
to the phosphorylation and activation of the core MAPK Hog1p. Hog1p is responsible for 
regulating the expression of 600 genes in response to increased osmolarity by 
controlling the activity of several transcriptional activators and repressors. In addition, it 
has been shown that Hog1p is also required for adaptation to other stress conditions, such 
as oxidative stress, arsenite, cold stress and acetic acid stress (HOHMANN 2009).  
 Our results indicate that hyperosmotic shock by addition of 1M Sorbitol does not 
activate the UPR. However it has been recently suggested that a connection exists 
between ER stress, the UPR and the HOG pathway.  Torres-Quiroz, et al. (2010) reported 
that in yeast, the presence of Hog1p is necessary for growth of cells in TM, however 
Hog1 is not phosphorylated in presence of TM after 2 hrs indicating that the basal 
activity of Hog1p is enough to confer resistance to TM. Also, TM treatment induces 
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expression of GPD1 and the accumulation of the compatible osmolyte glycerol in a Hog1 
dependent way. Their evidence ruled out an interaction between the UPR and the HOG 
pathways in activating or modulating each other in response to ER stress. Deletion of 
HOG1 had no effect on UPR activity based on β-galactosidase reporters of UPR 
activation or expression of UPR-dependent target genes, like KAR2. Furthermore, double 
mutants lacking Ire1p and Hog1p do not show epistatic defects with respect to ER stress. 
Finally, TM-induced accumulation of glycerol is not dependant on a functional UPR 
pathway. Therefore, these pathways appear to control different targets and different 
mechanisms that allow yeast cells to confront the challenge of increased unfolded 
proteins (TORRES-QUIROZ et al. 2010). However, in another research article published at 
the same time, Bicknell, et al. (2010) showed that Hog1 becomes phosphorylated during 
the late stage of ER stress and helps the ER regain homeostasis. Nonetheless, significant 
amounts of phosphorylated Hog1p were detected after 3 hrs of treatment with TM and 
not 2 hrs, and required both IRE1 and HAC1. Following its phosphorylation, Hog1 
translocates into the nucleus and regulates the expression of genes that are specifically 
activated during late stage ER stress including key autophagy genes (BICKNELL et al. 
2010). Therefore, it seems that the HOG pathway and UPR are interconnected; however 
the HOG pathway plays a role in the adaptation of the cell to sustained stress whereas the 
UPR is an almost immediate response to the insult. Taken together   we can suggest that 
different kinds of environmental stresses do not necessarily lead to UPR activation, 
however ER stress caused by DTT or TM can lead to activation of other responses 
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Degradation of misfolded mutant proteins seems to be preferred over refolding during 
ER stress. 
Upregulation of different targets by the UPR suggests that different mechanisms 
contribute to the tolerance of stress, perhaps by reducing the amount of misfolded 
proteins in the ER. Since chaperones and folding factors are upregulated upon UPR 
activation it is plausible that this newly synthesized folding machinery refolds aberrant 
proteins in order to decrease the amount of protein accumulated in the ER. It has been 
reported that chaperones aid in the correct folding of misfolded proteins; for example, the 
cytosolic chaperone Ssa1/2p is necessary for the refolding of denatured luciferase (BUSH 
and MEYER 1996). However there is no evidence that UPR induction can have this effect.  
Our results indicate that the model misfolded proteins, models Yor1ΔF-HA are Gas1*-
HA, are not refolded upon UPR activation but instead are degraded, as evidenced by 
trypsin sensitivity assays and pulse chase analysis. However, one point to consider is that 
misfolding of Gas1*-HA and Yor1ΔF-HA is caused by mutations in the sequence of the 
proteins that might alter their three dimensional conformation such that just increasing 
the amount of general chaperones in the ER is not enough to correct the folding of the 
protein. In addition, these two proteins might need special factors to aid in folding 
process that are not upregulated by the UPR.  
Many studies have previously characterized the ability of Hsp70 chaperones to 
improve refolding of either heat- or chemically-denatured substrates. However a recent 
report that assessed the in vitro folding abilities of the eukaryotic ER Hsp70 chaperone 
system, constituted by BiP, ERdj3 and BAP, indicated that the BiP system does not 
improve refolding of heat or chemically denatured firefly luciferase or β-galactosidase, 
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however it seems to facilitate co-translational folding of proteins that contain 
immunoglobulin domains (BONOMO et al. 2010). This effect remains to be tested in the 
yeast ER Hsp70 chaperone system however, yeast counterparts of this system like the 
chaperone Kar2p, nucleotide exchange factors for Kar2p, Sls1p and Lhs1p, and DnaJ-like 
homologs Scj1p and Jem1p are upregulated upon UPR activation (TRAVERS et al. 2000). 
Perhaps the chaperone machinery upregulated during the UPR is mostly dedicated to 
folding the newly synthesized targets or to aid in degradation of misfolded proteins 
instead of refolding them.   
Our results indicate that degradation of the mutant misfolded proteins Gas1*-HA and 
Yor1ΔF-HA is dominant over its folding upon activation of the UPR by exposure to DTT 
or the pcIRE1 system. Treatment with DTT seems to delay the degradation of Gas1*-HA. 
It has been previously reported that upon treatment with DTT, degradation of another 
misfolded protein, CPY*, is also delayed. These treatments generate pathologically high 
levels of misfolded protein; the blockage of ERAD may therefore result from saturation 
of the capacity of the ERAD system despite activation of the UPR and transcriptional 
upregulation of several ERAD components under these conditions. High levels of even a 
single misfolded protein can substantially decrease the rate of degradation: expression of 
CPY* from a strong promoter resulted in accumulation of the protein and a doubling of 
its half-life, consistent with the idea that ERAD capacity can be saturated by high 
concentrations of substrate (TRAVERS et al. 2000).   
In contrast to Gas1*-HA and CPY*, our results indicate that degradation of Yor1ΔF-
HA was accelerated upon UPR activation by DTT. This seems to contradict earlier 
results; however there are possible explanations for this outcome. Yor1ΔF-HA presents 
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multiple assembly defects that involve improperly arranged transmembrane segments as 
well as a destabilized cytoplasmic domain; therefore, it has been suggested that Yor1ΔF-
HA is a substrate for degradation by the ERAD-C and ERAD-L/M pathways. Yor1ΔF-
HA is not stabilized in cells lacking HRD1, which is involved in ERAD-M in addition to 
ERAD-L, or missing DOA10, a main player for ERAD-C, but it is stabilized in a hrd1Δ 
doa10Δ cells, suggesting that the absence of one ERAD branch can be compensated by 
another (PAGANT et al. 2007). In contrast, CPY* is only a substrate for ERAD-L, 
therefore if ERAD-L becomes saturated then CPY* degradation can become delayed.   
Another point to consider is that both, Gas1*-HA and CPY*, are glycoproteins 
whereas Yor1ΔF-HA is not.  It has been shown that glycoproteins need special machinery 
for their recognition as ERAD substrates including players like Yos9p (KIM et al. 2005). 
However, these components have not been identified as UPR upregulated targets. 
Therefore, it is plausible that, since components of the misfolded glycoprotein 
recognition machinery are not upregulated by the UPR, in order to accommodate the 
increase in the amount of misfolded glycoproteins in the ER then a “bottleneck” would be 
created in the process of ERAD substrate recognition thus leading to a delay in the 
degradation or stabilization of the misfolded glycoproteins. Our results suggest that 
saturation of the ERAD machinery upon accumulation of misfolded proteins is not a 
global effect but rather is specific to the machinery necessary for the degradation of a 
particular substrate. Nonetheless, these possibilities remain to be tested.  
Activation of the UPR using the GRE-HAC1S construct, thus in the absence of 
misfolded proteins, has been reported to accelerate the degradation of CPY* since 
components of the ERAD machinery are upregulated (TRAVERS et al. 2000).  Our results 
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indicate that, as for CPY*, degradation of Yor1ΔF-HA was accelerated in cells bearing 
the pcIRE1 construct, however this was not the case for Gas1*-HA. Degradation of 
Gas1*-HA in cells bearing the pcIRE1 construct was comparable to WT cells. ERAD 
components upregulated by the UPR (DER1, HRD1/DER3, HRD3 and  UBC7; TRAVERS 
et al. 2000) are known to be involved in the degradation of CPY*. For example, CPY* is 
stabilized in der1Δ and hrd1Δ cells (BORDALLO et al. 1998; HITT and WOLF 2004). 
However this is not the case for Gas1*-HA, since it is not stabilized in hrd1Δ cells 
(FUJITA et al. 2006b). Nonetheless, it remains to be determined if the other ERAD 
components upregulated by the UPR are involved in the degradation of Gas1*-HA.  
 
Packaging of proteins into ER-derived vesicles is increased upon ER stress. 
Since ER-to-Golgi trafficking components are upregulated upon UPR activation, we 
asked whether or not an increase in the availability of these proteins can lead to an 
improvement in the packaging of proteins into ER-derived vesicles in order to decrease 
the burden on the ER. In vitro budding reactions suggest that there is an increase in the 
packaging of certain proteins into COPII vesicles upon DTT treatment, including the 
misfolded protein Yor1ΔF-HA. However this effect was not seen when the UPR was 
activated in non-stress conditions by using the pcIRE1 or the GRE-HAC1s system. It has 
been documented that certain events that occur upon ER stress caused by DTT do not 
happen in cells where the UPR has been activated under non-stress conditions. For 
example, the formation of ER-derived autophagosomes seen in DTT-treated cells is not 
seen in GRE-HAC1s cells, however, ER membrane expansion, which is a prerequisite for 
the formation of the autophagosomes does require UPR activation (BERNALES et al. 
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2006; SCHUCK et al. 2009). Moreover, microarray analysis of cells in which the WT 
HAC1 gene was replaced with a spliced version revealed that only a subset of the early 
secretory pathway genes previously identified as UPR targets are upregulated (ERV29, 
SEC12, ERP1, ERP2, and YIP3; KIMATA et al. 2006).  It has been suggested that 
activation of the UPR in yeast might be more complex than anticipated and perhaps ER 
stress is necessary to upregulate the full spectrum of genes necessary to increase budding 
(PATIL et al. 2004). Another possibility is that the DTT had some sort of direct effect on 
the membrane making them more prone to spontaneous budding.  
Even though our results do not conclusively indicate that ER stress can lead to 
increased budding as a mechanism to decrease the amount of misfolded proteins, there is 
other evidence that supports this model. Studies done in mammalian cells indicate that 
activation of the UPR by over-expression of the misfolded protein GAT lead to an 
increase in number and size of ER exit sites. IRE1+/+  murine cells over-expressing GAT 
showed a higher number of ER exit sites, however this is not the case in  IRE1-/-  cells 
indicating that the UPR is responsible for the increase in ER exit sites (FARHAN et al. 
2008). However, these effects are seen as an adaptive response upon over-expression of 
GAT over a prolonged period of time.   
Also, it has been reported that treatment with thapsigargin, an inhibitor of calcium 
pumps in the ER membrane and known to activate the UPR in mammalian cells, releases 
misfolded CFTRΔF508 from the ER (EGAN et al. 2002).  DTT also induced the 
trafficking of the misfolded ATP binding cassette transporter ABCA1 Q597R from the 
ER to the plasma membrane via the Golgi (TANAKA et al. 2008). However, the role of the 
UPR in these events remains to be studied. 
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Another point to consider is the close connection between forward transport and 
ERAD.  It has been shown that degradation of a subset of misfolded proteins requires 
ER-to-Golgi transport. Degradation of Gas1p*, CPY* and KHN (simian virus 5 
hemagglutinin neuraminidase fused with a cleavable signal sequence from the yeast 
Kar2p) is delayed in sec18-1 and sec12-4 mutant cells which are required for vesicle 
fusion and formation respectively (FUJITA et al. 2006b; VASHIST et al. 2001).  Also, 
degradation of over-expressed CPY* that has been shown to be trafficked to the Golgi is 
delayed in cells lacking ERV29, a protein that is involved in vesicle formation and 
incorporation of specific secretory cargo (SPEAR and NG 2003).  Therefore, upregulation 
of COPII components upon UPR activation might facilitate efficient degradation of 
misfolded proteins by increasing flux through the Golgi arm of the pathway. 
 
UPR but not ER expansion is necessary for correct processing of proteins after ER 
stress is removed. 
Previous studies and our results indicate UPR activation has a major role in the 
processing and traffic of proteins during stress. In the presence of the reducing agent 
DTT, the GPI-anchored protein Gas1p becomes misfolded and targeted for degradation 
as evidenced by pulse chase analysis. However in the absence of HAC1, Gas1p is not 
degraded. This result highlights the importance of the UPR in the disposal of misfolded 
proteins during ER stress.  I also tracked the fate of another protein, CPY, in the presence 
of DTT by pulse chase analysis. Traffic of CPY to the vacuole was detected in the 
presence of DTT albeit with a delay compared to untreated cells. These experiments seem 
to indicate that under DTT conditions, CPY traffic is not totally blocked if, in fact, the 
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lower molecular weight band present is the vacuolar form. This is a surprising result 
since it has been reported that CPY contains disulfide bonds, therefore DTT should 
prevent its folding (JAMSA et al. 1994; SIMONS et al. 1995). Perhaps DTT is not able to 
completely destabilize CPY and therefore the protein is able to leave the ER. On the other 
hand, maybe reduced CPY leaves the ER in route to be degraded in another cellular 
compartment. When a similar experiment was done in hac1Δ cells, traffic of CPY in the 
presence of DTT was completely blocked. In fact, it has been reported that over-
expression of misfolded protein CPY* in ire1Δ cells blocks the traffic of Gas1p, 
carboxypeptidase S and proteinase A (SPEAR and NG 2003). Taken together, these results 
suggest that the UPR is necessary to maintain traffic of proteins during stress conditions.  
We also wanted to explore if the UPR has a role in the recovery of the cell after the 
episode of stress has finished. Our results indicate that in DTT-pretreated WT cells, 
where the DTT was removed just prior to labeling, processing of newly synthesized 
Gas1p is almost as fast as in untreated cells. When the same experiment was done in cells 
lacking HAC1, newly synthesized Gas1p seems to be trapped in the ER; nonetheless if 
the DTT is removed 30 min prior to labeling, newly synthesized Gas1p trafficked to the 
Golgi albeit with a delay. These results indicate that activation of the UPR is also 
important for the proper processing of Ga1p synthesized after the stress is removed.  
I also tracked the fate of Gas1p synthesized in presence of DTT followed by removal 
of the stress. Our results suggest that upon removal of stress, Gas1p that was labeled in 
presence of DTT is refolded, however a pool of the protein seems to also be degraded 
suggesting a competition between folding and degradation. UPR activation also 
upregulates components of oxidative folding like PDI1 and ERO1 (TRAVERS et al. 2000). 
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Sustained UPR induction and therefore prolonged oxidative folding can lead to oxidative 
stress, ROS accumulation and eventually to cell death (HAYNES et al. 2004). Refolding 
proteins in which disulfide bonds have been broken by DTT adds to the total oxidative 
folding load in addition to the newly synthesized machinery that needs to be folded. 
Therefore, by reducing the abundance of misfolded proteins through degradation, cells 
can reduce or delay the accumulation of ROS that would otherwise be produced by 
oxidative folding, thereby preventing premature cell death. Nonetheless, refolding cannot 
be ruled out since the fate of all the proteins that might become misfolded upon addition 
of DTT is not known. 
Similar experiments done in hac1Δ cells indicate that in the absence of the UPR, 
Gas1p that has become misfolded in the presence of DTT, is neither refolded nor 
degraded but stably accumulated in the ER after stress. DTT washout experiments were 
also done for CPY. Presence of an intact UPR seems to be more important to maintain 
traffic of CPY during stress rather than processing of newly synthesized CPY after stress 
is removed, since the protein is trafficked to the vacuole in hac1Δ cells. However as with 
Gas1p, CPY that was labeled in the presence of DTT remains trapped in the ER even 
after DTT is removed in cells lacking an intact UPR. Taken together, these results 
indicate that perhaps one of the roles of the UPR is to upregulate folding and trafficking 
machinery in order to allow for rapid recovery of the system when the stress episode has 
subsided. In the case of proteins that become misfolded during stress, the UPR allows for 
refolding and/or degradation after the stress is removed. In the case of proteins 
synthesized just after the stress is removed, the UPR contributes to efficient processing. 
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We also asked whether or not ER membrane expansion, which is induced by UPR 
activation, contributes to the recovery of cells after the stress is removed, since it has 
been reported that this event by itself is enough to confer resistance to DTT (SCHUCK et 
al. 2009) How ER expansion contributes to stress tolerance is still undetermined. One 
possibility is that by increasing the volume of the ER, the overall concentration of 
misfolded proteins is reduced. A larger ER could also promote protein folding itself. 
During folding, proteins expose hydrophobic residues that are buried in their final 
conformations. This renders folding intermediates vulnerable to aggregation should they 
encounter one another. Increasing the ER volume lowers the concentration of folding 
intermediates, which may give proteins more time to fold by avoiding aggregate 
formation. A similar mechanism might apply for membrane-associated proteins, whose 
dilution caused by an increase in membrane area could help avoid detrimental 
interactions. Finally, protein folding and membrane-associated processes such as protein 
glycosylation or ERAD could operate more efficiently when more luminal space as well 
as larger membrane area is available to accommodate the newly synthesized machinery 
involved in these processes. 
Our results indicate that membrane expansion is neither sufficient nor required for 
restoration of Gas1p traffic after DTT is removed. Also, it does not seem to play a role in 
degradation of Gas1p that becomes misfolded during an episode of stress. These results 
suggest that other targets of the UPR, especially chaperones, are more likely to be crucial 
for recovery after stress and in degradation of proteins that become misfolded during 
stress. In fact, it has been previously reported that the blockage in WT Gas1p traffic 
caused by over-expression of CPY* in ire1Δ cells can be partially restored when Kar2p is 
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also over-expressed. Furthermore, the delay in the degradation of over-expressed CPY* 
seen ire1Δ cells can be rescued by over-expression of Kar2p (LIU and CHANG 2008). 
These data highlight the importance of chaperones in aiding the degradation and traffic of 
proteins during ER stress. Perhaps the process of recovery after stress has subsided also 
relies on newly synthesized chaperones and/or other ERAD and vesicle formation 
machinery; however its role in this recovery process remains to be determined. Another 
issue to consider is that membrane expansion in opi1Δ cells and lack of expansion in 
ino2Δ cells grown in media without lipids was not corroborated, opening the possibility 
that these phenotypes were not present in the strains used for my experiments.   
From its initial activation to its downstream effects, the UPR has proven to be a 
complex reaction of the cell towards stress to promote survival.  This pathway has been 
implicated in numerous diseases (OTSU and SITIA 2007).  Therefore, understanding how 
the different components upregulated by the UPR work in concert to remodel the 
secretory pathway in order to regain ER homeostasis or eventually lead to cell death after 
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III. CHAPTER 3:  IDENTIFICATION OF NOVEL COMPONENTS INVOLVED IN ER 
HOMEOSTASIS AND ER QUALITY CONTROL 
 
Research Basis  
Maintenance of ER homeostasis is crucial for the biogenesis of secretory proteins, which 
constitute a third of proteins synthesized in yeast. Therefore, it is important to maintain the 
stability and number of the ER resident machineries that are in charge of the folding and 
processing of newly synthesized secretory proteins. Various mechanisms assist to maintain this 
population of ER resident proteins. These proteins are not actively recruited into ER-derived 
vesicles since they lack the positive signals or cargo receptors required to be packaged into the 
vesicles (BARLOWE 2003). However, some of these ER proteins can be captured non-specifically 
and transported to the Golgi, where they are recognized by COPI vesicle components for 
retrieval through a HDEL retrieval signal sequence (LEE et al. 2004).  
In addition to these mechanisms employed to maintain a suitable population of ER resident 
proteins, this organelle utilizes other methods for proper management of secretory proteins that 
transit the ER.  The ER has a quality control system (ERQC) that ensures that only properly 
folded native proteins proceed along the secretory pathway.  ERQC prevents the export of 
aberrant protein and retains protein precursors in an environment appropriate for their 
maturation. It increases local protein concentration to help assembly and polymerization. It 
prevents aggregation and degrades terminally misfolded proteins, possibly reducing the risks of 
proteotoxicity. It is also important for storing proteins for regulated secretion (ANELLI and SITIA 
2008).  If the ER becomes overloaded by accumulation of misfolded proteins, a pathway called 
the Unfolded Protein Response (UPR) is activated. It has been suggested that activation of the 
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UPR helps the cell cope with ER stress by upregulation of downstream targets involved in 
protein processing, ER exit, lipid biosynthesis, etc., thereby increasing ER capacity (TRAVERS et 
al. 2000).  
There is increasing evidence that these mechanisms communicate with each other in order to 
maintain ER function. For example, when the ER retrieval system is defective due to mutations 
in Erd2p, which recognizes the HDEL retrieval signal on escaped ER machinery, activation of 
the UPR is required, possibly to replenish the pool of ER resident proteins that are not able to be 
retrieved back to the ER (BEH and ROSE 1995). In a similar way, UPR activation is partially 
necessary to compensate for deficient protein secretion caused by defective COPI and COPII 
coat components or treatment with the Arf activation inhibitor Brefeldin A (CHANG et al. 2004). 
Nonetheless, the extent of the connections between these processes remains unknown, as well as 
the full range of components involved. For this reason, we have conducted a genome-wide 
screen to identify novel components involved in ER homeostasis and quality control.  
Previous attempts to discover components involved in the maintenance of ER homeostasis 
used a traditional genetic selection method.  This method consisted of strains containing an 
invertase fusion protein bearing the HDEL signal that were mutagenized and screened to identify 
mutants that failed to retain the protein (PELHAM et al. 1988; SEMENZA et al. 1990).  However, 
the results for this study were limited: the screen identified only two genes that seem to be 
directly involved in retention/retrieval of HDEL-containing proteins. Even though 
retention/retrieval of HDEL-containing proteins is crucial to maintain suitable pools of ER 
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In order to uncover novel components involved in ER homeostasis and ERQC, we employed 
a genomic screen in which we utilized the yeast deletion collection to identify mutant strains that 
exhibit extracellular secretion of the ER resident protein, Kar2p. Kar2p is a lumenal ER ATPase, 
orthologous to the mammalian BiP, which is involved in import of newly synthesized proteins 
into the ER and functions as a chaperone to mediate protein folding (ELLGAARD and HELENIUS 
2003; GETHING 1999). Kar2p is also one the chaperones upregulated by activation of UPR in 
response to accumulation of misfolded proteins in the ER (MORI et al. 1992).  Kar2p has been 
implicated in ER associated degradation (ERAD) by preventing protein aggregation (ZHANG et 
al. 2001)  and acting in association with Yos9p and Hrd3p in a lumenal surveillance complex 
that recruits nonnative proteins to the core ERAD machinery (DENIC et al. 2006).    
The yeast mutant strains tested in this screen are part of the yeast gene deletion collection 
originally created by the Saccharomyces Genome Deletion Project Consortium. This collection 
contains yeast strains in which individual non-essential genes have been systematically deleted 
using a PCR-mediated gene disruption strategy (GIAEVER et al. 2002; WINZELER et al. 1999). 
Since its release in  the year 2000, the yeast deletion collection has proven to be an invaluable 
and powerful tool in the identification of numerous new components of well-known pathways as 
well as interconnections between biological processes (SCHERENS and GOFFEAU 2004).  For 
example, the collection was used to assess growth responses to over 400 small molecules and 
diverse environmental stresses. This screen identified previously unknown genes that function in 
multidrug resistance as well as potential new drug targets (HILLENMEYER et al. 2008). More 
recently, a synthetic genetic array (SGA) screen, which utilizes the yeast deletion collection, was 
used to construct a  genome-scale genetic interaction map  by examination of 5.4 million gene-
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gene pairs for synthetic genetic interactions that, in turn, generated quantitative genetic 
interaction profiles for ~75% of all genes in the budding yeast (COSTANZO et al. 2010). 
We have reasoned that mutant yeast strains that secrete Kar2p proteins to the cell surface 
could have defects in several processes that contribute to maintain proper ER homeostasis 
including ER protein retention, retrieval or quality control.  It is known that mutations in the 
HDEL receptor Erd2p, responsible for retrieval of ER resident proteins, lead to extracellular 
secretion of Kar2p (SEMENZA et al. 1990). Furthermore, deletion of certain genes that cause 
abnormal Erd2p localization also produces defects in Kar2p retention, likely related to the poor 
retrieval of HDEL containing proteins, (SCHULDINER et al. 2005). Deletion of a gene involved in 
ER retention might cause the Kar2p secretion phenotype by saturating the retrieval system, 
resulting in surface delivery of Kar2p (TOWNSLEY et al. 1994).   
UPR activation by treatment with reducing agent β-mercaptoethanol also leads to 
extracellular secretion of Kar2p (BELDEN and BARLOWE 2001). It has been reported that the loss 
of  certain proteins, like the p24 protein Erv25p, causes UPR activation and extracellular 
secretion of Kar2p, which is dependent on an intact UPR (BELDEN and BARLOWE 2001). 
Deletion of its interacting partners EMP24, ERP1 and ERP2 also causes Kar2p secretion 
(MARZIOCH et al. 1999). These proteins are known to form a  physical complex (BELDEN and 
BARLOWE 1996; MARZIOCH et al. 1999) that is believed to be involved in cargo recruitment into 
ER-derived vesicles (BELDEN and BARLOWE 1996; MUNIZ et al. 2000) as well as in retrograde 
transport (AGUILERA-ROMERO et al. 2008).  Therefore, if deletion of a gene leads to UPR 
activation, in turn, this event can cause a Kar2p secretion phenotype. 
In the following section, I described the outcome of the genetic screen designed to identify 
mutant yeast strain that secrete ER resident protein Kar2p to the cell surface. Mutants confirmed 
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from this screen were further characterized to identify the mode of defect that leads to the 
secretion phenotype. Since activation of the UPR can lead to Kar2p secretion, we examined the 
dependence of Kar2p secretion phenotype on the presence of HAC1. I also measured UPR 
activation in these mutant strains using β-galactosidase reporter assay.  As expected, group of 
these strains depended on the UPR for secretion of Kar2p. I also tested these mutant strains for 
defects in Gas1p maturation and CPY glycosylation. Finally, I analyzed our panel of mutants for 
defects in quality control of the misfolded protein CPY*. These analysis uncovered novel genes 
involved in maturation of GPI-anchored proteins, glycosylation and quality control. This screen 
provided us with a set of novel genes that represent strong candidates to function in the different 
processes that contribute to ER homeostasis.  
 
Methods and Materials 
 
Yeast strains and growth conditions  
Yeast strains were grown in standard rich media YPD (2% w/v glucose, 1% w/v yeast 
extract and 2% w/v peptone), or synthetic complete media SC (0.67% w/v yeast nitrogen 
base, 2% w/v glucose and amino acids appropriate for auxotrophic growth) at 30oC. Cell 
transformations were done using standard lithium acetate protocols. Knock-out mutant 
strains were obtained from the MATα and MATa haploid yeast deletion collections (Open 
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Plasmids  
The UPRE-LacZ reporter plasmid was constructed from pMZ11 by EcoRI/Xho1 
digest and subsequent subcloning into pRS423 to create pLM38. pCP258 containing HA-
tagged form of CPY* was a gift from Peter Walter (UCSF).  
 
Kar2p secretion assay 
Strains from the deletion collection glycerol stocks were grown in YPD in 96-well 
trays for 2 days. 5uL of saturated cultures were spotted on to solid YPD plates and 
incubated for 8 hr at 30oC. Colonies were overlaid with nitrocellulose membranes and 
incubated for 30 min at 30oC. Membranes were washed with water to remove cell debris, 
blocked with 5% w/v milk in TBS-T and incubated with α-Kar2p antibodies (1/10,000) 
in TBS-T. For the primary screen, Kar2p secretion was detected by chemiluminescence 
using an HRP-conjugated goat-anti-rabbit antibodies and ECL reagents (Pierce, 
Rockford, IL). In a secondary screen, Kar2p was detected using IRDye800-conjugated 
ant-rabbit antibodies (Rockland Immunochemicals, Gilbertsville, PA) and the LiCor 
Odyssey fluorescent scanner and analyzed with the Odyssey software. Kar2p secretion 
signal for mutant strains was normalized to the signal of the WT strain.  
 
PCR analysis to verify gene disruption in knock-out mutant strains 
 
Genomic DNA was isolated from deletion mutant strains using PrepEase™ Mini Spin 
Plasmid Kit (USB, Cleveland, OH). Briefly, 1.5mL of saturated cultures were 
resuspended in 230μL of Resuspension Buffer (A1 buffer) and lysed by vortexing with 
glass beads for 15 min at 4°C. Lysate was separated from beads and Lysis Buffer (A2) 
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was added follow by Neutralization Buffer (A3). Lysate was cleared by centrifugation 
and DNA was bound to anion-exchange membrane filter spin-columns. Columns were 
washed and DNA was eluted using 25mL of Elution Buffer.  
Presence of the KanMX  antibiotic resistance cassette into the locus of interest was 
confirmed by PCR amplification using a pair of primers that flank the start and stop 
codon of gene or, alternatively, using a reverse primer that binds inside the KanMX 
cassette. The full list of primers is available in Supplementary Table 3. 50μL PCR 
reactions were prepared as follow: 2.5 U of EconoTaq™ DNA Polymerase, 1X Reaction 
Buffer, 0.5μM of each forward and reverse primers, 200μM of each dNTP and 5 μL of 
eluted genomic DNA.  PCR cycle: 98oC for 3 min; 98oC for 30 sec., 50oC for 30 sec. and 
72oC for 4 min (depending on the largest gene being verified) repeated 30 times; 72oC for 
10 min;  hold at 4oC. PCR products were visualized in a 0.2% w/v agarose gel containing 
Ethidium Bromide.  
 
Detection of UPR activation  
 
UPR activation on Kar2p secretion mutants was detected using the β-galactosidase 
reporter assay described above. (Chapter 2: Methods and Materials) 
 
Pulse chase analysis   
Pulse chase analysis of Gas1p and CPY was done using protocol described above 
(Chapter 2: Methods and Materials). To detect the α-1,6 mannose modification by CPY*, 
20 OD600 of cells bearing HA-tagged CPY* were harvested at mid-log phase, starved of 
Met and Cys for 15 min and labeled with 35S Met/Cys for 5 min. Cells were chased with 
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cold amino acids and 2  2.5OD600 aliquots of radiolabeled cells were taken per time point. 
One set of samples was lysed and subjected to immunoprecipitation with α-HA 
antibodies to identified the total amount of CPY* present. The second set was lysed and 
immunoprecipitated with α-HA antibodies to isolate CPY*-HA. CPY*-HA was released 
from antibody-conjugated beads by addition of  100μL of 1% w/v SDS and heating at 
55oC for 10 min. Solubilized CPY*-HA was separated from beads by centrifugation and 
500μL of IP buffer without SDS were added to samples.  Resulting sample was subjected 
to a second round of immunoprecipitation using an antibody against the α-1,6 mannose 
motif  also kindly provided by Randy Schekman. The quantity of α-1,6 mannose 
modified CPY*-HA was calculated relative to the amount of total CPY*-HA at each time 
point.  
 
Results and Discussion 
 
Details of the Kar2p secretion screen  
For our primary screen, we used the MATα  haploid yeast deletion collection which 
includes ~4,500 strains in which individual non-essential genes have been disrupted. In 
order to detect extracellular secretion of Kar2p, we employed a colony immunoblot 
assay. This screen was later repeated in a MATa background for validation purposes.  
Kar2p secreting strains were considered to be those strains that presented a secretion 
index (fold increase over the WT control) of 2 or more in both independent screens. Our 
analysis detected 73 strains that secreted 2 fold or more Kar2p to the extracellular media 
than a WT control (Supplementary Table 1).  
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It is possible that deletion of some genes might cause defects in the yeast cell 
wall, leading to lysis and eventually to the leakage of the intracellular contents. In order 
to verify that Kar2p secretion in these mutants is not caused by leakage of the 
intracellular pool of Kar2p due to cell lysis, Kar2p secretion was monitored in the 
presence of an osmotic support (Sorbitol 1M) during the growth and the colony overlay 
steps of the assay. From the secretion mutants tested in these conditions, only secretion 
from the she10Δ strain was rescued by osmotic support, indicating that Kar2p secretion in 
this strain may be due to cell lysis (data not shown). 
In order to verify that the secretion defect seen in these deletion mutants applies to 
other HDEL resident proteins, Pdi1p secretion was also assessed by colony 
immunoblotting in a subset of candidates. Pdi1p secretion analysis showed similar trends 
as the Kar2p secretion screen; however further quantitative analysis was not possible due 
to the low quality of the α-Pdi1p antibodies (data not shown).  
The yeast deletion collection has proven to be a very powerful tool that has been 
extensively used for novel screens. However, there are several concerns associated with 
the use of these collections. First, despite the fact that gene disruptions were verified by 
PCR for each strain when the collection was created, there is a possibility that in some of 
them genes are not deleted as advertised. Also, it has been documented that up to 8% of 
the mutant strains in the collection are known to retain a wild-type copy of the targeted 
gene, presumably because of aneuploidy or a duplication event (HUGHES et al. 2000).  
The transformation procedure that was used to create the deletion library is mutagenic; as 
a result, second-site mutations some distance away from the intended deletion might have 
developed in some strains masking the phenotype of interest. Finally, it has been reported 
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that when deletions are moved into a different genetic background, variations in the 
phenotype observed can occur. The naturally occurring variations among strain 
backgrounds might have synthetic interaction with the deleted gene masking or 
exacerbating the phenotype tested (GRUNENFELDER and WINZELER 2002; SCHERENS and 
GOFFEAU 2004). This highlights the importance of repeating genetic screens in different 
genetic backgrounds in order to reduce the number of possible false negatives.  
In order to validate the panel of Kar2p secretors, the screen was repeated in a yeast 
deletion collection of opposite mating type (MATa). Of the 73 mutant strains identified as 
Kar2p secretors, only 9 strains showed discrepancies in their phenotype between mating 
types (Figure III.1A). I tested these strains for irregularities in the disruption of the 
targeted gene by PCR analysis. The presence of the KanMX disruption cassette 
introduced to replace the targeted gene was probed in two ways (Figure III.1B).  First, I 
used a forward primer that binds upstream of the start codon (between -1000bp to -
100bp) and a reverse primer that binds inside the KanMX cassette.  Only if the KanMX 
cassette is present in the correct place, a PCR product would be generated. However, this 
approach would only indicate the presence of a correctly inserted KanMX cassette, but 
would not reveal other irregularities in the genome like the existence of an additional 
wild-type copy of the gene. For this reason, the PCR analysis of these mutants was also 
done using a reverse primer that binds downstream of the stop codon of the gene of 
interest.  If the KanMX cassette is present, a PCR product of ~ 1500kb would be 
obtained. If the cassette is not present or if there is also an extra copy of the wild-type 
gene, then the PCR product would correspond to the predicted size of the gene (plus the 
size of upstream region depending on the forward primer used).  
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Figure III.1. Verification of gene 
disruption in Kar2p secretion 
mutants  
A. Venn diagram ilustrates overlap 
between results generated from 
MATα (purple) and MATa (blue) 
collections. 62 mutant strains 
showed Kar2p secretion phenotype 
in both mating types. 5 strains 
showed secretion of Kar2p only in 
the MATα background and 6 strains, 
only on the MATa counterpart. B.  
Strains that showed discrepancies 
were tested for correct integration of 
the KanMX cassette by PCR 
analysis. Diagram depicts primers 
used as well as the PCR product 
sizes obtained for each case. Dash 
lines indicate binding of primer to 
DNA.  C. Genomic DNA was 
isolated from strains and KanMX 
presence was probed by PCR. 
Products were visualized in a 0.2% 







Of the strains tested, only one showed an anomaly in the insertion of the KanMX 
cassette. As showed in Figure III.1C, the ilm1Δ MATα, which secrets Kar2p, has a 
correctly deleted gene. However, the ilm1Δ MATa counterpart, which does not secrete 
Kar2p, still has the ILM1 gene as determined by the presence of a band about ~ 2 kb that 
corresponds to the size of the gene (plus the upstream region). 
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 The other two strains that displayed anomalies are pmt1Δ and pro1Δ . Pmt1Δ 
exhibits Kar2p secretion in the MATa background but not in MATα, and for pro1Δ,  the 
situation is reversed.  PCR analysis indicates that for pmt1ΔMATα and pro1ΔMATa, in 
addition to having the KanMX cassette correctly integrated into their genome, they also 
have a wild-type copy of their respective genes. In the case of pmt1ΔMATα, the higher 
molecular weight band corresponds to the PMT1 gene and the lower to the KanMX 
cassette. For pro1ΔMATa, the bottom band is the PRO1 gene and the top product 
corresponds to the KanMX cassette. Presence of the wild type copies of the genes can 
account for the lack of Kar2p secretion phenotypes seen in these strains. The rest of the 
strains showed proper deletion and absence of extra wild-type copies of gene of interest 
in both mating types indicative that the discrepancies in the Kar2p secretion phenotype 
might arise from mating type specific effects or by the presence of spontaneous second-
site suppressor mutations.  
 
Identity of the Kar2p secretors 
Genes whose deletion causes a Kar2p secretion phenotype are involved in a variety of 
cellular functions. Figure III.2 shows the identity and distribution of genes according to 
the annotated biological function indicated in the Saccharomyces Genome Database.  As 
expected, a considerable number of genes identified by this screen are known to be 
involved in ER-to-Golgi traffic, protein maturation and modification.  Notably, genes 
within the ER-to-Golgi traffic category are known to share functionalities and have 
extensive genetic interactions. For instance, deletion of members of the p24 family 
ERV25, EMP24, ERP1 and ERP2, known to be involved in cargo loading into ER- 
 
 























Figure III.2.  Distribution of genes which deletion causes defects in Kar2p retention by bioprocesses 
Strains from the yeast deletion collection were grown to steady state and spotted on solid YPD media. 
Colonies were overlaid with  nitrocellulose membranes that were later washed and probed for Kar2p by 
immunoblotting using α-Kar2p primary antibody and HRP conjugated- secondary antibody for screening 
or a florescent secondary antibody for quantification purposes.  Strains that presented a Kar2p secretion 
index of 2 or more were considered as Kar2p secretors. Genes corresponding to the mutant strains are 
classified according to their annotated functional category assigned by SGD. 
 
derived vesicles, cause Kar2p secretion as previously documented (MARZIOCH et al. 
1999). These p24 proteins have been shown to have extensive genetic interactions with 
members of the GET complex, which were also identified by this screen, and previously 
shown to cause Kar2p secretion when deleted (COSTANZO et al. 2010; SCHULDINER et al. 
2005).  The GET complex mediates insertion of tail- anchored (TA) protein into the ER 
membrane. Yeast two hybrid analysis and, more recently, crystallographic data, indicates 
that cytosolic Get3p binds to the hydrophobic tails of TA proteins and delivers them to a 
membrane receptor in the cytosolic face of the ER formed by Get1p and Get2p (MATEJA 
 
 
  102 
et al. 2009; SCHULDINER et al. 2008). The GET members show positive genetic 
interactions with another two genes identified in our screen, MDY2 and YOR164C. 
Mdy2p was originally identified to be necessary for efficient mating possibly by playing 
a role in shmoo formation and in nuclear migration in the pre-zygote (HU et al. 2006), 
and was also identified to be associated with ribosomal complexes (FLEISCHER et al. 
2006). Yor164cp is a poorly understood protein that presents physical interactions with 
Mdy2p (CHANG et al.; FLEISCHER et al. 2006; KROGAN et al. 2006) and Get3p (CHANG et 
al.; ITO et al. 2001). Further characterization of mdy2Δ and yor164cΔ mutants done by 
other members of the Miller lab (Marcus Lee) showed that both mutant strains presented 
aberrant ERD2-GFP localization (data not shown), a documented phenotype 
characteristic of the get mutant strains (SCHULDINER et al. 2005; SCHULDINER et al. 
2008).  
Machinery necessary for retrograde transport includes TA proteins like the SNARE 
(Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor) proteins. 
Thus improper insertion of these TA proteins can lead to inefficient or impaired 
retrograde transport of Erd2p leading to the Kar2p secretion phenotype. Genetic and 
physical interaction data as well as the phenotypes presented by the mdy2Δ and yor164cΔ 
strongly suggest a role of these proteins in GET-mediated TA protein insertion into the 
ER membrane possibly upstream of Get3p, by serving as a link between the ribosome 
and the ER membrane.  Another parallel study also identified Yor164cp and Mdy2p, 
which have now been renamed to Get4p and Get5p respectively, as potential components 
of the GET complex (JONIKAS et al. 2009). 
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Other categories comprise 10 genes with unknown function and 13 proteins with 
ambiguous functions, including the ERD1 gene believe to be involved in ER retention 
(PELHAM et al. 1988). The erd1Δ strain was the mutant with the highest Kar2p secretion 
index (9.0). One unexpected functional category that is overrepresented in this screen is 
chromatin assembly which includes components involved in chromatin silencing and 
members of the SWR1 complex that incorporates variant histone Htz1p into nucleosomes 
(MIZUGUCHI et al. 2004) . Some of these mutants have been reported to show other 
defects in the secretory pathway like misorting of vacuolar protein carboxypeptidase Y 
(BONANGELINO et al. 2002) and  defects in karmellae assembly (WRIGHT et al. 2003) 
Also, according to other studies done in our lab, deletion of HTZ1 causes mislocalization 
of ERD2-GFP suggesting that the Kar2p secretion phenotype is due to defects in the 
retention/retrieval system. Perhaps deletion of these components causes deregulation of 
other genes that influence the secretory pathway, therefore resulting in these defects.  
 
UPR leads to Kar2p secretion phenotype in some mutant strains. 
Kar2p is closely related to the Unfolded Protein Response since it is one of its genetic 
targets (MORI et al. 1992) and has a possible role in the regulation of Ire1p activation 
(KIMATA et al. 2007; KIMATA et al. 2004). The UPR is triggered upon accumulation of 
unfolded proteins to help the cell cope with the stress by upregulating components of the 
protein folding machinery, ERAD, and the secretory pathway, among others (TRAVERS et 
al. 2000). Activation of the UPR by addition of a reducing agent such as β-
mercaptoethanol can lead to extracellular secretion of the Kar2p (BELDEN and BARLOWE 
2001). Also, activation of the UPR using a constitutively active version of Ire1p or 
 
 
  104 
spliced version of Hac1p can lead to Kar2p secretion (Figure III.3A). If a certain gene is 
involved in protein biogenesis, then its absence can cause accumulation of unfolded 
proteins leading to activation of the UPR and therefore, to Kar2p secretion simply as a 
result of UPR-mediated over-expression of the KAR2 gene. On the other hand, if a gene 
is involved in the retention/retrieval processes, its deletion may cause Kar2p secretion 
and depletion of the pool of resident proteins in the ER that in turn activates the UPR to 
restore the lost ER machinery.  
Determining activation of the UPR in these strains is not sufficient to reveal if the 
Kar2p secretion is a result of UPR induction or if Kar2p secretion leads to the activation 
of the UPR to replenish the missing pool ER resident proteins. In order to distinguish 
between these possibilities, Alenka Čopič, a postdoctoral fellow in our laboratory, 
conducted a study to determine dependency of Kar2p secretion on an intact UPR. For this 
purpose, a second deletion of the gene that encodes the transcription factor that mediates 
upregulation of the UPR targets, HAC1, was introduced into the mutant strains. The 
resulting viable double mutant strains were tested for Kar2p secretion by colony 
immunoblotting  and quantified relative to the Kar2p secretion of a single hac1Δ mutant.  
The double mutation studies yielded 3 different groups of results (Supplementary 
Table 1). First, as anticipated, we identified mutant strains in which Kar2p secretion was 
dependent on the UPR, suggesting that Kar2p secretion phenotype is the result of KAR2 
over-expression. I tested these strains for UPR activation using a UPRE-LacZ reporter 
and, as expected, a number of them have a constitutively active UPR (Figure III.3B).  
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FigureIII.3. UPR activation 
in Kar2p secretors  
A. Cells bearing pcIRE1, 
pHAC1Δ238 or an empty 
vector were grown to steady 
state. 5uL of saturated 
cultures were spotted on to 
YPD plates for 8 hours at 
30oC. Colonies were overlaid 
with nitrocellulose 
membranes and incubated for 
30 min at 30oC.  Membranes 
were washed, blocked, 
incubated with α-Kar2p 
antibodies. Kar2p secretion 
was detected using an HRP-
conjugated goat-anti-rabbit 
antibodies and ECL reagents. 
B. Mutants strains bearing 
UPRE-LacZ reporter were 
grown to mid-log phase and 
100μL of resuspended cells in 
Z buffer were used for 
experiment. Cells were lysed 
and incubated with ONPG. β-
galactosidase activity was 
measured using 
spectrophotometry and 
normalized to the activity of a 
wild-type control. Only those 
strains that had a 1.5 fold 
increase or greater in β-
galactosidase activity over the 
wild-type control are shown. 
Asterisk denotes strains that are synthetic lethal with deletion of HAC1. C. Diagram depicts distribution 
of genes whose deletion results in constitutive UPR activation by place of function according to SGD. 
 
 
A group of 22 strains were synthetic sick or lethal with deletion of HAC1, some of 
them previously know to present this kind of interaction (SCHULDINER et al. 2005). If 
deletion of a gene creates an environment of severe stress where protein folding is 
impaired, activation of the UPR would be necessary for tolerance and cell viability 
(SPEAR and NG 2003).  Our UPRE-LacZ reporter assay shows that almost all the strains 
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that are synthetic sick or lethal with a hac1Δ have a constitutively active UPR (Figure 
III.3C). Alg3Δ and mnn11Δ  showed UPR activation higher than the wild-type control but 
below our cut-off, however, another genome-wide study was able to identify a robust 
UPR activation in these strains (JONIKAS et al. 2009).  Yblo83cΔ and ymr013w-aΔ were 
not identified to be UPR-active by either study, nevertheless, the YBL083C ORF overlaps 
with the ALG3 ORF and YMR013W-A is a dubious ORF unlikely to encode a protein.  
Constitutive UPR activation in these mutant strains and dependence on HAC1 for 
viability suggests a role in protein folding and processing. Further examples include, 
LHS1 and SCJ1, which encode ER lumenal chaperones (BAXTER et al. 1996; BLUMBERG 
and SILVER 1991); STE24 is a metalloprotease involved in maturation of a-factor 
(FUJIMURA-KAMADA et al. 1997); ALG3, OST3, EOS1 and MNN11 are involved in N-
glycosylation (JUNGMANN et al. 1999; KNAUER and LEHLE 1999; NAKAMURA et al. 2007; 
SHARMA et al. 2001); BST1 and LAS21 are involved in GPI anchor synthesis 
(BENACHOUR et al. 1999; TANAKA et al. 2004). Other genes that encode proteins whose 
functions are not well understood (CSF1, PHO88, MRPL16) are also synthetic lethal with 
hac1Δ placing them as prime candidates for functions in protein folding and 
modification. 
Around 40% of the strains still secrete Kar2p in the absence of the HAC1 gene. We 
propose that these genes are involved more directly in ER retention and/or retrieval 
mechanisms. For example, the majority of the get mutants which show aberrant ERD2-
GFP localization, have a constitutive active UPR (JONIKAS et al. 2009) but still have 
Kar2p secretion in the hac1Δ double mutant. This situation suggests that cells with 
defects in ER retention/retrieval can activate the UPR as means to replenish the pool of 
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escaped ER resident proteins. It is somewhat surprising that some of these strains are still 
viable without upregulation of Kar2p through activation of the UPR.  However, is 
possible that these strains can tolerate low levels of the protein or that they replace the 
missing pool of Kar2p in a UPR-independent manner. For example, the htz1Δ mutant 
which does not have a constitutive active UPR (JONIKAS et al. 2009) and secretes Kar2p 
in the absence of HAC1, presents upregulation of KAR2 according to microarray analysis 
of gene expression (MENEGHINI et al. 2003).  
The Kar2p promoter region contains other regulatory domains that include a 
pyrimidine-rich region which contributes to the high level basal expression and heat 
shock element (HSE) (KOHNO et al. 1993).  The HSE is in the promoter region of the 
Heat Shock Response (HSR) genes which is triggered as a result of a variety of stress 
conditions in the cytosol. There is evidence that suggest that HSR can be activated in the 
absence of an external stressor. For example, over-expression of a misfolded version of 
plasma membrane ATPase, Pma1p, drives the expression of a HSE-LacZ but not a 
UPRE-LacZ reporter (HAN et al. 2007) and over-expression of the mutant forms of the 
von Hippel Lindau tumor-suppressor proteins (VHL) results in the induction of cytosolic 
chaperone genes with similar timing and degree as during the HSR (METZGER and 
MICHAELIS 2009). It would be interesting to see if it is possible that the Kar2p secretion 
of some of these knock-out strains is a result of activation of the HSR in a similar manner 
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Some Kar2p secretors showed defects in post-translational modification of Gas1p and 
CPY. 
Kar2p secretion can result from deleting genes involved in protein modification and 
processing. Deletion of genes involved in these processes can lead to accumulation of 
folding intermediates or misfolded proteins that in turn can activate the UPR leading to 
over-expression of Kar2p. In order to identify genes involved in these processes, I tested 
our panel of mutant strains for defects in maturation of Gas1p and CPY.  Gas1p is a cell 
wall GPI-anchored protein that is co-translationally translocated into the ER where it is 
glycosylated and receives its GPI anchor, then packaged into ER-derived vesicles for 
delivery to the Golgi where it is further modified (DOERING and SCHEKMAN 1996) and 
finally, to its destination in the cell wall (DE SAMPAIO et al. 1999). This maturation 
process is easily tracked by pulse chase analysis, which has been extensively used to 
identify conditions and strains in which Gas1p processing is defective (BOSSON et al. 
2006; FUJITA et al. 2006a; MARZIOCH et al. 1999). Strains defective in Gas1p processing 
show a delay in the appearance of the mature form of Gas1p and persistence of the ER 
precursor over time compared to a WT strain.  
My study detected 14 mutant strains that present defective Gas1p maturation of which 
7 were known to have deficiencies in secretory protein processing (Figure III.4A). 
Several of the strains that presented a more severe phenotype correspond to known 
components of the remodeling machinery of GPI anchors. BST1, GUP1 and PER1 
encode proteins that function in the same path to modify the GP1 anchor once the protein 
component has been attached (FUJITA and JIGAMI 2008). Also, deletion of p24 family 
member EMP24, the presumed cargo receptor of Gas1p (MUNIZ et al. 2000), and its  
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Figure III.4. Pulse-chase analysis of the GPI-anchored protein Gas1p in Kar2p secretion mutants 
Cultures were grown to mid-log phase and labeled for 5 min with 35S ProMix. Cells were chased with 
cold amino acids and samples were taken at 0, 10 and 30 min. Cells were lysed and Gas1p was isolated 
from samples by immunoprecipitation with α-Gas1 antibody-conjugated beads.  Proteins were eluted 
from beads, separated by SDS-PAGE and visualized by phosphorimaging. Only strains that showed a 
delay in the maturation of Gas1p are shown. A. Mutant strains previously known to have a delay in Gas1p 
processing. B. Mutant strains previously unknown to have a severe Gas1p processing defect. C. Mutant 
strains previously unknown to have a mild Gas1p processing defect.  
 
interacting partners ERV25, ERP1 and ERP2 (BELDEN and BARLOWE 1996; MARZIOCH et 
al. 1999; SCHIMMOLLER et al. 1995) caused delays in Gas1p processing. 
The rest of the mutants identified to have a delay in Gas1p maturation were not 
previously known to have defects in this process. The more severe phenotypes were 
exhibited by mutants that correspond to proteins with poorly characterized functions 
(Figure III.4B). Csf1p is a predicted transmembrane protein necessary for fermentation at 
low temperatures (TOKAI et al. 2000). Arv1p has been implicated in distribution of 
sterols, sphingolipid metabolism and delivery of GPI intermediates into the ER 
(KAJIWARA et al. 2008) which might account for the delay in Gas1p processing seen in 
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the arv1Δ strain. Ted1p was recently identified as a possible regulator of the p24 proteins 
(HAASS et al. 2007).  
The final 4 strains present milder defects in the maturation of Gas1p (Figure III.4C): 
Lhs1p is an ER luminal chaperone (BAXTER et al. 1996);  Sec22 is a SNARE involved in 
transport between the ER and the Golgi (NEWMAN et al. 1990); Fat1p is involved in 
import of fatty acids (CHOI and MARTIN 1999) and Nem1p in regulation of fatty acid 
biosynthesis (SANTOS-ROSA et al. 2005).   Deletion of genes that interfere with the 
biogenesis of Gas1p or its targeting to ER exit sites can cause accumulation of immature 
forms of Gas1p leading to activation of the UPR and subsequent upregulation of the 
Kar2p. In fact, all the strains that showed a severe Gas1p processing delay have a 
constitutive active UPR (Supplementary Table 2) 
I also tested the Kar2p secretors for defects in glycosylation of the vacuolar hydrolase 
CPY. Glycosylated CPY is trafficked from the ER (p1 form) to the Golgi where is further 
modified (p2 form) and finally to the vacuole where it is cleaved yielding a mature 
version of the protein (m form). This process is also easily tracked by pulse-chase 
analysis where underglycosylated forms of CPY can be detected by the appearance of 
multiple lower molecular weight mature forms of the protein.  
My study identified 7 strains that present underglycosylated forms of CPY (Figure 
III.5A). Both alg3Δ and ost3Δ  correspond to previously known components of the N-
glycosylation machinery in the ER lumen (KNAUER and LEHLE 1999; SHARMA et al. 
2001). Ybl083cΔ corresponds to an ORF that overlaps with the ALG3 ORF. The 4 












Figure III.5. Pulse-chase analysis of the vacuolar hydrolase CPY in the Kar2p secretion mutants 
Cultures were grown to mid-log phase and labeled for 5 min with 35S ProMix. Cells were chase with cold 
amino acids and samples were taken at 0, 10 and 30 min. Cells were lysed and CPY was isolated from 
samples by immunoprecipitation with α-CPY antibody-conjugated beads.  Proteins were eluted from 
washed beads, separated by SDS-PAGE and visualized by phosphorimaging. Only strains that showed 
underglycosylated forms of mature CPY are presented. A. Mutant strains previously known to have 
defects in glycosylation. B. Mutant strains previously unknown to have defects in glycosylation of CPY.  
 
Ics3p is a protein of unknown function and Mdy2p was identified to be involved in 
insertion of TA proteins in the ER (JONIKAS et al. 2009). Mrpll6p is a mitochondrial 
ribosomal protein (GRAACK and WITTMANN-LIEBOLD 1998) whose deletion shows 
synthetic lethality with hac1Δ, suggesting a role in glycosylation of secretory proteins, 
however, because of its localization in the mitochondria, its role is likely to be indirect. In 
contrast, Pho88p is an ER-localized putative membrane protein involved in phosphate 
transport that also shows synthetic lethality with hac1Δ, positioning it as a prime 
candidate to be involved in glycosylation in the ER. It is possible that deletion of genes 
that cause defects in the glycosylation process can lead to the Kar2p secretion phenotype 
by activation of the UPR, at least for ost3Δ, alg3Δ, mrpl16Δ pho88Δ and ybl083Δ which 
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Kar2p secretors showed defects in ER quality control. 
The ER has a quality control system that ensures that only properly folded proteins 
are packaged into vesicles for transport to the Golgi, and prevents unfolded or 
unassembled proteins from departing the ER, instead, targeting them for degradation 
(ANELLI and SITIA 2008).  A breach in ER quality control by deletion of one of its 
components can lead to Kar2p secretion in 2 possible ways. First, a break down in the 
system can now let unfolded proteins bound to Kar2p be packaged into ER-derived 
vesicles subsequently leading to Kar2p secretion. Second, it is plausible the missing gene 
is also involved in the retention of ER resident proteins, thereby, directly causing the 
secretion phenotype.   
In order to determine if these Kar2p retention mutants also show defects in quality 
control, I examined whether or not misfolded proteins are transported to the Golgi by 
assessing the glycosylation state of the misfolded protein model CPY*. Contrary to CPY,  
CPY*, is imported into the ER but retained and targeted for degradation, unable to 
receive further carbohydrate modifications in the Golgi (WOLF and SCHAFER 2005). 
I tested the mutant strains for the presence of CPY* that has received a particular 
Golgi-specific modification (α−1, 6 mannose) indicative of a breach in the ER quality 
control system. This event can be tracked by pulse chase analysis of mutant strains 
bearing a copy of a HA-tagged CPY*. Briefly, newly synthesized proteins were 
metabolically labeled with 35S met/cys and chased over time. Total CPY*-HA was 
isolated from each sample and then subjected to a second immunoprecipitation using 
antibodies against the α−1, 6 mannose moiety. α-1, 6 mannose CPY*-HA was quantified 
relative to the total CPY*-HA present in each sample and normalized to the WT control.  
 
 



























Figure III.6. Acquisition of a Golgi specific modification by CPY*-HA on Kar2p secretion mutants 
 Mutant strains bearing a HA-tagged CPY* were grown to mid-log phase and labeled for 5 min with 35S 
ProMix. Cells were chased with cold amino acids and samples were taken at 0, 10 and 30 min. Cells were 
lysed and total CPY*-HA was isolated from samples by immunoprecipitation with α-HA antibody-
conjugated beads. Proteins were solubilized from beads and re-immunoprecipitated using α-1, 6 mannose 
antibody to detect the fraction of CPY*-HA that acquired the 1, 6 mannose modification. Proteins were 
eluted from beads, separated by SDS-PAGE and visualized by phosphorimaging. The fraction of 1, 6 
mannose CPY*-HA was quantified relative to the total CPY*-HA present in each sample. A. Acquisition 
of 1, 6 mannose modification in the emp24Δ  strain. B. Strains that showed an average of 1.5 fold of 
increase in 1, 6 mannose modified CPY*-HA over the wild-type control at 30 min.  
 
A total of 15 strains were identified to have α-1,6 mannose CPY*-HA levels more than 
1.5 fold greater than the wild-type strain, indicative of a breakdown in the quality control 
(Figure III.6B).  
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It has been reported that the emp24Δ  and  bst1Δ strains show defects in ER retention 
of  the misfolded secretory protein S11 invertase (ELROD-ERICKSON and KAISER 1996). 
Not surprisingly, mutant strains corresponding to p24 family components EMP24 (Figure 
III.6A), ERV25, ERP1 and ERP2 and its presumed regulator TED1 as well as components 
of the GPI anchor remodeling pathway BST1 and GUP, also display defects in retention 
of misfolded CPY*-HA, suggesting with a more general defect in the quality control 
system. Other strains that present defects in quality control correspond to genes involved 
to chromatin remodeling SIR4 and SWC3; HOC1 encodes a glycosyltransferase localized 
to the Golgi (NEIMAN et al. 1997); and CWC21 is a poorly characterized gene  identified  
to be involved in pre-mRNA splicing (OHI et al. 2002). 
Two proteins that seem to be involved in ER quality control and are of particular 
interest are Slp1p and Yer140wp. Both are conserved predicted membrane proteins of 
unknown function and cellular location that present a physical interaction between each 
other (COLLINS et al. 2007). Preliminary solubilization experiments confirmed the 
transmembrane topology of these proteins (data not shown). Other studies have shown 
that both slp1Δ and yer140wΔ have a constitutive active UPR and, moreover, that SLP1 
and YER140W show alleviating genetic interactions with each other (JONIKAS et al. 2009) 
and share interactions with other genes involved in protein folding and post translational 
modification specially in glycosylation (COSTANZO et al. 2010). Taken together, this 
genetic interaction data as well as the phenotypes presented by slp1Δ and 
yer140wΔ  strains suggest a possible role of these proteins in quality control of 
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Conclusions 
  In order to discover novel components involved in ER homeostasis, we conducted a genome-
wide screen to identify mutant strains that fail to retain the ER resident protein Kar2p. The 
screen identified 73 mutant strains in which deletion of a single gene resulted in the Kar2p 
secretion phenotype. The corresponding gene products contribute to a variety of cellular 
functions from ER-to-Golgi traffic, protein maturation and modification, to unexpectedly, 
chromatin remodeling. Genes in these categories display vast genetic interaction within the same 
functional categories as well as with genes of other functional bioprocess (COSTANZO et al. 2010; 
SCHULDINER et al. 2005).   
To examine the possible causes for the Kar2p secretion present in these mutant strains, we 
observed the dependence of the phenotype on activation of the Unfolded Protein Response. We 
hypothesized that Kar2p secretion can result from over-expression of the KAR2 gene due to 
activation of the UPR in these strains.  Indeed, a good number of the mutants have a 
constitutively active UPR and fail to secrete Kar2p when the UPR pathway is disrupted by 
deletion of the HAC1 gene.  Moreover, 22 strains are synthetic lethal with hac1Δ, which 
highlights the importance of the activation of the UPR to compensate for the loss of a particular 
gene.  We propose that genes whose deletion causes UPR activation that leads to Kar2p secretion 
are involved in protein folding and processing. Lack of a gene that encodes a protein involved in 
these processes can create an environment where misfolded proteins or protein intermediates 
accumulate, thereby imposing severe stress in the ER leading to activation of the UPR. Certainly, 
many strains that show lethality with deletion of HAC1 correspond to proteins with known 
functions in protein folding and modification, like ER lumenal chaperones, Lhs1p and Scj1p, and 
proteins involved in N-linked glycosylation Alg3p and Ost3p.  Also, strains corresponding to 
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genes previously unknown to have any function in protein biogenesis like CSF1, MRPl16 and 
PHO88 were found to depend on the UPR for viability and furthermore, to show defects in the 
processing of Gas1p or CPY, placing these genes as strong contenders for functions in these 
processes.  However more studies must to be done to characterize the molecular functions of 
these genes in protein biogenesis. 
 A considerable number of the strains still secrete Kar2p in the absence of HAC1  . We 
proposed the corresponding gene products are involved in retention/retrieval processes and that 
the Kar2p secretion defect seen in these strains leads to UPR activation to restore the lost ER 
machinery. However, some of these strains do not have a constitutive UPR, suggesting that they 
are able to live with low amounts of Kar2p or that the protein is able to be replenished in a UPR-
independent way. 
Kar2p secretion can result from defective processing of proteins since accumulation of 
improperly folded or post-translationally modified proteins can lead to activation of the UPR. 
This study uncovered novel strains defective in protein processing (Figure III.7). Three novel 
strains showed a severe delay in the processing of Gas1. Among them is csf1Δ, which is also 
synthetic lethal with a hac1Δ, placing CSF1 as a prime candidate for a role in protein folding. 
Four other strains show a milder defect in the processing of Gas1 including nem1Δ and 
fat1Δ. Both of these corresponding proteins have roles in transport and regulation of fatty acids. 
Defects in the synthesis or distribution of fatty acids can affect the attachment of the GPI anchor 
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Figure III.7. Genes 
involved in GPI–anchored 
protein maturation, 
protein glycosylation and     
ER quality control  
The Kar2p secretion 
genome-wide screen 
identified components 
involved in various aspects 
of ER function, including 
protein glycosylation, GPI 
maturation, and ER quality 
control. Underlined proteins 
represent novel functional 




4 novel strains also showed deficiencies in the glycosylation of CPY; mdy2Δ also showed 
aberrant ERD2-GFP (data not shown) and has been suggested to be part of the GET machinery; 
ics3Δ which corresponding protein has an unknown function; and pho88Δ and mrpl16Δ who are 
synthetic lethal with hac1Δ positioning them as prime candidates to function in glycosylation. 
The Kar2p secretion phenotype can result from a breach in ER quality control either because 
Kar2p is bound to misfolded proteins indiscriminately packaged into ER derived vesicles or the 
gene deleted is also involved in the retention/retrieval process. My study identified a number of 
mutant strains in which the misfolded protein CPY*-HA receives a Golgi specific modification 
beyond the levels found in a WT strain, which is indicative of a defective quality control system 
(Figure III.7). Among these strains, we are particularly interested in further studying slp1Δ and 
yer140wΔ.  Even though very little is known about these two corresponding proteins, there is 
increasing evidence of their possible role in protein biogenesis and quality control, however, 
their exact functions are still to be determined.  
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This screen has revealed novel candidates involved in protein modification and quality 
control representing a strong starting point to get further insight in how the processes necessary 




Table 1: Compiled data for the Kar2p secretion screen 























traffic 9.0 + N/D + ++ - + 
YFL025C Bst1 ER 
O-linked 
glyc./ GPI 8.8 + N/D + ++ - + 
YML012W Erv25 ER 
ER-Golgi 
traffic 8.4 + N/D + ++ - + 
YKL073W Lhs1 vacuole 
Protein 
maturation 6.8 + N/D + + - - 
YGL084C Gup1 ER 
O-linked 
glyc./ GPI 6.7 - - + ++ - + 
YCR044C Per1 ER 
O-linked 
glyc./ GPI 6.1 - - + ++ - - 
YAR002C-A Erp1 vacuole 
ER-Golgi 
traffic 5.9 - + N/D + - + 
YLR242C Arv1 - Lipid 5.6 + N/D + ++ - - 
YIL039W Ted1 ER 
ER-Golgi 
traffic 5.6 - + N/D ++ - + 
YOR154W Slp1 ambiguous ambiguous 5.0 - - - - - + 
YGL020C Get1 ER 
ER-Golgi 
traffic 5.0 - + N/D - - - 
YJL077C Ics3 - ambiguous 4.7 - - - - + - 
YDL100C Get3 ER 
ER-Golgi 
traffic 4.6 - + N/D - - - 
YMR214W Scj1 ambiguous 
Protein 
maturation 4.3 + N/D + - - - 
YHR078W ORF - Unknown 4.2 - + N/D - - - 
YOR164C ORF cytoplasm Unknown 4.1 - + N/D - - - 
YER083C Get2 ER 
ER-Golgi 
traffic 4.1 - - - + - - 





glyc. 3.8 + N/D - + + - 
YBR276C Pps1 - Cell cycle 3.7 - - - - - - 
YJL183W Mnn11 Golgi 
N-linked 
glyc. 3.7 + N/D - - - - 
YLR087C Csf1 - ambiguous 3.7 + N/D + ++ - - 
YBR106W Pho88 ER ambiguous 3.7 + N/D + + + - 
YNL080C Eos1 - 
N-linked 
glyc. 3.7 + N/D + - - - 
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YHR181W Erv26 ER 
ER-Golgi 
traffic 3.7 - - N/D - - - 
YLR268W Sec22 Golgi 
ER-Golgi 
traffic 3.5 + N/D + + - - 
YDR310C Sum1 nucleus Chromatin 3.4 - + N/D - - - 
YLR065C ORF ambiguous Unknown 3.4 + N/D + - - + 
YMR031W-
A dubious - Unknown 3.4 + N/D - - - + 
YOL111C Mdy2 cytoplasm ambiguous 3.3 - + N/D - + - 
YBL083C dubious - Unknown 3.2 + N/D - - + - 
YLR110C Ccw12 ER ambiguous 3.2 - - - - - - 
YLR085C Arp6 nucleus Chromatin 3.2 - + N/D - - - 
YOL012C Htz1 nucleus Chromatin 3.2 - + N/D - - - 
YML041C Swc6 nucleus Chromatin 3.1 - + N/D - - - 
YLR374C dubious - Unknown 3.1 - + N/D - - - 
YML013W Ubx2 ER ERAD 3.1 sick N/D + - - - 
YAL007C Erp2 ER 
ER-Golgi 
traffic 3.1 - + N/D + - + 
YML013C-A dubious - Unknown 3.0 + N/D + - - - 
YIR033W Mga2 - Lipid 3.0 - - + - - - 
YJR075W Hoc1 Golgi 
N-linked 
glyc. 3.0 - + - - - + 
YNL107W Yaf9 nucleus Chromatin 3.0 - N/D - - - - 
YJR117W Ste24 ER 
Protein 
maturation 3.0 + N/D + - - - 
YER140W ORF ambiguous Unknown 3.0 - + N/D - - + 
YBL051C Pin4 cytoplasm Cell cycle 2.9 - - - - - - 
YNL087W Tcb2 cell periphery ambiguous 2.8 - - - - - - 
YDR300C Pro1 cytoplasm 
Amino acid 
biosynth. 2.8 - - - - - - 
YLR111W dubious - Unknown 2.7 - - - - - - 
YDR485C Swc2 nucleus Chromatin 2.6 - + N/D - - - 
YAL011W Swc3 nucleus Chromatin 2.6 - + N/D - - + 
YOR085W Ost3 ambiguous 
N-linked 
glyc. 2.6 + N/D + - + - 
YDL095W Pmt1 ER 
O-linked 
glyc./ GPI 2.6 - - + - - - 
YDR372C Vps74 nucleus 
intra-Golgi 
traffic 2.5 - - - - - - 
YJR118C Ilm1 ER ambiguous 2.5 + N/D + - - - 
YML115C Van1 Golgi 
N-linked 
glyc. 2.5 - + N/D - - - 
YDR108W Gsg1 cytoplasm 
ER-Golgi 
traffic 2.4 - + N/D - - - 
YBR041W Fat1 lipid particle Lipid 2.4 - - - + - - 
YDR245W Mnn10 Golgi 
N-linked 
glyc. 2.4 - - - - - - 
YFR013W Ioc3 nucleus Chromatin 2.3 - - - - - - 
YMR274C Rce1 - 
Protein 
maturation 2.3 - + N/D - - - 
YDR334W Swr1 nucleus Chromatin 2.3 - + N/D - - - 
YDR227W Sir4 
nuclear 
periphery Chromatin 2.3 N/D N/D + - - + 
YJL062W Las21 ER 
O-linked 
glyc./ GPI 2.2 + N/D + + - - 
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traffic 2.2 - + N/D - - - 
YBL038W Mrpl16 mitochondrion mitochondria 2.2 + N/D + - + - 
YDR469W Sdc1 nucleus Chromatin 2.2 - + N/D - - - 
YJL123C ORF Golgi Unknown 2.2 - + N/D - - - 
YOR355W Gds1 nucleus ambiguous 2.1 - - - - - - 
YMR036C Mih1 nucleus Cell cycle 2.1 - + N/D - - - 
YHR004C Nem1 
punctate 
composite ambiguous 2.1 - + N/D + - - 
YDL099W Bug1 Golgi 
ER-Golgi 
traffic 2.0 - - + - - - 
 
1. Localization as determined by high throughput GFP localization studies (HUH et al. 2003) 
2. Functional category was assigned from SGD annotations. 
3. Kar2p secretion index determined by quantitative immunoblotting; represented as a fold change over wild-type 
(2-fold cutoff designated as significant for further analysis). Studies done by Justine Barry. 
4. Synthetic genetic interactions between individual mutations and hac1 null allele (+ indicates a synthetic lethal 
or synthetic sick phenotype of the double mutants; N/D = not determined). Studies done by Alenka Čopič. 
5. Kar2p secretion was measured in the double mutant strains by quantitative immunoblotting and a 2-fold 
secretion index over a hac1 null strain was designated as significant secretion (+). Studies done by Alenka 
Čopič. 
6. Activation of the unfolded protein response was measured in strains that show synthetic interactions with hac1 
or that secrete Kar2p dependent on HAC1. 
7.  Gas1p maturation was measured by pulse-chase and a delay in processing indicated by a + sign. 
8.  CPY maturation was monitored by pulse-chase and defects in maturation indicated by a + sign. 
9. Golgi modification of CPY* was measured by pulse-chase and mutants with enhanced α-1, 6-mannose 




Table 2: UPR activation in strains with protein processing defects  
ORF Gene UPR (1) Gas1 (2) CPY (3) 
YGL200C Emp24 + ++ - 
YFL025C Bst1 + ++ - 
YML012W Erv25 + ++ - 
YKL073W Lhs1 + + - 
YGL084C Gup1 + ++ - 
YCR044C Per1 + ++ - 
YAR002C-A Erp1 + + - 
YLR242C Arv1 + ++ - 
YIL039W Ted1 + ++ - 
YJL077C Ics3 - - + 
YER083C Get2 + + - 
YBL082C Alg3 + + + 
YLR087C Csf1 + ++ - 
YBR106W Pho88 + + + 
YLR268W Sec22 + + - 
YOL111C Mdy2 - - + 
YBL083C dubious - - + 
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ORF Gene UPR (1) Gas1 (2) CPY (3) 
YML013W Ubx2 + - - 
YAL007C Erp2 - + - 
YOR085W Ost3 + - + 
YDL095W Pmt1 + - - 
YBR041W Fat1 + + - 
YJL062W Las21 + + - 
YBL038W Mrpl16 + - + 
YHR004C Nem1 - + - 
 
1. Strains that showed constituve active UPR in our study or in  JONIKAS et al. 2009 are denote by a + sing. 
2. Gas1p maturation was measured by pulse-chase and a delay in processing indicated by a + sign. 
3.  CPY maturation was monitored by pulse-chase and defects in maturation indicated by a + sign. 
 
 
Table 3: Sequences of primers used to check insertion of KanMX cassette in deletion mutants 
Gene Forward primer  Forward primer sequence (1) 
Reverse 
primer  Reverse primer sequence (2) 
Ics3 oLM2064 CATCGTGCTAGCTACTCTTCACTAG oLM2065 CCCGAGCTTA ACACAACACA ACGG 
Yhr078w oLM2066 GAAAAGATCTCAACTCTGGCGGTG oLM2067 ACCTATACTA CTTTTCTCAT CCCTAC 
Ymr031w-a oLM2070 GATTTAGAGCCGTGTTTCAGCGAC oLM2071 GTTTACAACTTGCCCAAAGAGGAAATC 
Ylr374c oLM2074 GAGTTCGACCGGGACACATC ATTG oLM2075 GTCCATCGCT CTCATATGTG CTCTC 
Mga2 oLM2076 GTCGTTCTTG GGGTCGTTAA GAC oLM2077 CATTATCGTT ACGCTGACAT TTACAAG 
Pro1 oLM2078 GTCTA GTTGCTTCAA AGATAGGC oLM2079 GAAAC AGCTGCTCTG CACAATTCTT C 
Pmt1 oLM2080 CAAACAGGTGCATTGTTAAAGCGG oLM2081 CGCTCGAGAGCTTA TAGAAGACTT TAC 
Bug1 oLM2084 GAGAAT CCCCAGCACTATTAATTAG oLM2085 GTC GGGACTCAGA TCAGATCATT AG 
Gup1 oLM0699 CTTTATGTTTAGTGGGTGTG oLM0926 AGCTTTTCACGCTTCCTCTC 
Ilm1 oLM0912 TTTTGAATTCGATATGTCACCAGAC oLM0995 CCAGAACTCATGAATATCAAGC 
Per1 oLM0698 TCTCTTGCGTATTCTTGTAC oLM0914 TAAACAGAATGTGATAACGG 
KanMX n/a n/a oLM0573 TTAGAAAAACTCATCGAGCATC 
 
1. Forward primers bind between -1000bp and -100 bp upstream start codon of gene. 
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IV. FINAL CONCLUSIONS 
 
In order to gain new insights into the mechanisms that encompass the ER quality control 
system in budding yeast, I undertook two distinct but interrelated studies. In the first study, I 
wanted to assess more closely the role of the Unfolded Protein Response (UPR) in folding and 
traffic of misfolded proteins. The UPR is one of the major mechanisms that cell utilizes to 
maintain ER homeostasis in events of stress that can lead to accumulation of aberrant proteins.  
Upregulation of a variety of targets upon UPR activation suggest that multiple mechanisms assist 
the cell to cope with stress events, perhaps by decreasing the amount misfolded proteins in the 
ER.  
Since a group of chaperones and folding factors are upregulated during this response, I first 
wanted to ask if refolding of an aberrant protein is a plausible mechanism to reduce the 
concentration of misfolded protein in the ER lumen. In order to answer this question, I looked at 
the folding state of two unfolded protein models, Yor1ΔF-HA and Gas1*-HA upon activation of 
the UPR. My results indicate that Yor1ΔF-HA and Gas1*-HA are degraded rather than refolded 
upon UPR activation. However, the rate of degradation seems to differ between these 2 proteins 
upon activation of the UPR by DTT addition since Gas1*-HA seems to degrade at a slower rate 
than untreated cells while Yor1ΔF-HA degrades faster than in an untreated control. These results 
suggest that, even though components of ERAD are upregulated upon UPR activation, different 
branches can be selectively saturated. However, this idea of selective saturation needs to be 
further explored by testing degradation of different ERAD substrates upon insults with different 
stresses known to activate the UPR. Taken together, these results suggest that degradation is one 
of the major mechanisms upregulated by the UPR that the cell uses to reduce the amount of 
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misfolded proteins and also suggest that the major function of chaperones during stress is to aid 
in folding of newly synthesized machinery and degradation rather than refolding misfolded 
proteins.  
Components of the ER-to-Golgi machinery are also upregulated upon UPR activation 
suggesting that increasing the packaging of proteins into ER-derived vesicles can also be a way 
to reduce the folding load in the ER. In order to answer this question, I looked at direct 
packaging of proteins into ER-derived vesicles using an in vitro budding assay. Results indicate 
that packaging of cargo clients Yor1-HA, Vph1p and Sec22p as well as misfolded Yor1ΔF-HA 
is increased when the UPR is activated by DTT but not when a constitutive active version of 
Ire1p is used, suggesting that perhaps the presence of stress is necessary to see this effect. These 
results imply that, while the traffic of some proteins to the Golgi is blocked upon ER stress, 
packaging of certain proteins into ER-derived vesicles seems to be increased in order to counter 
balance the load in the ER. To complement these studies, it will be interesting to look at 
formation of ER exit sites upon activation of the UPR in order to determine if general ER-to-
Golgi traffic is increased in yeast. Our lab is in the process of constructing fluorescent fusion 
proteins to mark ER-exit sites that would eventually let us do this type of experiment.  
Finally, I assessed the role of the UPR in protein processing upon removal of the stress. For 
this, I tracked the fate of the model proteins Gas1p and CPY during and after DTT treatment in 
cells lacking HAC1 by pulse-chase analysis. Results indicate that during stress, activation of the 
UPR is necessary for the degradation of Gas1p that has become misfolded and to maintain traffic 
of CPY to the vacuole. After the stress is removed the UPR is necessary for the proper 
processing of newly synthesized Gas1p and CPY as well as for refolding and/or degradation of 
the Gas1p that became misfolded during DTT treatment. However, these events do not appear to 
 
 
  124 
be dependent on the ER expansion component of the UPR but rather likely dependent in other 
players like chaperones, ERAD and ER-to-Golgi traffic machinery.  
One particular question that interests me is if there are differences in the way the cell utilizes 
activation of the UPR to cope with accumulation of misfolded proteins depending on the kind of 
stress that is imposed. DTT and TM have been used extensively to activate the UPR, however 
their mode of action is completely different: DTT breaks disulfide bonds while TM prevents 
glycosylation. My results suggest that in presence of DTT, Gas1p that has become misfolded is 
degraded, however upon addition of TM, Gas1p is underglycosyated and stably accumulates in 
the ER. This suggests that the fate of Gas1p in stress conditions depends on the nature of the 
stress imposed. It has been suggested that glycosylation is necessary for degradation by ERAD 
of certain glycoproteins (KOSTOVA and WOLF 2005); therefore, in the presence of TM, ERAD is 
an unlikely mechanism to dispose of these terminally misfolded glycoproteins. Perhaps this is 
one of the reasons why other degradation mechanisms are also upregulated by action of the UPR. 
I suggest that while activation of the UPR is a global response to ER stress, how the cell utilizes 
the different machineries induced by the UPR to cope with stress might depend on the type of 
stress and how different proteins are affected by it. 
Another aspect of the UPR that calls my attention is how the duration of UPR activation 
affects how the cell handles misfolded proteins. My experiments were done upon DTT treatment 
for 1 hr. However, increasing evidence suggests that upon prolonged treatment with ER stressors 
other pathways become activated, including the HOG pathway (BICKNELL et al. 2010; TORRES-
QUIROZ et al. 2010).  Furthermore,  prolonged activation of the UPR seems to induce oxidative 
stress that can lead to cell death (KIM et al. 2006). Perhaps these other events that occur upon 
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prolonged ER stress can change how misfolded proteins are handled by the cell in order to 
reduce their abundance in the ER.  
The UPR has proven to be a complex reaction of the cell towards stress.  This pathway has 
been implicated in numerous diseases ranging from neurodegenerative diseases like Parkinson 
and Alzheimer to metabolic conditions like diabetes (OTSU and SITIA 2007). Therefore, we can 
gain insights in the pathologies of these diseases by understanding how the different components 
upregulated by the UPR work in concert to remodel the secretory pathway during ER stress. 
In the second part of this dissertation, I described a genetic screen done to identify novel 
components involved in ER quality control. For this, strains of the MATα yeast deletion 
collection were tested for extracellular secretion of the ER resident protein Kar2p. This screen 
yielded 73 genes which deletion causes the Kar2p secretion phenotype. These gene products 
participate in a variety of functions including protein folding and modification, ER-to-Golgi 
traffic as well as genes with ambiguous and unknown function. This screen was repeated in 
MATa collection to validate the list of candidate genes. Datasets generated from both collections 
presented a high degree of overlap with only 9 strains that did not show Kar2p secretion in the 
opposite mating type. PCR analysis to confirm correct gene disruption indicated that most of 
these 9 strains have correctly disrupted genes suggesting that lack of the Kar2p phenotype can be 
due to accumulation of suppressor mutations somewhere in the genome.  
My work concentrated on determining what kind of defect caused by deletion of a particular 
gene lead to the Kar2p secretion phenotype. First, we reasoned that constitutive activation of 
UPR due to deletion of a gene can lead to Kar2p secretion. Therefore, dependence of the Kar2p 
secretion phenotype on the presence of on the HAC1 gene was tested. As expected, a large 
number of the strains secreted Kar2p in a HAC1 dependent-manner and moreover, some mutants 
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were synthetic lethal with hac1Δ suggesting a strong role for these genes in protein processing. 
Surprisingly, some of these strain still secreted Kar2p when combined with a deletion of HAC1. 
We proposed a role for these genes in mechanisms of ER retrieval and/or retention. Other studies 
done by other members of our laboratory indicated that some of these strains, like mdy2Δ and 
yor164cΔ, also present mislocalization of the HDEL receptor Erd2p, further supporting this idea.  
We reasoned that if a gene involved in protein folding and processing is deleted, this can lead 
to accumulation of misfolded proteins or folding intermediates that can lead to UPR activation 
and then to Kar2p secretion.  Therefore, I also tested all 73 Kar2p secretors strains for defects in 
processing of Gas1p and glycosylation of CPY. This analysis yielded 7 novel genes involved in 
Gas1p processing and 5 novel genes involved in CPY glycosylation. Among them, genes with 
poorly known functions like CSF1 and PHO88 are also synthetic lethal with hac1Δ, therefore 
placing them as prime candidates for roles in GPI-anchored protein maturation and glycosylation 
respectively.  However, more research needs to be done to identify its specific role in these 
processes.  
We also reasoned that if a gene involved in quality control system is deleted, then it is 
plausible that misfolded proteins bound to Kar2p can escape the ER leading to the Kar2p 
secretion phenotype. My results indicate that 15 mutant strains showed Golgi-modified 
misfolded CPY* beyond WT levels, indicative of a breach in the quality control system. From 
these genes, two candidates that seem to be involved in ER quality control are of particular 
interest: Slp1p and Yer140wp. Both are conserved proteins of unknown function and cellular 
location that present a physical interaction according to studies using affinity capture coupled 
with mass spectrometry (COLLINS et al. 2007). Yer140p has 5 predicted transmembrane domains 
while Slp1p has 2 predicted transmembrane domains and galactose-binding like domain. Slp1 is 
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a SUN-like protein due to the presence of a predicted Sad1-UNC-84 homology domain. SUN 
(Sad1-UNC-84 homology) domain–containing proteins are family of nuclear envelope proteins 
that are suggested to play a role in connecting centrosomes with the nuclear envelope 
(JASPERSEN et al. 2006). Both Slp1 and Yer140 present genetic interactions with proteins 
associated with the nuclear pore complex Nup188p, Nup133p and Apq12p suggesting a plausible 
role in the nuclear membrane (COSTANZO et al. 2010).  
However, most of the genetic interactions presented by this both genes are with genes 
involved in protein folding and processing in the ER. One group of genes over-represented 
corresponds to proteins that compose the oligosaccharyltransferase (OST) complex.  The OST 
complex is composed of eight different membrane-spanning proteins in 3 subcomplexes that 
mediate the transfer of a preassembled high-mannose oligosaccharide onto asparagine residues of 
nascent polypeptides entering the lumen of the ER (KELLEHER and GILMORE 2006). Slp1 
interacts with 3 members (Stt3, Wbp1 and Swp1) while Yer140w interacts with 5 members (Stt3, 
Wbp1, Swp1, Ost1 and Ost3; COSTANZO et al. 2010). Both also present interaction with 
chaperones and folding factors, more over, Slp1 also physically interacts with Crp6, a cytosolic 
peptidyl-prolyl cis-trans isomerase (HO et al. 2002). A genome-wide study done to identify 
proteins involved in protein folding also identified slp1Δ and yer140wΔ strains to have a 
constitutively active UPR  furthering implicating these two proteins in a ER-related process 
(JONIKAS et al. 2009).  Taken together, it seems that these two proteins have role in protein 
processing and quality control in the ER, perhaps by monitoring the state of glycosylation and/or 
folding of glycoproteins. I initiated basic biochemical characterization of these two proteins. 
Preliminary solubilization experiments using non-ionic detergents confirm the predicted 
topology for both, Slp1 and Yer140w.  I also tried to determine the cellular localization of these 
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proteins by microscopy; however, fluorescent tagging of the endogenous proteins has been 
unsuccessful.    
This screen represents a strong starting point to further expand our knowledge of the different 
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